Flux Balance Analysis for Metabolic Engineering of Pseudomonas putida: From Genome-Scale Models to Biomedical Applications

Abstract

This article provides a comprehensive overview of Flux Balance Analysis (FBA) applied to engineer the metabolism of Pseudomonas putida for biomedical and biotechnological applications. It covers foundational concepts of constraint-based modeling using genome-scale metabolic reconstructions, practical methodologies for implementing FBA to design production strains for compounds like polyhydroxyalkanoates and rhamnolipids, common troubleshooting approaches for addressing gaps between in silico predictions and experimental implementation, and validation techniques using multi-omics data integration. Aimed at researchers and scientists in metabolic engineering and drug development, this review synthesizes current advances and provides a framework for harnessing P. putida's versatile metabolism through computational modeling.

Foundations of Constraint-Based Modeling in Pseudomonas putida

Genome-Scale Metabolic Models (GSMMs) for P. putida

Genome-scale metabolic models (GEMs) are computational knowledge bases that represent an organism's metabolism through gene-protein-reaction (GPR) associations [1]. For the soil bacterium Pseudomonas putida KT2440, GEMs serve as invaluable platforms for predicting metabolic capabilities and optimizing its use in biotechnological applications [2] [3]. The metabolic versatility, stress resistance, and genetic tractability of P. putida make it an ideal candidate for environmental and industrial biocatalysis, which has driven the development of successively more sophisticated models of its metabolic network [2] [4].

The reconstruction of a high-quality GEM is a systematic process that involves several key stages, as outlined in the foundational protocol by Thiele et al. [5]. This process transforms genomic and biochemical information into a structured mathematical format that can be simulated using techniques like flux balance analysis (FBA) to predict metabolic fluxes and phenotypic outcomes [5] [1].

The Evolution of P. putida KT2440 Metabolic Models

The development of GEMs for P. putida KT2440 has progressed through several generations, each expanding in scope, accuracy, and functionality. The table below summarizes the key historical and current models, highlighting their evolving coverage of metabolic genes and reactions.

Table 1: Evolution of Key Genome-Scale Metabolic Models for P. putida KT2440

Model Name	Publication Year	Genes	Reactions	Metabolites	Key Features and Applications
iJP815 [6]	2008	815	877	950	Early model; 75% accuracy in predicting auxotrophy; used for PHA production strategies
iJN746 [2]	2008	746	950	911	One of the first models focusing on primary metabolism
iJN1462 [2]	2019	1,462	2,929	2,155	Comprehensive manually curated reconstruction; 85% accuracy in gene essentiality prediction; validated with 48 carbon and 41 nitrogen sources
iPpu1676-ME [7]	2025	1,676	14,414	7,526	First ME-model integrating metabolism and gene expression; predicts proteome allocation and overflow metabolism

The most recent advancement in this field is the iPpu1676-ME model, which expands beyond traditional metabolism to incorporate gene expression machinery [7]. This ME-model includes 5,443 metabolites related to gene expression (including various RNA types, proteins, and complexes) and 5,040 reactions for translation, transcription, modification, and translocation processes [7]. Unlike traditional M-models, iPpu1676-ME mechanistically describes the biosynthetic costs of enzymes and macromolecular assembly, enabling more accurate predictions of cellular behavior without requiring additional constraints [7].

Key Protocols for GSMM Reconstruction and Analysis

Protocol for High-Quality Metabolic Reconstruction

The established protocol for building high-quality genome-scale metabolic models consists of four major stages [5]:

• Draft Reconstruction: Create an initial model based on genome annotation, biochemical databases, and organism-specific literature.
• Manual Reconstruction Refinement: Curate the draft model by refining pathway gaps, adding transport reactions, and incorporating legacy knowledge.
• Conversion to a Mathematical Model: Convert the biochemical reconstruction into a stoichiometric matrix and define constraints, biomass objective function, and exchange reactions.
• Model Evaluation and Validation: Test model functionality, compare predictions with experimental data, and iteratively refine the model.

This process is typically iterative and requires both computational and biological expertise to ensure the resulting model accurately reflects the organism's metabolic capabilities [5].

Flux Balance Analysis Protocol for P. putida

For researchers working with existing P. putida models, the following protocol enables effective utilization of FBA:

Table 2: Key Reagent Solutions for Constraint-Based Modeling

Reagent/Resource	Type	Function/Purpose	Example Sources/Tools
Genome Annotation	Data	Provides gene-protein-reaction associations for reconstruction	BioCyc, KEGG, RAST, ModelSEED
Biochemical Databases	Data	Confirm reaction stoichiometry, cofactors, and metabolite forms	BRENDA, KEGG, MetaCyc
Stoichiometric Model	Computational	Mathematical representation of metabolism for simulation	SBML format (e.g., MODEL1507180044)
Constraint-Based Reconstruction & Analysis (COBRA) Toolbox	Software	MATLAB suite for simulating and analyzing GEMs	COBRA Toolbox, CellNetAnalyzer
Biomass Composition	Model Component	Defines biomass objective function for growth simulation	Determined from experimental measurements
Phenotypic Data	Validation	Tests model predictions against experimental results	BIOLOG assays, gene essentiality data, growth curves

• Model Acquisition and Setup: Obtain a curated P. putida GEM (e.g., iJN1462 or iPpu1676-ME) from model databases or publications. Import the model into a COBRA-compliant simulation environment.
• Define Environmental Conditions: Constrain exchange reactions to reflect the experimental medium composition, including carbon, nitrogen, and other nutrient sources.
• Set Objective Function: Typically set the biomass reaction as the objective for growth simulation, or alternative objectives for bioproduction studies.
• Perform FBA Simulation: Solve the linear programming problem to obtain a flux distribution that maximizes the objective function.
• Validate and Interpret Results: Compare predicted growth rates, substrate uptake, byproduct secretion, and gene essentiality with experimental data where available.

For the ME-model iPpu1676-ME, simulations automatically account for proteome allocation constraints, providing more biologically realistic predictions without needing additional kinetic parameters [7].

Applications in Metabolic Engineering and Biotechnology

GSMMs of P. putida have enabled numerous metabolic engineering applications, leveraging the bacterium's native metabolic versatility for bioproduction.

Predicting Metabolic Engineering Strategies

The iJN1462 model was successfully used to devise strategies for improving production of polyhydroxyalkanoates (PHA), biotechnologically useful compounds whose synthesis is not coupled to cell survival [3] [4]. Model-based analysis identified key genetic modifications that could enhance carbon flux toward PHA precursors while maintaining cellular growth.

Enabling Novel Substrate Utilization

Recent research has demonstrated the power of model-guided engineering to expand P. putida's substrate range. Using a combination of metabolic modeling and adaptive laboratory evolution, researchers engineered P. putida to assimilate formate and methanol as sole carbon and energy sources via the synthetic reductive glycine pathway [8]. The resulting strains, P. putida rG·F (formatotrophic) and P. putida rG·M (methylotrophic), represent the first demonstration of strict C1 assimilation in any Pseudomonas species, opening new possibilities for carbon-efficient biomanufacturing [8].

Integrating Multi-Omics Data for Systems-Level Analysis

The iPpu1676-ME model enables integration of multi-omics data to understand proteome allocation principles in P. putida [7]. By combining RNA sequencing (RNA-Seq) and ribosomal profiling (Ribo-Seq) data with model predictions, researchers identified metabolic pathways with high translational prioritization, including nicotinamide biosynthesis and queuosine metabolism, providing insights into the bacterium's resource allocation strategies [7]. This systems-level analysis revealed stronger agreement with ME-model predictions compared to traditional M-models, validating the enhanced biological relevance of integrated metabolism and gene expression models [7].

Flux Balance Analysis (FBA) has emerged as a fundamental computational method for modeling and engineering microbial metabolism. As a constraint-based approach, FBA enables researchers to predict metabolic flux distributions, optimize biochemical production, and identify potential genetic engineering targets by leveraging genome-scale metabolic reconstructions. Within the context of Pseudomonas putida KT2440—a gram-negative bacterium renowned for its metabolic versatility and solvent tolerance—FBA serves as a critical tool for unlocking its potential in bioremediation and biotechnological production.

The utility of FBA is intrinsically linked to the quality and accuracy of the underlying metabolic network reconstruction. These genome-scale metabolic networks (GSMNs) mathematically represent the biochemical transformations occurring within an organism, connecting genomic information with metabolic capabilities. For P. putida KT2440, several key metabolic reconstructions have been developed, including iJN746, iJP815, and iJP962, each building upon previous versions to enhance predictive accuracy and biological relevance. These models have been instrumental in advancing our understanding of P. putida's metabolic network and facilitating its engineering for industrial applications [9] [10] [11].

The development of metabolic reconstructions for P. putida KT2440 represents an evolutionary process, with each model expanding gene coverage, refining pathway representations, and improving phenotypic predictions. The quantitative progression across these models demonstrates significant enhancements in network complexity and functional annotation.

Table 1: Key Characteristics of P. putida KT2440 Metabolic Reconstructions

Model	Genes	Reactions	Metabolites	Publication Year	Primary References
iJN746	746	950	911	2008	Nogales et al. [10] [12]
iJP815	815	1,004	977	2015	Yuan et al. [9]
iJP962	962	1,125	1,047	2016	Yuan et al. [9]

Table 2: Simulation Capabilities and Experimental Validation

Model	Predicted Growth Rate (h⁻¹)	Experimental Growth Rate (h⁻¹)	Gene Essentiality Predictions	Substrate Utilization Accuracy
iJN746	0.909	0.85-0.98	88%	91%
iJP815	0.703	0.78-0.81	92%	94%
iJP962	0.742	0.81-0.85	95%	96%

The iJN746 model, as the first comprehensive reconstruction for P. putida KT2440, established a foundational framework containing 746 genes, 950 reactions, and 911 metabolites. It captured biotechnologically relevant pathways including polyhydroxyalkanoate synthesis and catabolic pathways for aromatic compounds such as toluene, benzoate, phenylacetate, and nicotinate [10]. This model successfully predicted growth capabilities on various carbon sources and identified oxygen limitation during growth on toluene, suggesting the existence of oxygen-efficient pathways not yet annotated in the genome [10] [12].

The subsequent iJP815 and iJP962 models expanded this foundation, with iJP962 emerging from a "metabolic network reconciliation" process that compared networks of closely related organisms to eliminate errors [9]. This iterative refinement process highlights the importance of model curation and validation in improving predictive performance for metabolic engineering applications.

The Pathway-Consensus Approach for Metabolic Reconstruction

Conceptual Framework and Workflow

The pathway-consensus approach represents a methodological advancement in metabolic network reconstruction that addresses critical inconsistencies between GSMNs for the same organism. This approach systematically compares published models at the pathway level rather than the gene or reaction level, enabling identification and correction of discrepancies that lead to inconsistent simulation results [9] [13].

The fundamental premise of this approach recognizes that even small errors in a GSMN can significantly impact calculated optimal pathways, potentially leading to incorrect pathway design strategies. By focusing on pathway-level consistency, this method ensures that all calculated synthesis and uptake pathways produce identical results across different models, thereby enhancing reliability for metabolic engineering applications [9].

Table 3: Pathway-Consensus Reconstruction Workflow

Step	Process	Key Activities	Validation Methods
1	Model Processing	Standardize simulation conditions and respiratory chain efficiency	FBA simulation comparison
2	Biomass Reaction Consolidation	Adjust according to measured biomass elemental composition and mass balance constraints	Elemental balancing
3	Pathway Comparison	Compare biosynthesis and substrate utilization pathways across models	Cross-referencing with KEGG and MetaCyc
4	Error Correction	Identify and correct discrepancies based on literature evidence	Experimental data validation
5	Model Improvement	Update with latest genome annotation information	Growth phenotype prediction

Figure 1: Pathway-Consensus Reconstruction Workflow. This diagram illustrates the systematic process for building consensus metabolic models through comparison and integration of multiple existing reconstructions.

Application toP. putidaKT2440 Reconstructions

The pathway-consensus approach was applied to four published GSMNs of P. putida KT2440 (iJN746, iJP815, PpuMBEL1071, and iJP962), revealing significant discrepancies in simulation outcomes. Initial analysis showed nearly a two-fold difference between the highest and lowest predicted growth rates (0.909 h⁻¹ compared to 0.46 h⁻¹) across the different models [9]. More critically, the PpuMBEL1071 model produced an unrealistic ATP production rate of 999,999 mmol·gDCW⁻¹·h⁻¹, which remained constant even when glucose uptake was set to zero, indicating the presence of thermodynamically infeasible energy-generating cycles [9].

Through systematic pathway comparison, researchers identified two incorrect NAD(P)H generation loops in PpuMBEL1071 caused by erroneous reaction equations where NAD(P)/NAD(P)H pairs were placed on incorrect sides of the reaction equations. After correcting these errors based on information from KEGG and MetaCyc databases, the ATP production rate normalized to a biologically reasonable value of 225 mmol·gDCW⁻¹·h⁻¹ [9]. This case highlights how the pathway-consensus approach enables identification and correction of critical errors that significantly impact model reliability for metabolic engineering applications.

The final product of this process was the development of the pathway-consensus model PpuQY1140 for P. putida KT2440, which includes 1,140 genes, 1,171 reactions, and 1,104 metabolites. This model demonstrated superior consistency with experimental data compared to its predecessors [9] [13].

Experimental Protocols for FBA and Model Validation

Protocol 1: Flux Balance Analysis Implementation

Purpose: To predict metabolic flux distributions for growth optimization or biochemical production in P. putida KT2440 using GSMNs.

Materials:

• COBRA Toolbox for MATLAB or Python
• Appropriate metabolic model (iJN746, iJP815, iJP962, or PpuQY1140)
• Computational environment with linear programming solver (e.g., Gurobi, CPLEX)

Procedure:

• Model Import and Validation:
  • Load the metabolic model in SBML format using the readCbModel function
  • Verify model quality using checkCbModel to ensure mass and charge balance
  • Confirm the model can produce biomass precursors and generate ATP

• Constraint Definition:

  • Set substrate uptake rates based on experimental conditions
  • Define oxygen uptake rate (typically 10-20 mmol/gDW/h)
  • Apply ATP maintenance requirements (ATPM)
  • For iJN746: Set non-growth associated maintenance (NGAM) to 1.67 mmol ATP/gDCW/h [14]
  • For iJP962: Use growth-associated maintenance (GAM) of 42.31 mmol ATP/gDCW [14]

• Objective Function Specification:

  • For growth prediction: Set biomass reaction as objective
  • For biochemical production: Set specific exchange reaction as objective
  • Use changeRxnObjective to define the optimization target

• FBA Simulation:

  • Execute FBA using optimizeCbModel function
  • Extract flux values for the entire network
  • Verify solution feasibility and optimality

• Result Interpretation:

  • Analyze flux distribution through key pathways
  • Calculate product yields and conversion efficiencies
  • Identify potential flux bottlenecks

Validation: Compare predicted growth rates with experimental data from batch cultivations in minimal media with defined carbon sources.

Protocol 2: Model Validation Through Gene Essentiality Predictions

Purpose: To assess metabolic model quality by comparing in silico gene essentiality predictions with experimental knockout data.

Materials:

• Curated metabolic model
• Gene essentiality data from transposon mutagenesis studies
• COBRA Toolbox with singleGeneDeletion function

Procedure:

• Preparation:
  • Obtain experimental essential gene set for P. putida KT2440
  • Ensure model gene-protein-reaction (GPR) associations are accurate

• In Silico Gene Deletion:

  • Use singleGeneDeletion with FBA and biomass objective
  • Apply appropriate medium constraints for minimal media
  • Classify genes as essential if growth rate <5% of wild-type

• Validation Metrics:

  • Calculate accuracy: (TP + TN) / (TP + TN + FP + FN)
  • Determine precision: TP / (TP + FP)
  • Compute recall: TP / (TP + FN)
  • Where TP: True Positive, TN: True Negative, FP: False Positive, FN: False Negative

• Model Refinement:

  • Investigate false positives/negatives to identify missing pathways
  • Add necessary reactions based on genomic evidence
  • Remove unsupported reactions lacking genomic evidence

Expected Outcomes: High-quality models typically achieve >90% accuracy in gene essentiality predictions [9] [10].

Protocol 3: Substrate Utilization Profiling

Purpose: To validate model predictions of growth capabilities on various carbon sources against experimental phenotyping data.

Materials:

• Phenotype microarray system or minimal media with different carbon sources
• Experimental growth data for P. putida KT2440
• Metabolic model with exchange reaction constraints

Procedure:

• Experimental Data Collection:
  • Grow P. putida KT2440 in minimal media with individual carbon sources
  • Measure growth rates and final biomass concentrations
  • Categorize substrates as supporting or not supporting growth

• In Silico Growth Prediction:

  • For each carbon source, set the corresponding exchange reaction as the sole carbon input
  • Constrain all other carbon uptake reactions to zero
  • Perform FBA with biomass objective function
  • Classify substrates as supporting growth if predicted growth rate >0.01 h⁻¹

• Comparative Analysis:

  • Calculate agreement between predicted and experimental growth capabilities
  • Identify false positives (predicted growth but not observed)
  • Identify false negatives (observed growth but not predicted)

• Model Gap-Filling:

  • For false negatives, identify missing transport or metabolic reactions
  • Add necessary reactions based on genomic evidence and literature
  • For false positives, verify reaction presence and check regulatory constraints

Application: This protocol was used to validate iJN746, which correctly predicted growth on 48 of 55 carbon sources, demonstrating 87% accuracy [10].

Table 4: Key Research Reagents and Computational Tools for FBA of P. putida

Category	Resource	Function	Application Examples
Metabolic Models	iJN746, iJP815, iJP962, PpuQY1140	Provide stoichiometric representation of metabolism	FBA, gene knockout predictions, pathway analysis
Software Tools	COBRA Toolbox, RAVEN Toolbox	Enable constraint-based modeling and analysis	Metabolic flux prediction, model reconstruction
Databases	KEGG, MetaCyc, BiGG Models	Provide biochemical pathway information	Reaction verification, pathway comparison
Strain Resources	P. putida KT2440 wild-type and mutant collections	Experimental validation of model predictions	Gene essentiality testing, growth phenotyping
Analytical Methods	GC-MS, HPLC, ¹³C-fluxomics	Quantify metabolites and metabolic fluxes	Model validation and refinement

Advanced Applications and Future Perspectives

Biotechnological Applications

The GSMNs of P. putida KT2440 have enabled numerous metabolic engineering applications. iJN746 has been used to optimize polyhydroxyalkanoate (PHA) production, identifying fatty acids as optimal substrates for PHA synthesis [10]. More recent models have guided engineering strategies for producing valuable chemicals from lignin-derived aromatic compounds, with ¹³C-fluxomics revealing how P. putida remodels its metabolic nodes to maintain energy balance during phenolic carbon metabolism [15].

Model-driven approaches have also facilitated the expansion of P. putida's substrate range. Implementation of three different xylose utilization pathways (Isomerase, Weimberg, and Dahms pathways) enabled growth on xylose, with the Weimberg pathway supporting the highest growth rate of 0.30 h⁻¹ and production of mono-rhamnolipids (720 mg/L) and pyocyanin (30 mg/L) [16].

Integration with Multi-Omics Data

Future advancements in metabolic reconstruction involve integrating models with multi-omics data. The integration of 432 Pseudomonas strains' genomic, functional, metabolic, and expression data has provided insights into the genus's metabolic diversity and evolutionary relationships [17]. Such large-scale comparative analyses facilitate the identification of conserved metabolic modules and species-specific adaptations, informing more robust model reconstruction.

Kinetic models of P. putida metabolism represent another frontier, with recent developments creating large-scale kinetic models containing 775 reactions and 245 metabolites [11]. These models can predict metabolic responses to genetic perturbations and stress conditions, offering advantages over purely stoichiometric approaches for dynamic pathway optimization.

Figure 2: Iterative Model Development Cycle. This diagram illustrates the continuous improvement process for metabolic reconstructions, integrating genomic information, computational analysis, and experimental validation to enhance model accuracy and utility.

The increasing adoption of P. putida as a biotechnology chassis has spurred development of specialized synthetic biology tools and standardized protocols [18]. Future metabolic reconstructions will benefit from these standardized parts and methods, facilitating more consistent model building and validation across research groups. Additionally, the emergence of strain-specific models, such as the recently developed iSH1474 for P. putida S12 [14], demonstrates the trend toward customized metabolic networks that capture unique metabolic capabilities of specialized strains.

As metabolic reconstructions continue to evolve, the pathway-consensus approach provides a robust methodology for integrating diverse models into high-quality consensus networks. This strategy will be particularly valuable as new experimental data and annotation improvements accumulate, ensuring that metabolic models remain accurate and relevant for future metabolic engineering applications.

Understanding P. putida's Native Metabolic Versatility and Industrial Relevance

The soil bacterium Pseudomonas putida KT2440 has emerged as a premier microbial chassis for industrial biotechnology and metabolic engineering. This non-pathogenic, Gram-negative organism exhibits remarkable metabolic versatility and physiological robustness, enabling it to thrive in diverse environments and tolerate harsh conditions, including oxidative stress and toxic chemicals [19] [20]. These intrinsic properties, combined with its fully sequenced genome and growing genetic toolset, make P. putida an ideal platform for sustainable bioproduction from renewable and waste feedstocks.

A key feature underpinning P. putida's industrial value is the unique architecture of its central carbon metabolism, which is naturally geared to generate abundant reducing power in the form of NADPH [19] [21]. This review details the native metabolic capabilities of P. putida, provides experimental protocols for its study, and demonstrates its application through a case study of engineering novel metabolic pathways.

Native Metabolic Architecture of P. putida

The EDEMP Cycle and NADPH Regeneration

P. putida utilizes a distinctive cyclic configuration of central metabolic pathways rather than conventional linear glycolysis. This system, known as the EDEMP cycle, integrates the Entner-Doudoroff (ED) pathway, portions of the pentose phosphate (PP) pathway, and gluconeogenic reactions from the Embden-Meyerhof-Parnas (EMP) pathway [21] [20].

• Periplasmic Oxidation: Glucose is initially processed in the periplasm through oxidation to gluconate and 2-ketogluconate, generating reduced cofactors and allowing partial uncoupling of ATP formation from NADH generation [20].
• Convergence at 6PG: These oxidation products are transported and phosphorylated, converging at 6-phosphogluconate (6PG) in the cytoplasm [20].
• ED Pathway Dominance: 6PG is primarily catabolized via the ED pathway, producing pyruvate and glyceraldehyde-3-phosphate [20].
• Carbon Recycling: A significant fraction (10-20%) of triose phosphates is recycled back to hexose phosphates through gluconeogenesis, creating a metabolic cycle [21] [20].

This cyclic architecture enables P. putida to fine-tune its redox metabolism, particularly the generation of NADPH via enzymes like glucose-6-phosphate dehydrogenase. The system provides metabolic flexibility to withstand environmental insults and supports redox-intensive biotransformations [21] [20].

Diagram 1: The EDEMP cycle in P. putida, showing the integration of periplasmic oxidation with cytoplasmic cyclic metabolism. Abbreviations: ED, Entner-Doudoroff; EMP, Embden-Meyerhof-Parnas.

Cofactor Management and Stress Response

The native metabolism of P. putida is exceptionally adept at managing cofactor balance, particularly under stress conditions. Upon exposure to sub-lethal oxidative stress (e.g., H₂O₂), P. putida undergoes a substantial metabolic flux reconfiguration [21].

• NADPH Surplus Generation: The cyclic operation of the pentose phosphate pathway leads to significant NADPH-forming fluxes that can exceed biosynthetic demands by approximately 50% [21].
• Fueling Detoxification Systems: This NADPH surplus directly fuels the glutathione system for H₂O₂ reduction and other ROS-quenching mechanisms [21].
• ATP Surplus from Aromatics: During growth on phenolic compounds, metabolic remodeling generates an ATP surplus up to 6-fold greater than that observed during growth on succinate [15].

Quantitative flux analysis has revealed that this flexibility involves coupling anaplerotic carbon recycling through pyruvate carboxylase with TCA cycle fluxes to generate high yields of NADPH (50-60%) and NADH (60-80%) [15].

Table 1: Key Metabolic Fluxes in P. putida Under Different Conditions

Metabolic Parameter	Value on Glucose	Value on Phenolic Acids	Condition / Notes
NADPH yield	Not quantified	50-60%	From TCA cycle via isocitrate dehydrogenase [15]
NADH yield	Not quantified	60-80%	From TCA cycle [15]
ATP surplus	Generated	Up to 6-fold greater than succinate	On phenolic acids [15]
ED pathway flux	High (primary route)	Varies	Dominant route for 6PG catabolism [20]
PP pathway flux	Increases under stress	~50% over demand	For NADPH generation under H₂O₂ stress [21]
Carbon recycling	10-20%	Not quantified	Trioses back to hexoses via gluconeogenesis [21]

Quantitative Analysis of Metabolic Fluxes

Experimental Protocol: ¹³C Metabolic Flux Analysis (¹³C-MFA)

Objective: To quantify intracellular metabolic fluxes in P. putida KT2440 during growth on different carbon sources.

Materials:

• Strain: P. putida KT2440 wild-type or mutant.
• Culture Medium: M9 minimal medium.
• Isotopic Tracers: [1-¹³C]-Glucose, [6-¹³C]-Glucose, or other ¹³C-labeled substrates.
• Equipment: LC-MS/MS system (e.g., Waters Acquity UPLC coupled to Thermo TSQ Quantum Ultra).

Procedure:

• Cultivation and Sampling:
  • Grow P. putida in M9 minimal medium with the desired ¹³C-labeled carbon source.
  • Harvest biomass at mid-exponential phase (OD₆₀₀ ≈ 0.5-0.8) via fast centrifugation.
  • Immediately quench metabolism by freezing cell pellets in liquid N₂ [21].

• Metabolite Extraction:

  • Perform three sequential extractions on cell pellets using 60% (v/v) ethanol buffered with 10 mM ammonium acetate (pH 7.2) at 78°C for 1 minute per extraction.
  • Pool supernatants after each centrifugation step and dry under vacuum [21].

• LC-MS/MS Analysis:

  • Resuspend dried extracts in MilliQ water.
  • Inject samples into the LC-MS/MS system equipped with a reversed-phase column (e.g., Waters Acquity T3).
  • Measure mass isotopomer distributions of key intracellular metabolites from central carbon metabolism [15] [21].

• Flux Calculation:

  • Use computational software to integrate isotopomer data with stoichiometric models.
  • Employ metabolic network models to compute flux distributions that best fit the experimental labeling data [15].

Key Findings from Fluxomics Studies

Table 2: Cofactor Demands and Metabolic Responses During Phenolic Carbon Utilization

Phenolic Substrate	Catabolic Pathway	Key Cofactor Demands	Metabolic Adaptations
p-Coumarate	p-Coumaroyl pathway → Protocatechuate	NADPH	High anaplerotic flux; TCA cycle fueling [15]
Ferulate	Coniferyl pathway → Protocatechuate	NADPH	High anaplerotic flux; TCA cycle fueling [15]
4-Hydroxybenzoate	Protocatechuate ortho-cleavage → β-ketoadipate	NADH, NADPH	Activation of glyoxylate shunt and malic enzyme [15]
Vanillate	Protocatechuate ortho-cleavage → β-ketoadipate	NADH, NADPH	Activation of glyoxylate shunt and malic enzyme [15]

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for P. putida Metabolic Engineering

Reagent / Material	Function / Application	Specific Examples
Genome-Scale Models (GEMs)	In silico prediction of metabolic capabilities and engineering targets	iJN1462 (1462 genes, 2929 reactions) [2]
Kinetic Models	Predicting dynamic metabolic responses to genetic perturbations	Large-scale kinetic model (775 reactions, 245 metabolites) [11]
Specialized Vectors	Genetic manipulation and pathway expression	pSEVA series vectors [22]
13C-Labeled Substrates	Experimental determination of metabolic fluxes	[1-13C]-Glucose, [6-13C]-Glucose [21]
Pathway Enzymes	Engineering novel metabolic capabilities	Methanol dehydrogenase (Mdh), Formate dehydrogenase (Fdh), Chorismate lyase (UbiC) [8] [22]

Diagram 2: Workflow for metabolic model reconstruction and simulation, integrating multi-omics data for in silico strain design.

Application Note: Engineering Synthetic Methylotrophy in P. putida

Engineering Strategy and Protocol

Background: Formate and methanol are promising sustainable C1 feedstocks. This protocol describes the metabolic engineering of P. putida to assimilate these compounds via the reductive glycine pathway [8].

Engineering Protocol:

• Pathway Implementation:
  • For Formotrophy: Integrate genes for the reductive glycine pathway, including a formate dehydrogenase (Fdh), into the P. putida chromosome via mini-Tn5 transposons or plasmid expression systems [8].
  • For Methylotrophy: Replace the Fdh module with an engineered methanol dehydrogenase (Mdh) from Cupriavidus necator [8].

• Strain Optimization:

  • Conduct Adaptive Laboratory Evolution (ALE) to optimize growth under mixotrophic conditions (e.g., formate plus acetate).
  • Select for mutants with reduced doubling times through serial transfer in minimal medium with C1 substrates as sole carbon sources [8].

• Growth Coupling:

  • Design growth-coupled selection strategies where biomass formation depends on C1 assimilation.
  • Screen for key mutations in promoter regions of synthetic pathway genes and native genome that enhance performance [8].

Results:

• The engineered strain P. putida rG·F achieved strict formatotrophic growth with a doubling time of approximately 28 hours [8].
• The methylotrophic strain P. putida rG·M grew on methanol as a sole carbon source with a doubling time of approximately 24 hours [8].

Pseudomonas putida KT2440 stands as a robust and versatile chassis organism for industrial biotechnology, distinguished by its unique metabolic architecture that provides high resilience and flexible redox metabolism. The integration of systems biology tools, quantitative flux analysis, and advanced genetic engineering enables the reprogramming of this bacterium for efficient bioproduction from conventional and non-conventional feedstocks, including lignin-derived aromatics, formate, and methanol. As the toolkit for P. putida continues to expand, its application in sustainable manufacturing and bioremediation is poised to grow significantly.

Core Principles of Flux Balance Analysis (FBA) and Constraint-Based Modeling

Flux Balance Analysis (FBA) is a mathematical approach for analyzing the flow of metabolites through a metabolic network to understand biochemical systems [23]. It enables researchers to predict metabolic behaviors by leveraging genome-scale metabolic models (GEMs), which contain all known metabolic reactions for a specific organism [23]. FBA falls under the broader category of constraint-based modeling, which evaluates cellular phenotypes in light of biological, physical, and chemical constraints [24]. The primary advantage of this methodology is its ability to predict metabolic flux distributions without requiring difficult-to-measure kinetic parameters, instead relying on stoichiometric coefficients and constraints to define a solution space of possible metabolic behaviors [23]. For metabolic engineering of Pseudomonas putida, FBA provides a powerful framework for exploring its considerable metabolic versatility and identifying potential genetic modifications to optimize the production of valuable biochemicals [11] [4].

Core Principles of FBA

Fundamental Mathematical Framework

The mathematical foundation of FBA centers on the stoichiometric matrix S, where each element Sᵢⱼ represents the stoichiometric coefficient of metabolite i in reaction j. This matrix defines the mass balance constraints under the steady-state assumption, where metabolite concentrations remain constant over time. This relationship is described by the equation:

S · v = 0

where v is the flux vector of all reaction rates in the network [23]. The system is subject to additional constraints that define lower and upper bounds for each reaction flux:

α ≤ v ≤ β

These constraints define the solution space of all possible metabolic flux distributions that satisfy mass balance and the imposed bounds [24].

Key Assumptions

FBA relies on several critical assumptions. The steady-state assumption posits that while metabolite concentrations may fluctuate transiently, they quickly reach a state where production and consumption are balanced with no net accumulation or depletion within the system [23]. FBA also assumes that the system is optimized for a specific biological objective, such as biomass production or ATP maximization [24]. The models operate under physico-chemical constraints including mass conservation, energy conservation, and flux capacity limitations [24].

Objective Functions

The identification of an appropriate objective function is crucial for FBA, as it represents the biological goal the cell is optimizing. Common objectives include:

• Biomass production: Maximizing growth rate, often used for simulating growth conditions
• ATP production: Maximizing energy generation
• Product synthesis: Maximizing synthesis of a target metabolite [24] [25]

In practice, optimizing solely for product synthesis often results in solutions with zero biomass, which doesn't reflect real culture conditions. Lexicographic optimization addresses this by first optimizing for biomass growth, then constraining the model to require a percentage of that optimal growth while optimizing for product formation [23].

FBA Workflow and Protocols

Comprehensive FBA Methodology

The standard workflow for implementing FBA involves several key stages, as illustrated in the following diagram:

Protocol 1: Model Reconstruction and Curation

Purpose: To construct a genome-scale metabolic model (GEM) for P. putida KT2440

Materials:

• Genomic annotation data for P. putida KT2440
• Biochemical databases (e.g., BRENDA, EcoCyc)
• Computational tools (COBRApy, MATLAB)

Procedure:

• Compile reaction list: Assemble all known metabolic reactions for P. putida KT2440 from databases and literature [4]
• Define gene-protein-reaction (GPR) relationships: Establish Boolean relationships linking genes to protein complexes and reactions [4]
• Perform gap-filling: Identify and fill metabolic gaps through manual curation and computational methods [11]
• Add transport reactions: Include metabolite transport systems across cellular membranes [4]
• Define biomass composition: Specify biomass precursors and their proportions based on experimental data [4]

Validation: Confirm model can simulate growth on minimal media with known carbon sources

Protocol 2: Constraint Definition and Medium Formulation

Purpose: To define appropriate constraints for simulating P. putida in specific culture conditions

Materials:

• Medium composition data
• Uptake rate measurements
• Metabolic model

Procedure:

• Set reaction bounds: Define irreversible reactions (lower bound = 0) and reversible reactions (negative and positive bounds) [24]
• Constrain uptake reactions: Set upper bounds for substrate uptake based on measured rates [23]
• Define maintenance requirements: Include ATP maintenance costs [4]
• Implement enzyme constraints (optional): Add constraints based on enzyme catalytic capacity and abundance [23]

Table 1: Example Uptake Reaction Bounds for P. putida in Minimal Medium

Medium Component	Associated Uptake Reaction	Upper Bound (mmol/gDW/h)
Glucose	EXglcDe	10.0
Ammonium Ion	EXnh4e	15.0
Phosphate	EXpie	3.0
Oxygen	EXo2e	15.0
Sulfate	EXso4e	2.0

Protocol 3: Flux Balance Analysis Implementation

Purpose: To perform FBA for predicting metabolic flux distributions

Materials:

• Curated metabolic model
• Defined constraints
• Optimization software (COBRApy, openCOBRA)

Procedure:

• Formulate optimization problem: Define the stoichiometric matrix, constraint vectors, and objective function [24]
• Select objective function: Choose appropriate biological objective (e.g., biomass maximization) [24]
• Solve linear programming problem: Use optimization algorithms (e.g., simplex, interior point) [24]
• Extract flux distribution: Obtain the optimized flux values for all reactions [24]
• Validate solution: Check feasibility and physiological relevance

Troubleshooting:

• If solution is infeasible, check constraint consistency
• If growth rate is zero, verify medium components and uptake rates
• If flux distributions seem unrealistic, add additional constraints

Advanced FBA Applications for Pseudomonas putida

Enzyme-Constrained Modeling

Traditional FBA relies primarily on stoichiometric coefficients and can predict unrealistically high fluxes. Incorporating enzyme constraints ensures that fluxes through pathways are capped by enzyme availability and catalytic efficiency, avoiding arbitrarily high flux predictions [23]. The ECMpy workflow provides a method for adding enzyme constraints without significantly altering the GEM structure, offering increased accuracy compared to other approaches like GECKO and MOMENT [23].

Protocol: Implementing Enzyme Constraints in P. putida Models

• Split reversible reactions: Separate into forward and reverse reactions to assign corresponding Kcat values [23]
• Split isoenzyme reactions: Separate reactions catalyzed by multiple isoenzymes into independent reactions [23]
• Collect enzyme data: Obtain molecular weights from EcoCyc, protein abundance from PAXdb, and Kcat values from BRENDA [23]
• Set protein fraction constraint: Apply total enzyme capacity constraint based on literature values (e.g., 0.56 protein mass fraction) [23]
• Modify parameters for engineered enzymes: Adjust Kcat values and gene abundance to reflect genetic modifications [23]

Table 2: Example Modifications for Engineered P. putida Strains

Parameter	Gene/Enzyme/Reaction	Original Value	Modified Value	Engineering Rationale
Kcat_forward	TargetReaction	20 1/s	2000 1/s	Enzyme mutagenesis for enhanced activity [23]
Gene Abundance	TargetGene	626 ppm	5,643,000 ppm	Promoter modification and copy number increase [23]
Kcat_reverse	ReverseReaction	15.79 1/s	42.15 1/s	Removal of feedback inhibition [23]

Metabolic Engineering Strategies

The "driven by demand" engineering strategy exploits the natural regulation of central carbon metabolism in P. putida, which appears to be driven by demand rather than transcriptional control of central pathways [26]. This approach involves creating synthetic demand for target compounds, allowing the central metabolism to naturally adjust flux to meet this demand.

Case Study: Rhamnolipid Production in P. putida

• Identify precursor requirements: Determine central carbon intermediates needed (acetyl-CoA for HAA, glucose-6-phosphate for rhamnose) [26]
• Engineer peripheral pathways: Introduce and optimize expression of rhamnolipid synthesis genes (rhlAB) [26]
• Screen promoter variants: Use synthetic promoter library to identify optimal expression levels [26]
• Evaluate flux redistribution: Measure increases in pathway fluxes (300% increase in rhamnose pathway, 50% in fatty acid synthesis) [26]

Advanced FBA Techniques

Flux Variability Analysis (FVA): FVA calculates the minimum and maximum possible fluxes through each reaction while maintaining optimal objective function value, identifying alternative optimal solutions and flexible reactions [24].

Thermodynamics-Based Flux Analysis (TFA): Integrating thermodynamic constraints eliminates thermodynamically infeasible flux distributions and helps identify reactions operating far from equilibrium [11].

Dynamic FBA: Extending FBA to dynamic conditions allows simulation of time-dependent behaviors, such as substrate depletion and product accumulation in batch cultures.

Table 3: Key Research Reagents and Computational Tools for FBA

Resource	Function/Application	Relevance to P. putida Research
iJN1411 GEM	Genome-scale model of P. putida KT2440 containing 2,581 reactions and 1,411 genes [11]	Most complete metabolic reconstruction for P. putida; foundation for constraint-based modeling
COBRApy	Python package for constraint-based reconstruction and analysis [23]	Primary tool for implementing FBA and related analyses
BRENDA Database	Comprehensive enzyme information including Kcat values [23]	Source of kinetic parameters for enzyme-constrained modeling
EcoCyc Database	Encyclopedia of E. coli genes and metabolism [23]	Reference for metabolic pathways and gene annotations
ECMpy Workflow	Python package for incorporating enzyme constraints into GEMs [23]	Method for adding enzyme constraints without altering stoichiometric matrix
TIObjFind Framework	Optimization framework for identifying cellular objective functions [25]	Approach for determining appropriate objective functions in different conditions

Integration of Multi-Omics Data

The integration of multi-omics data significantly enhances the predictive capability of constraint-based models. Transcriptomic data can be incorporated using methods like GIMME to find steady-state flux distributions that maximize objective function while matching expression data [24]. Proteomic data from sources like PAXdb provides enzyme abundance information for implementing enzyme constraints [23]. Metabolomic data enables refinement of thermodynamic constraints and gap-filling of metabolic networks [11].

The following diagram illustrates the workflow for integrating enzyme constraints into metabolic models of P. putida:

Flux Balance Analysis provides a powerful computational framework for metabolic engineering of Pseudomonas putida, enabling prediction of metabolic behaviors and identification of engineering targets without extensive kinetic data. The core principles of stoichiometric modeling, constraint-based analysis, and optimization can be effectively applied to leverage the native metabolic versatility of P. putida for biotechnological applications. Advanced implementations incorporating enzyme constraints, thermodynamic considerations, and multi-omics data integration further enhance the predictive power of these models. As resource allocation constraints and kinetic modeling approaches continue to evolve, FBA will remain an essential tool for rational design of P. putida strains with enhanced capabilities for chemical production and bioremediation.

Defining System Boundaries and Physicochemical Constraints for Realistic Simulations

Flux Balance Analysis (FBA) has emerged as a powerful mathematical framework for simulating metabolism in biological systems, particularly using genome-scale metabolic reconstructions. The predictive capability of FBA fundamentally depends on the accurate definition of system boundaries and the imposition of physicochemical constraints that reflect biological reality. Unlike kinetic models that require extensive parameterization, FBA leverages constraints-based modeling to predict metabolic fluxes by applying mass-balance, thermodynamic, and capacity constraints to a stoichiometric representation of metabolism [27] [28]. Within the context of Pseudomonas putida metabolic engineering, proper constraint definition enables researchers to transform a genomic inventory of metabolic reactions into a predictive model capable of simulating growth phenotypes, predicting gene essentiality, and identifying metabolic engineering targets for biotechnological applications [10] [29] [19].

The soil bacterium Pseudomonas putida KT2440 represents a particularly valuable chassis for industrial biotechnology due to its robust redox metabolism, exceptional stress tolerance, and versatile metabolic capabilities [19] [30]. These properties, coupled with the availability of increasingly sophisticated genome-scale models, make it an ideal testbed for examining how proper constraint definition enhances predictive accuracy in metabolic simulations. This protocol details the methodologies for establishing appropriate computational boundaries and constraints to maximize the biological relevance of FBA simulations for P. putida strain engineering.

Theoretical Foundation: Principles of Constraint-Based Modeling

Mathematical Formulation of Flux Balance Analysis

FBA operates on the fundamental principle that metabolic networks at steady-state must obey mass conservation. This is mathematically represented by the stoichiometric matrix S, where rows correspond to metabolites and columns represent metabolic reactions. The steady-state mass balance equation is expressed as:

Sv = 0

where v is the vector of metabolic fluxes [27] [28]. This equation constitutes the primary physicochemical constraint, ensuring that for each metabolite, the combined rates of production and consumption sum to zero, indicating no net accumulation.

The underdetermined nature of this system (typically more reactions than metabolites) necessitates additional constraints to identify biologically relevant solutions. These include:

Lower and upper bounds: αi ≤ vi ≤ βi

where αi and βi represent the minimum and maximum allowable fluxes for reaction i [27]. The final solution space is then explored by optimizing an objective function (Z), typically chosen to represent biological goals such as maximization of biomass production:

Maximize Z = c^Tv

where c is a vector of weights indicating how much each reaction contributes to the objective [28].

The Spectrum of Constraints in Metabolic Models

Table 1: Categories of Constraints in Metabolic Models of P. putida

Constraint Category	Specific Examples	Mathematical Representation	Biological Interpretation
Mass Balance	Stoichiometric constraints	Sv = 0	Metabolic intermediates do not accumulate at steady state
Capacity Constraints	Enzyme capacity, Substrate uptake	vglc ≤ 18.5 mmol/gDW/h	Maximum glucose uptake rate observed experimentally
Thermodynamic Constraints	Reaction directionality	virreversible ≥ 0	Reactions proceed in thermodynamically favorable directions
Environmental Constraints	Oxygen availability	vo2 = 0 (anaerobic)	Simulation of specific environmental conditions
Genetic Constraints	Gene knockouts	vreaction = 0	Removal of metabolic capabilities via gene deletion
Spatial Constraints	Compartmentalization	Separate metabolite pools for cytoplasm, periplasm	Accounting for subcellular localization [10]

Defining System Boundaries for P. putida Metabolic Models

Compartmentalization and Transport Processes

The first genome-scale metabolic reconstruction of P. putida KT2440, iJN746, accounted for 911 metabolites distributed across three cellular compartments: cytoplasm, periplasm, and extracellular space [10]. This compartmentalization is essential for realistic simulations, as it imposes additional constraints on metabolite transport and accessibility. Later reconstructions have maintained this multi-compartmental architecture while expanding the reaction and gene content.

Transport reactions represent a critical boundary component in P. putida models, with approximately 12% of the organism's genome encoding transport-associated proteins [10]. Properly accounting for these transport systems is particularly important when simulating P. putida's versatile metabolism, including its ability to utilize diverse carbon sources and tolerate toxic compounds [30].

Exchange Reactions and Nutrient Availability

Exchange reactions define the interface between the metabolic network and its environment, controlling which metabolites can enter or exit the system. The composition of these exchange reactions directly determines the nutrient availability and secretory capabilities in simulations. The iJN746 model included 90 exchange reactions, while more recent reconstructions have expanded this number substantially [10] [14].

Diagram Title: System Boundaries in Metabolic Models

Implementing Physicochemical Constraints: A Practical Protocol

Thermodynamic Constraints and Directionality

Thermodynamic curation of metabolic models ensures that reaction directionality aligns with thermodynamic feasibility. Recent work on P. putida models has integrated Group Contribution Methods (GCM) to estimate standard Gibbs free energy of formation for metabolites and reactions [11]. This allows for the imposition of thermodynamic constraints that:

• Eliminate thermodynamically infeasible cycles
• Constrain reaction directions based on energy calculations
• Identify reactions operating far from equilibrium

For the iJN1411 genome-scale model of P. putida KT2440, thermodynamic curation enabled the estimation of standard Gibbs free energy for 62.3% of metabolites and 59.3% of reactions [11]. Implementation requires adjustment for physiological pH and ionic strength to calculate transformed Gibbs free energy values relevant to cellular conditions.

Kinetic and Capacity Constraints

While FBA does not require detailed kinetic parameters, incorporating capacity constraints based on enzyme abundance and catalytic efficiency significantly improves prediction accuracy. The development of ME-models (Metabolism and Expression models) for P. putida represents a significant advancement in this area [7].

The P. putida ME-model (iPpu1676-ME) expands on traditional metabolic models by explicitly accounting for:

• Biosynthetic costs of enzymes and macromolecules
• Proteome allocation constraints
• Translation and transcription machinery limitations

This approach naturally recapitulates proteome limitation and overflow metabolism without requiring additional constraints, as demonstrated by the model's accurate prediction of maximum growth rates on glucose minimal medium [7].

Table 2: Experimentally Determined Flux Constraints for P. putida KT2440

Reaction/Parameter	Constraint Value	Growth Condition	Experimental Basis
Glucose uptake	8.15 ± 2.00 mmol/gDW/h	Minimal medium [7]	Multiple cultivation studies
Maximum growth rate	0.58 ± 0.02 h-1	Minimal medium [7]	Multiple cultivation studies
Non-growth associated maintenance (NGAM)	1.67 mmol ATP/gDW/h	Glucose-limited chemostat [14]	Maintenance coefficient calculation
Growth-associated maintenance (GAM)	42.31 mmol ATP/gDCW	Glucose-limited chemostat [14]	Yield-based parameter fitting
Oxygen uptake	0 (anaerobic) to ~15 mmol/gDW/h (aerobic)	Condition-dependent	Physiological range

Genetic Constraints and Gene-Protein-Reaction Associations

Genetic constraints are implemented through Gene-Protein-Reaction (GPR) associations, which map genes to catalytic functions using Boolean logic [27]. For example, a GPR of "(Gene A AND Gene B)" indicates that both genes encode essential subunits of an enzyme complex, while "(Gene A OR Gene B)" indicates isozymes where either gene product can catalyze the reaction independently.

In the iJN746 reconstruction, 746 genes were associated with 810 metabolic reactions, while 140 additional reactions were included based on physiological evidence despite lacking genetic associations [10]. These GPR relationships enable the simulation of gene knockout strains by constraining the associated reaction fluxes to zero.

Protocol: Implementing Constraints for P. putida FBA Simulations

Step-by-Step Constraint Definition Workflow

Diagram Title: Constraint Implementation Workflow

Step 1: Initialize with a Curated Metabolic Reconstruction Begin with an established genome-scale model such as iJN1411 (containing 2,581 reactions, 2,057 metabolites, and 1,411 genes) or iSH1474 for solvent-tolerant S12 strains (containing 2,938 reactions, 1,436 metabolites, and 1,474 genes) [11] [14]. Ensure the model includes appropriate GPR associations and compartmentalization.

Step 2: Define Environmental Conditions through Exchange Reactions Set bounds on exchange reactions to reflect specific cultivation conditions:

• Carbon source: Set upper bound for glucose uptake to ~8.15 mmol/gDW/h based on experimental measurements [7]
• Oxygen availability: Set oxygen uptake according to aerobic (high bound) or anaerobic (zero bound) conditions
• Nutrient limitations: Constrain specific exchange reactions to simulate nutrient limitations
• By-product secretion: Allow appropriate secretion reactions based on known metabolic capabilities

Step 3: Apply Thermodynamic Constraints

• Assign directionality to reactions based on thermodynamic feasibility calculations
• Implement transformed Gibbs free energy values adjusted for physiological pH and ionic strength
• Eliminate thermodynamically infeasible loops using network gap-filling algorithms

Step 4: Incorporate Physiological Constraints

• Set maintenance energy requirements: NGAM = 1.67 mmol ATP/gDW/h and GAM = 42.31 mmol ATP/gDCW for S12 strains [14]
• Apply enzyme capacity constraints where available from proteomic data
• Implement kinetic constraints for well-characterized reactions when available

Step 5: Impose Genetic Manipulations

• For gene knockout simulations: Constrain associated reaction fluxes to zero based on GPR rules
• For overexpression: Increase upper flux bounds for corresponding reactions
• For heterologous pathway insertion: Add necessary reactions and constrain appropriately

Validation and Refinement Protocol

Validation Metrics:

• Compare predicted versus experimental growth rates across different conditions
• Assess accuracy of gene essentiality predictions (iJN1411 achieves 85% accuracy [7])
• Validate intracellular flux predictions using ¹³C metabolic flux analysis data
• Compare predicted substrate utilization profiles with phenotypic array data

Refinement Process:

• Identify gaps in growth prediction and add missing reactions iteratively
• Adjust constraint bounds to improve agreement with experimental data
• Incorporate additional omics data (transcriptomics, proteomics) to further constrain fluxes
• Validate against dynamic cultivation data where available

Table 3: Key Research Reagents and Computational Tools for P. putida Constraint-Based Modeling

Resource Type	Specific Tools/Databases	Application in Constraint Definition
Genome-Scale Models	iJN1411, iJN746, iSH1474, iPpu1676-ME	Starting point for constraint implementation; iJN1411 contains 2,581 reactions and 1,411 genes [11] [14]
Software Tools	COBRA Toolbox, RAVEN Toolbox, ORACLE	Implement constraints, perform FBA, and analyze results [27] [11] [14]
Thermodynamic Databases	Group Contribution Method, TECRdatabase	Estimate Gibbs free energy values for metabolites and reactions [11]
Genomic Databases	BioCyc, KEGG, PSEUDOCYC, SYSTOMONAS	Retrieve gene annotations, metabolic pathways, and enzyme information [10]
Strain Resources	P. putida KT2440, S12, engineered variants	Experimental validation of constraint-based predictions [10] [29] [14]

Application Case Study: Constraint-Driven Engineering for PHA Production

A compelling demonstration of constraint-defined modeling for metabolic engineering comes from the enhanced production of poly-hydroxyalkanoates (PHAs) in P. putida [29]. Using elementary flux mode analysis of a large-scale metabolic model with physiological constraints from the wild-type strain, researchers identified glucose dehydrogenase (gcd) as a promising knockout target for enhancing PHA accumulation.

The implementation followed this constrained approach:

• Applied wild-type physiological parameters as model constraints
• Used flux variability analysis to identify priority ranked targets
• Predicted Δgcd mutant would exhibit 100% increased PHA accumulation
• Experimentally validated computational prediction with engineered strain

The resulting Δgcd mutant showed:

• 100% increased PHA accumulation compared to wild-type
• 80% increase in PHA yield
• 100% increase in PHA titer
• 50% increase in cellular PHA content
• Minimal impact on growth rate and gene expression profiles

This success illustrates how properly constrained models can accurately predict metabolic engineering strategies that enhance biotechnological performance while maintaining robust growth characteristics [29].

Proper definition of system boundaries and physicochemical constraints is fundamental to transforming genomic information into predictive metabolic models for P. putida. The protocols outlined here provide a framework for implementing mass balance, thermodynamic, capacity, and genetic constraints that reflect biological reality. As modeling approaches evolve beyond traditional FBA to include ME-models that explicitly account for proteome allocation costs [7], the definition and implementation of appropriate constraints will remain essential for accurate metabolic prediction and successful strain engineering.

The integration of additional cellular processes—including regulation, signaling, and multi-scale resource allocation—represents the frontier of constraint-based modeling. For P. putida, this will enable more sophisticated engineering of this versatile chassis for sustainable bioproduction and bioremediation applications, solidifying its position as a premier platform for industrial biotechnology.

Implementing FBA for Strain Design and Bioproduction

Flux Balance Analysis (FBA) is a cornerstone computational method in systems biology that enables the prediction of metabolic flux distributions in genome-scale metabolic models (GSMMs). For metabolic engineering of Pseudomonas putida, a Gram-negative bacterium renowned for its remarkable metabolic versatility and stress resistance, FBA provides a powerful framework for unraveling genotype-phenotype relationships and designing biotechnological applications [4]. P. putida KT2440, in particular, has emerged as a privileged microbial chassis for environmental and industrial biotechnology due to its ability to sustain difficult redox reactions and process diverse carbon sources, including lignin-derived aromatic compounds [18] [15].

This protocol details a comprehensive workflow for implementing FBA specifically for P. putida research, from initial model curation to final flux prediction and validation. The structured approach enables researchers to leverage the full potential of constraint-based modeling for fundamental investigation and metabolic engineering applications.

The diagram below illustrates the comprehensive FBA workflow for P. putida, from initial model setup to final prediction and validation.

Phase 1: Model Curation and Reconstruction

Obtain and Validate Base Genomic Data

Begin with the annotated genome sequence of your target P. putida strain. For KT2440, reference annotations are available from databases like Pseudomonas.com [4]. The quality of the initial annotation directly impacts reconstruction accuracy.

Experimental Protocol: Genome Annotation Refinement

• Objective: Identify and correct incomplete or erroneous gene annotations
• Procedure:
  • Download latest genome annotation from Pseudomonas Genome Database
  • Perform comparative genomics with closely related strains
  • Identify metabolic gaps through in silico growth simulations
  • Conduct homology searches with verified enzymes from other organisms
  • Validate putative annotations with biochemical literature
• Validation: Experimental confirmation of gene function via knock-out mutants

Reconstruct Metabolic Network

Convert genomic data into a biochemical network by defining all metabolic reactions and their gene-protein-reaction (GPR) associations.

Table 1: Core Components of P. putida GSMM Reconstruction

Component	Description	P. putida KT2440 Example
Metabolic Reactions	Biochemical transformations in the network	877 reactions (94% gene-associated) [4]
Metabolites	Chemical species participating in reactions	886 metabolites (824 intracellular, 62 extracellular) [4]
GPR Associations	Boolean logic linking genes to reactions	821 reactions with assigned genes [4]
Transport Reactions	Metabolite exchange across membrane	Specific for carbon sources (e.g., p-coumarate uptake) [31]
Biomass Equation	Composition of macromolecules for growth	Carefully curated for accurate growth prediction [4]

Define Biomass Objective Function

The biomass objective function quantitatively represents the metabolic requirements for cellular growth.

Experimental Protocol: Determining Biomass Composition

• Objective: Establish accurate macromolecular composition for growth simulations
• Materials:
  • P. putida cells in mid-exponential phase
  • Standardized minimal medium with defined carbon source
  • Analytical instruments for protein, lipid, RNA, DNA quantification
• Procedure:
  • Grow P. putida in controlled bioreactor under defined conditions
  • Harvest cells during balanced exponential growth
  • Quantify cellular components: protein (Lowry method), RNA/DNA (spectrophotometric methods), lipids (extraction and gravimetric analysis)
  • Determine nucleotide and amino acid composition via HPLC
  • Calculate molar coefficients for each biomass precursor
• Validation: Ensure in silico growth predictions match experimental growth rates

Phase 2: Condition-Specific Model Configuration

Define Environmental Constraints

Constrain the model to reflect specific experimental conditions, particularly the carbon and energy sources.

Table 2: Constraint Settings for Different Carbon Sources in P. putida

Carbon Source	Uptake Rate (mmol/gDW/h)	Key Pathway Activation	Application Context
Glucose	2.5-4.0 [4]	Oxidative PPP, ED pathway	Standard growth condition [4]
p-Coumarate	1.2-2.0 [31]	β-ketoadipate pathway, TCA cycle	Lignin valorization [15] [31]
Ferulate	1.0-1.8 [15]	Coniferyl branch, PCA cleavage	Lignin bioconversion [15]
Vanillate	0.8-1.5 [15]	Vanillate demethylation, TCA cycle	Aromatic compound metabolism [15]
Succinate	3.0-5.0 [15]	Gluconeogenesis, TCA cycle	Reference condition [15]

Incorporate Omics Data as Constraints

Integrate experimental data to enhance model prediction accuracy by constraining flux through observed metabolic routes.

Experimental Protocol: 13C-Metabolic Flux Analysis (13C-MFA)

• Objective: Determine internal metabolic fluxes for model validation
• Materials:
  • 13C-labeled carbon source (e.g., [U-13C] glucose or p-coumarate)
  • P. putida culture in controlled bioreactor
  • GC-MS or LC-MS for isotopic labeling measurement
  • Quenching solution (cold methanol)
  • Metabolite extraction buffers
• Procedure:
  • Grow P. putida on 13C-labeled substrate until steady-state labeling achieved
  • Rapidly quench metabolism (cold methanol)
  • Extract intracellular metabolites
  • Measure mass isotopomer distributions of key metabolites via GC-MS/LC-MS
  • Calculate metabolic fluxes using computational software (e.g., INCA, OpenFlux)
• Application: Validate FBA predictions and identify metabolic bottlenecks [15]

Phase 3: Model Simulation and Analysis

Perform Flux Balance Analysis

FBA calculates flux distributions by optimizing an objective function (typically biomass production) subject to physicochemical constraints.

Computational Protocol: Standard FBA Implementation

Essentiality Analysis and Robustness Testing

Identify critical genes and reactions required for growth under specific conditions.

Table 3: Gene Essentiality Predictions for P. putida on p-Coumarate

Gene ID	Gene Name	Predicted Essentiality	Experimental Validation	Functional Role
PP_1378	-	Essential	Confirmed [31]	α-ketoglutarate/3-oxoadipate permease
PP_0897	-	Conditional	Confirmed [31]	Fumarate hydratase
PP_0944	fumC1	Non-essential	Confirmed [31]	Fumarate hydratase isozyme
PP_1755	fumC2	Non-essential	Confirmed [31]	Fumarate hydratase isozyme
pobA	-	Non-essential	Function-dependent [15]	p-hydroxybenzoate hydroxylase

Phase 4: Model Validation and Application

Experimental Validation of Predictions

Rigorously test model predictions through targeted experiments.

Experimental Protocol: Gene Essentiality Validation

• Objective: Experimentally verify computationally predicted essential genes
• Materials:
  • P. putida KT2440 wild-type strain
  • CRISPR/recombineering system for gene deletion
  • Rich and minimal media with various carbon sources
  • Colony formation monitoring systems
• Procedure:
  • Design deletion mutants for predicted essential and non-essential genes
  • Attempt to generate knockouts via homologous recombination
  • Assess viability on permissive and non-permissive conditions
  • Quantify growth rates of successful knockouts
  • Compare experimental results with computational predictions
• Troubleshooting: Failed deletion of predicted non-essential genes may indicate missing isozymes or pathway redundancies not captured in model [31]

Applications in Metabolic Engineering

Implement model-driven metabolic engineering strategies for improved bioproduction.

Case Study: Growth-Coupled Production Design The diagram below illustrates a metabolic engineering strategy for growth-coupled production in P. putida.

Experimental Protocol: Implementing Growth-Coupled Production

• Objective: Engineer P. putida for product formation coupled to growth
• Materials:
  • P. putida KT2440 wild-type and engineered strains
  • p-Coumarate as carbon source
  • Gene deletion tools (CRISPR/recombineering)
  • Bioreactor for controlled cultivation
  • Analytics for product quantification (HPLC, colorimetric assays)
• Procedure:
  • Identify intervention targets using constraint-based design algorithms (e.g., OptKnock, cMCS)
  • Implement gene deletions sequentially (e.g., PP1378, PP0944, PP1755, PP0897)
  • Assess growth and production phenotypes on p-coumarate
  • Use promoter titration for fine-tuning essential reaction fluxes
  • Validate growth-coupled production in bioreactor studies
• Key Consideration: Complete implementation of design may require careful modulation rather than complete deletion of some reactions [31]

The Scientist's Toolkit

Table 4: Essential Research Reagent Solutions for P. putida FBA

Reagent/Resource	Function/Application	Example/Source
GSMM of P. putida	Foundation for in silico simulations	iJP815 model [4]
Gene Deletion Tools	Experimental validation of predictions	CRISPR/recombineering systems [31]
13C-Labeled Substrates	Metabolic flux validation	[U-13C] glucose, p-coumarate [15]
Analytical Instruments	Quantification of metabolites and fluxes	GC-MS, LC-MS, HPLC [15]
Biolog Phenotype Microarrays	Substrate utilization profiling	Validation of model predictions [4]
Enzyme Assay Kits	Verification of catalytic activities	Validation of bottleneck predictions [15]
Synthetic Biology Tools	Genetic parts for pathway engineering	Promoter libraries, expression vectors [18]

This structured FBA workflow provides a comprehensive framework for metabolic modeling and engineering of Pseudomonas putida. By integrating computational predictions with experimental validation, researchers can systematically unravel the complex metabolic wiring of this industrially relevant bacterium and design optimized strains for biotechnological applications. The iterative nature of the process—where model predictions inform experiments and experimental results refine the model—creates a powerful cycle for advancing our understanding of P. putida metabolism and harnessing its potential for sustainable bioproduction.

Growth-Coupling Strategies for Essential Product Synthesis

Growth-coupling is a foundational strategy in metabolic engineering that genetically rewires microbial metabolism to directly link the synthesis of a target product to cellular growth [32] [33]. This approach creates a selective advantage for high-producing cells, as variants that reduce or eliminate production suffer impaired growth or become non-viable [34]. In the context of Pseudomonas putida—a robust soil bacterium valued for its metabolic versatility and stress tolerance—implementing growth-coupling strategies enables the development of stable, high-performance biocatalysts for industrial bioprocesses [31] [35]. The theoretical framework for growth-coupling is built upon stoichiometric models of metabolism, with Flux Balance Analysis (FBA) serving as the primary computational method for designing such strategies [32] [36].

The strength of growth-coupling exists on a spectrum, classified into three distinct categories based on the relationship between product formation and growth rate across the metabolic network's capabilities [32] [33]. Weak Growth-Coupling (wGC) describes scenarios where product formation only occurs at elevated growth rates, similar to native overflow metabolism in many microorganisms. Holistic Growth-Coupling (hGC) occurs when the lower production bound remains above zero for all growth rates greater than zero. The strongest form, Strong Growth-Coupling (sGC), mandates active target compound production across all metabolic states, including zero growth, making the product an essential byproduct of core metabolic activity [32] [33]. For model organisms like P. putida, implementing sGC designs ensures that productive strains dominate the population during scale-up, addressing critical challenges in production stability that often plague industrial bioprocesses [31] [34].

Computational Framework and FBA Protocols

Theoretical Foundations and Algorithm Selection

Computational identification of growth-coupling interventions leverages genome-scale metabolic models (GSMMs) to simulate metabolic flux distributions under genetic constraints [32] [36]. The core principle involves strategically eliminating metabolic functionalities that allow growth without product formation, thereby forcing the coupling between these objectives [32]. Multiple algorithmic frameworks have been developed for this purpose, falling into two primary categories: Flux Balance Analysis (FBA)-based methods and Elementary Modes Analysis (EMA)-based methods [32] [33].

FBA-based approaches, including OptKnock and its derivatives, identify gene knockout strategies by solving bi-level optimization problems where the outer level maximizes product formation and the inner level maximizes biomass growth [32]. Recent advancements like gcOpt adapt this framework to maximize the minimally guaranteed production rate at a fixed, medium growth rate, prioritizing designs with elevated coupling strength [32] [33]. EMA-based methods, particularly those utilizing Minimal Cut Sets (MCSs), identify the smallest sets of reaction deletions that disable all elementary modes supporting growth without product formation [36]. The constrained Minimal Cut Sets (cMCS) approach further extends this capability by allowing user-defined constraints on growth rate and product yield [31]. For P. putida strain engineering, these computational approaches have been successfully deployed to design four-gene deletion strategies for coupling aromatic compound utilization to target metabolite production [31].

Table 1: Computational Frameworks for Growth-Coupling Strain Design

Method	Underlying Approach	Key Features	Applications in P. putida
OptKnock	FBA-based, bi-level optimization	Maximizes product at maximal growth	General metabolic engineering
gcOpt	FBA-based, adapted OptKnock	Maximizes minimal production at medium growth	Central carbon metabolism interventions
MCS/cMCS	Elementary Modes Analysis	Identifies minimal reaction knockout sets	Aromatic catabolism strain designs [31]
OptCouple	Community FBA modeling	Designs co-dependent microbial communities	Multi-strain cultivation systems

Protocol: Implementing gcOpt forP. putidaStrain Design

The following protocol details the application of the gcOpt algorithm to identify growth-coupling strategies for P. putida, based on established computational workflows [32] [33]:

Step 1: Model Preparation and Curation

• Obtain a genome-scale metabolic model of P. putida (e.g., iJN1462 or similar consensus model)
• Verify model completeness for central carbon metabolism, cofactor balancing, and energy generation
• Set constraints to reflect target cultivation conditions:
  • Carbon source uptake rate (e.g., glucose: 10 mmol/gDCW/h)
  • Oxygen uptake rate (aerobic: 15-20 mmol/gDCW/h; anaerobic: 0 mmol/gDCW/h)
  • ATP maintenance requirement (ATPM): 1-3 mmol/gDCW/h [32] [33]

Step 2: Algorithm Parameterization

• Define the fixed, medium growth rate (μfix): typically 50-70% of maximum theoretical growth rate
• Set the maximum number of allowed reaction deletions (KOs): start with 3-5 deletions
• Specify the target product reaction and its directionality
• Define minimum growth rate threshold (e.g., 0.05 h⁻¹) to ensure viability

Step 3: Mathematical Formulation Implementation Implement the core gcOpt optimization problem [32]:

Step 4: Solution Validation and Analysis

• Verify that identified knockout strategies do not render the model non-viable
• Calculate production envelopes for designed strains to visualize coupling strength
• Check for alternative optimal solutions that may offer easier implementation
• Validate essentiality predictions against experimental data when available

Step 5: Prioritization of Strain Designs

• Rank solutions by coupling strength (minimal guaranteed production)
• Evaluate thermodynamic feasibility of flux distributions
• Consider implementation complexity (e.g., essential gene conflicts)
• Assess potential bypass routes through promiscuous enzyme activities

The following diagram illustrates the core computational workflow for growth-coupling strain design using gcOpt and related algorithms:

Experimental Implementation and Validation

Protocol: Implementing Growth-Coupled Strains inP. putida

The transition from in silico designs to functional microbial strains requires careful genetic implementation and validation. The following protocol outlines the key steps for implementing and validating growth-coupling strategies in P. putida, based on established metabolic engineering workflows [31] [35]:

Step 1: Genetic Modification of P. putida

• Select appropriate genetic tools based on target modifications:
  • CRISPR/recombineering for single gene deletions [31]
  • Suicide vectors with counterselection for multiple deletions
  • Lambda Red recombinase system for markerless deletions
• Implement computational designs sequentially, validating strain viability after each modification
• For essential gene disruptions, implement complementation systems (inducible promoters) to maintain viability during construction

Step 2: Adaptive Laboratory Evolution (ALE)

• Inoculate engineered strains in minimal medium with target substrate as sole carbon source
• Maintain selective pressure by limiting auxiliary carbon sources
• Serial transfer protocol:
  • Culture volume: 5-10 mL in baffled flasks
  • Transfer schedule: At mid-log phase (OD600 ≈ 0.5-0.8) or fixed time intervals (24-48h)
  • Dilution factor: 1:20 to 1:100 into fresh medium
  • Duration: Continue for 20-50 transfers or until productivity stabilizes
• Monitor population dynamics through periodic plating and productivity assays

Step 3: Productivity Validation and Analysis

• Quantify product formation using appropriate analytical methods:
  • HPLC for organic acids, alcohols, aromatics
  • GC-MS for volatile compounds, terpenoids
  • Colorimetric assays for amino acids, pigments (e.g., indigoidine for glutamine proxy) [31]
• Measure growth parameters:
  • Optical density (OD600) for growth rate
  • Substrate consumption rates
  • Biomass yield
• Calculate key performance metrics:
  • Product yield (Yp/s): g product per g substrate
  • Specific productivity: g product per g biomass per hour
  • Coupling strength: Production rate vs. growth rate correlation

Step 4: Reverse Engineering of Evolved Strains

• Sequence genomes of endpoint isolates to identify causal mutations
• Map mutations to metabolic network to understand adaptive responses
• Validate mutation effects by reconstruction in parental strain
• Proteomic analysis to assess enzyme abundance changes in key pathways

Research Reagent Solutions forP. putidaEngineering

Table 2: Essential Research Reagents for Growth-Coupling Implementation

Reagent/Resource	Function/Purpose	Example Application	Key Considerations
p-coumarate (p-CA)	Lignin-derived carbon source	Testing aromatic catabolism designs [31]	Substrate toxicity at high concentrations
Indigoidine biosynthesis genes (bpsA, sfp)	Colorimetric reporter for glutamine	Visual screening of productive strains [31]	Requires Mg2+, FMN, ATP cofactors
Constitutive promoters (P14g, P4)	Modular pathway expression	rGlyP implementation in P. putida [35]	Strength matching to avoid bottlenecks
Fumarate hydratase mutants (PP_0897)	TCA cycle disruption	Creating metabolic dependency nodes [31]	Essentiality requires titration
Phosphoketolase (PKT) shunt	Synthetic C2 metabolism	Alternative sugar catabolism [37]	Bifidobacterial origin, requires optimization
Reductive glycine pathway (rGlyP)	C1 assimilation module	Formate/methanol utilization [35]	Three-module structure with GCS reversal

Case Study: Growth-Coupling for Aromatic Catabolism inP. putida

Implementation of a Four-Gene Deletion Design

A representative case of growth-coupling strategy implementation in P. putida involves the conversion of the lignin-derived aromatic compound p-coumarate (p-CA) to glutamine, with indigoidine as a colorimetric proxy for product quantification [31]. The computational design identified a requirement for four gene deletions to achieve strong growth-coupled production:

Table 3: Gene Deletion Strategy for p-Coumarate to Glutamine Coupling

Gene ID	Gene Annotation	Metabolic Role	Implementation Notes
PP_1378	α-ketoglutarate/3-oxoadipate permease	C5-dicarboxylate transport	Blocked α-ketoglutarate shuttle
PP_0944 (fumC1)	Class I fumarate hydratase	TCA cycle: fumarate to malate	Non-essential isozyme
PP_1755 (fumC2)	Class II fumarate hydratase	TCA cycle: fumarate to malate	Non-essential isozyme
PP_0897	Fumarate hydratase	TCA cycle: fumarate to malate	Required at low activity levels

The implementation process revealed critical insights into the challenges of complete growth-coupling designs. While single deletion of PP0897 was viable, its combination with other fumarate hydratase deletions resulted in non-viable phenotypes under p-CA conditions, indicating an essential requirement for minimal fumarase activity in aromatic catabolism [31]. This necessitated a promoter titration approach rather than complete deletion, using weak promoters (pJ23109, PPP0415) to reduce PP_0897 expression approximately 8-fold while maintaining minimal activity [31].

Metabolic Principles and Pathway Analysis

The growth-coupling mechanism in this design operates through two interconnected principles confirmed in the experimental validation [31]. First, the disruption of α-ketoglutarate transport creates an auxotrophy that must be satisfied through de novo glutamine synthesis. Second, the coordinated reduction of fumarase activity creates an imbalance in TCA cycle function that can only be resolved when the target product pathway is active. The resulting metabolic network forces carbon flux through the glutamine synthesis pathway to maintain energy and redox balance.

The following diagram illustrates the metabolic network and key interventions in this growth-coupled design:

Advanced Applications and Future Directions

Growth-Coupling for Non-Conventional Substrates

The application of growth-coupling strategies extends beyond traditional sugar substrates to include one-carbon (C1) compounds and aromatic streams derived from lignin depolymerization [31] [35]. For P. putida, implementing the reductive glycine pathway (rGlyP) enables formatotrophic and methylotrophic growth on formate and methanol, respectively [35]. This synthetic metabolism was optimized through growth-coupled selection, where adaptive laboratory evolution improved doubling times from approximately 60 hours to 24-28 hours under C1 conditions [35].

The modular implementation of rGlyP demonstrates how growth-coupling facilitates the stepwise optimization of complex synthetic pathways. The pathway was divided into three functional modules: M1 (formate to methylene-THF), M2 (glycine cleavage system operating in reverse), and M3 (serine and pyruvate synthesis) [35]. By coupling each module's activity to growth under selective conditions, the pathway was systematically improved through iterative DBTL (Design-Build-Test-Learn) cycles [38].

Community-Based Growth-Coupling Strategies

Recent computational advances extend growth-coupling principles to microbial communities through adapted algorithms like OptCouple [39]. This approach designs co-dependent consortia where cross-feeding of metabolites creates mutual dependencies that stabilize community composition while coupling target chemical production to collective growth [39]. For P. putida, this enables division of metabolic labor between specialized strains, potentially improving overall yield and stability in industrial bioreactors.

The mathematical formulation for community growth-coupling modifies the OptCouple framework to incorporate multiple strain compartments with cross-feeding reactions [39]. The optimization objective shifts to maximizing the difference in community growth rate between the fully connected system and one without cross-feeding capabilities, ensuring mutual dependency between strains [39]. This approach represents the frontier of growth-coupling applications, moving beyond single-strain engineering to synthetic ecology.

Within the framework of Flux Balance Analysis (FBA) for metabolic engineering of Pseudomonas putida, optimizing cofactor balance is paramount for achieving high-yield bioproduction. NADPH provides essential reducing power for biosynthesis, while acetyl-CoA serves as a central precursor for numerous valuable compounds. The inherent metabolic versatility of P. putida presents both opportunities and challenges for manipulating these cofactors. This application note details recent, successful cases and protocols for engineering NADPH and acetyl-CoA metabolism in P. putida, providing quantitative data, experimental methodologies, and visual guides to inform research strategies for scientists and drug development professionals.

NADPH Optimization: Metabolic Node Engineering

Native Pathways and Engineering Targets

2.1.1 Quantitative Flux Analysis of Native Metabolism During growth on lignin-derived phenolic acids (ferulate, p-coumarate, vanillate, and 4-hydroxybenzoate), P. putida KT2440 undergoes significant metabolic remodeling to meet cofactor demands. Quantitative 13C-fluxomics reveals that the native metabolism couples phenolic carbon processing with substantial NADPH generation through specific routing [15].

Key Findings:

• Anaplerotic carbon recycling through pyruvate carboxylase promotes tricarboxylic acid (TCA) cycle fluxes that generate 50-60% of the total NADPH yield [15].
• The glyoxylate shunt sustains cataplerotic flux through malic enzyme, producing the remaining NADPH (40-50%) [15].
• This rewired metabolic network results in up to 6-fold greater ATP surplus compared to succinate metabolism [15].

2.1.2 Computational Prediction of Engineering Targets Flux Balance Analysis (FBA) using the iJN1463 model for P. putida KT2440 enables systematic identification of gene targets for NADPH enhancement. The COBRApy Python package facilitates this constraints-based modeling approach [40].

Table 1: Flux Balance Analysis of NADPH Engineering Targets in P. putida

Target Gene	Associated Reaction	Theoretical NADPH Outflux Change	Optimal Weighting Ratio (G6PD:PDH)
zwf	G6PBDH	+10,000 mmol/gDW/h	0.5:0.5
serA	PGCD	+327.24 mmol/gDW/h	0.5:0.5
serA, serB, serC	PGC, PSP_L, OHPBAT	+327.24 mmol/gDW/h	0.5:0.5
zwf + serA	G6PBDH + PGCD	+10,327.24 mmol/gDW/h	0.5:0.5

Protocol: Implementing NADPH Enhancement

2.2.1 Gene Overexpression for NADPH Enhancement

Materials:

• P. putida KT2440 strain
• Plasmid vectors with inducible promoters (e.g., pSEVA series)
• Primers for zwf (PP5351) and *serA* (PP5155) amplification
• Restriction enzymes and ligase for cloning
• Minimal salt medium (MSM) with appropriate carbon sources

Method:

• Amplify zwf and serA coding sequences from P. putida KT2440 genomic DNA.
• Clone each gene into separate expression vectors under control of inducible promoters.
• Transform constructs individually and combinatorially into P. putida KT2440.
• Culture engineered strains in MSM with target carbon sources.
• Induce gene expression during mid-exponential phase.
• Quantify NADPH/NADP+ ratios using spectrophotometric assays.
• Validate metabolic flux changes via 13C-tracer experiments and fluxomics analysis.

2.2.2 Quantitative Verification of NADPH Production

Analytical Techniques:

• LC-MS/MS for intracellular NADPH quantification
• 13C-metabolomics for flux distribution analysis
• Enzymatic assays for glucose-6-phosphate dehydrogenase and phosphoglycerate dehydrogenase activities

Acetyl-CoA Optimization: CRISPRi-Mediated Metabolic Rewiring

Model-Guided Target Identification

3.1.1 Kinetic Modeling for Acetyl-CoA Enhancement A core kinetic model of P. putida central metabolism, integrating fluxomics and metabolomics datasets, identified two key nodes controlling acetyl-CoA availability [41]:

• Citrate synthase (GltA) - Diverts acetyl-CoA into TCA cycle
• Acetyl-CoA carboxylase (AccA) - Consumes acetyl-CoA for fatty acid synthesis

3.1.2 CRISPRi Implementation for Gene Silencing Dynamic knockdown of gltA and accA using CRISPR interference (CRISPRi) resulted in an 8-fold increase in intracellular acetyl-CoA levels [41]. Poly(3-hydroxybutyrate) (PHB) accumulation served as a proxy for acetyl-CoA availability, with rewired strains showing 5-fold increased PHB titers in bioreactor cultures [41].

Table 2: Acetyl-CoA Engineering Targets and Outcomes in P. putida

Target Gene	Encoded Enzyme	Effect on Acetyl-CoA	Bioproduction Outcome
gltA	Citrate synthase	4.5-fold increase	Enhanced PHB accumulation
accA	Acetyl-CoA carboxylase subunit A	3.2-fold increase	Increased fatty acid precursors
gltA + accA	Both enzymes	8-fold increase	5-fold higher PHB titers

Protocol: CRISPRi-Mediated Acetyl-CoA Enhancement

3.2.1 CRISPRi System Implementation

Materials:

• dCas9 expression plasmid (e.g., pSEVA-dCas9)
• sgRNA cloning vectors with inducible promoters
• Oligonucleotides for sgRNA template assembly
• Electrocompetent P. putida KT2440 cells
• PHB production medium with glucose

Method:

• Design sgRNAs targeting gltA (PP1014) and *accA* (PP1934) coding regions.
• Clone sgRNA sequences into appropriate expression vectors.
• Co-transform dCas9 and sgRNA plasmids into P. putida KT2440.
• Culture engineered strains in PHB production medium with 20 g/L glucose.
• Induce dCas9 and sgRNA expression during early exponential phase.
• Monitor cell growth and PHB accumulation over 48-72 hours.
• Quantify acetyl-CoA levels using LC-MS/MS.
• Analyze PHB content via gas chromatography after methanolysis.

3.2.2 Analytical Verification

Key Analyses:

• Intracellular acetyl-CoA quantification using HPLC-MS
• PHB content measurement via GC-FID after acidic methanolysis
• Fluxomic analysis using 13C-glucose tracing
• Microscopy for cell morphology assessment

Integrated Cofactor Balancing for Bioproduction

Case Study: PHB Production via Cofactor Optimization

Engineering P. putida for enhanced poly(3-hydroxybutyrate) production demonstrates the interplay between NADPH and acetyl-CoA optimization. The PHB biosynthetic pathway requires both acetyl-CoA as direct precursor and NADPH as reducing equivalent [40].

Successful Strategy:

• Increase acetyl-CoA availability through CRISPRi-mediated knockdown of gltA and accA [41].
• Enhance NADPH supply via overexpression of zwf and serA [40].
• Combine approaches for synergistic improvement of PHB yield.

Protocol: Integrated Strain Engineering

Materials:

• P. putida strains with engineered acetyl-CoA nodes
• NADPH enhancement constructs (zwf, serA)
• PHB production medium
• Induction agents

Method:

• Transform NADPH enhancement constructs into acetyl-CoA optimized strains.
• Screen for colonies with successful integration of all genetic modifications.
• Cultivate engineered strains in bioreactors with controlled feeding strategies.
• Implement dynamic induction of genetic circuits based on growth phase.
• Monitor cofactor ratios and precursor concentrations throughout cultivation.
• Quantify final product yields and calculate mass balances.

The Scientist's Toolkit

Table 3: Essential Research Reagents for Cofactor Engineering in P. putida

Reagent/Resource	Function/Application	Example/Catalog Reference
iJN1463 Metabolic Model	FBA simulation of P. putida metabolism	Available from BioModels Database
COBRApy Python Package	Constraints-based modeling and FBA	Ebrahim et al., 2013
pSEVA Vector Series	Modular cloning and expression in Pseudomonas	Standard European Vector Architecture
dCas9 Expression Systems	CRISPRi-mediated gene knockdown	pSEVA-dCas9 variants
13C-labeled Substrates	Metabolic flux analysis	Cambridge Isotope Laboratories
NADP/NADPH Assay Kits	Cofactor ratio quantification	Colorimetric/Luminescent assays
LC-MS/MS Systems	Acetyl-CoA and metabolite quantification	Triple quadrupole instruments

Visual Guide to Metabolic Engineering Workflows

Cofactor Optimization Engineering Workflow

NADPH and Acetyl-CoA Metabolic Nodes

Engineering cofactor balance in P. putida requires integrated approaches that combine computational modeling, precise genetic tools, and quantitative validation. The cases presented demonstrate that NADPH optimization benefits from targeting multiple nodes, including the oxidative pentose phosphate pathway and TCA cycle anaplerotic routes, while acetyl-CoA enhancement requires careful modulation of key metabolic nodes like citrate synthase and acetyl-CoA carboxylase. Implementation of these strategies within the Design-Build-Test-Learn (DBTL) framework, supported by robust analytical verification, enables successful bioproduction of target compounds in this industrially relevant microbial host.

Polyhydroxyalkanoates (PHAs) represent a class of biopolymers naturally synthesized by diverse bacteria as carbon and energy storage molecules, offering a sustainable and biodegradable alternative to conventional petroleum-based plastics [42] [43]. The relevance of PHA extends beyond packaging into the biomedical field, where its monomers, such as β-hydroxybutyrate (BHB), and its polymer properties show significant promise for pharmaceutical applications, drug delivery systems, and tissue engineering [40] [44]. The soil bacterium Pseudomonas putida KT2440 has emerged as a particularly versatile chassis for biotechnology due to its metabolic robustness and ability to utilize a wide range of carbon sources, including lignin-derived aromatics and industrial waste like glycerol [15] [45]. Framed within a broader thesis on Flux Balance Analysis (FBA) for metabolic engineering, this application note details how FBA-driven strategies are employed to optimize P. putida for the enhanced production of PHA and its valuable precursors, providing detailed protocols for researchers and scientists in drug development.

Biomedical Applications of PHA and Its Precursors

PHAs are not merely bioplastics; they are a source of valuable biochemical precursors. The depolymerization of PHAs, such as poly(3-hydroxybutyrate) (PHB), yields monomers like BHB, which serves as a crucial biomedical precursor [40]. The application of PHA in medicine, agriculture, and packaging industries is well-documented [42] [44]. Specifically, in the biomedical field, PHA is utilized for:

• Tissue engineering and bio-implant patches [44].
• Drug delivery carriers and wound dressing materials [44] [45]. The inherent biocompatibility and complete biodegradability of PHA into carbon dioxide and water make it an excellent material for these applications, aligning with the UN's sustainability goals, including SDG 3 (Good Health) [44] [43].

Metabolic Engineering Strategies Using Flux Balance Analysis

Flux Balance Analysis (FBA) is a constraint-based metabolic modeling method that enables the prediction of metabolic flux distributions in a biological system, allowing for the identification of key genetic targets for strain improvement [40]. The iterative Design-Build-Test-Learn (DBTL) cycle is central to this metabolic engineering approach.

Case Study: EngineeringP. putidafor Enhanced PHB Production

Objective: To increase the production of PHB, which can be downstream depolymerized into the high-value product BHB [40]. Strategy: FBA was employed to identify gene/protein targets that increase the availability of NADPH and Acetyl-CoA, two key precursors for the PHB biosynthesis pathway [40]. Implementation: Using genome-scale models (e.g., iJN1463 for P. putida KT2440) and the COBRApy package in Python, metabolic fluxes were calculated. The upper and lower bounds of reactions associated with target genes were modulated to simulate their overexpression [40]. Key Findings:

• Increasing zwf (Glucose-6-phosphate dehydrogenase): This gene is associated with the Beta-D-Glucose-6-phosphate NADP+ 1-oxidoreductase (G6PBDH) reaction. Modeling showed that increasing zwf led to a dramatic increase in NADPH flux, from approximately 197.080 to 10,197.080 mmol/gDW/h under a specific weighting scheme, thereby directly supplying essential reducing power for biosynthesis [40].
• Increasing serA, serB, serC (Serine biosynthesis pathway): Overexpression of these genes also significantly altered NADPH and Acetyl-CoA flux distributions, though the effects were highly dependent on the specific flux weighting between different pathways [40].

The diagram below illustrates this integrated metabolic engineering workflow.

Synthesis of Customizable PHA Blends

A advanced application of promoter engineering in P. putida enables the one-step synthesis of PHA blends with tailored compositions. By using different inducible and constitutive promoters to control the expression of PHA biosynthetic genes, researchers have produced blends of poly-3-hydroxybutyrate [P(3HB)] and medium-chain-length PHA (mcl-PHA) with a 3HB monomer content ranging from 17.9 mol% to 99.6 mol% [46] [47]. This direct microbial synthesis of blends eliminates the need for post-synthesis melt compounding and allows for the fine-tuning of material properties suitable for specific biomedical devices [46].

The diagram below outlines the precursor biosynthesis and polymerization process in the engineered strain.

Experimental Protocols

Protocol 1: Flux Balance Analysis for Target Identification

This protocol describes how to use FBA to identify metabolic engineering targets for enhancing PHA production in P. putida.

Key Research Reagent Solutions:

• Genome-Scale Metabolic Model: iJN1463 for Pseudomonas putida KT2440 [40].
• Software Tool: COBRApy (Constraint-Based Reconstruction and Analysis) Python package [40].
• Culture Medium: Defined mineral salt medium (MSM) [45].

Procedure:

• Model Configuration: Load the genome-scale model (iJN1463). Set the constraints to reflect the growth medium, typically limiting carbon (e.g., glycerol, succinate) or nitrogen (ammonium) sources [40] [45].
• Objective Function: Set the objective function to maximize biomass production or a specific reaction flux, such as PHA synthesis.
• Gene Target Simulation: Identify candidate genes from literature (e.g., zwf, serA). To simulate overexpression, increase the upper and lower bounds of the reaction(s) associated with the target gene [40].
• Flux Calculation: Perform FBA using COBRApy to solve for the metabolic flux distribution under the new constraints.
• Analysis: Compare the predicted flux values for key metabolites like NADPH and Acetyl-CoA before and after the simulated genetic modification. A significant increase indicates a promising target [40].

Protocol 2: Microbial Synthesis and Analysis of PHA Blends

This protocol details the fermentation and analytical processes for producing and characterizing PHA blends in engineered P. putida.

Key Research Reagent Solutions:

• Engineered Strain: Pseudomonas putida engineered with constitutive or inducible promoters controlling PHA synthase genes [46] [47].
• Fermentation Medium: Mineral Salt Medium (MSM) supplemented with a carbon source (e.g., 20-60 g/L glucose, glycerol, or lignin-derived phenolics) [46] [44].
• Extraction Solvents: Chloroform and Sodium hypochlorite (4%) for PHA extraction [48] [44].
• Analytical Standards: Commercial PHA standards for chromatography.

Procedure:

• Inoculum Preparation: Inoculate a loopful of the engineered P. putida strain into 10 mL of sterile Nutrient Broth. Incubate overnight at 30-37°C with shaking at 120 rpm [44].
• Submerged Fermentation: Transfer the seed culture (10% v/v inoculum) to a bioreactor containing optimized production medium. For PHA accumulation, use nitrogen-limited conditions (e.g., low (NH₄)₂SO₄) with an excess carbon source [46] [45].
  • Typical Bioreactor Parameters: Working volume 1-3 L, temperature 30-32°C, pH 7.0, dissolved oxygen maintained >20%, agitation at 200 rpm [48].
• Harvesting and Extraction: a. Centrifuge the culture broth at 5,000-10,000 rpm for 10-30 min to collect cell biomass [48] [44]. b. Wash the pellet with distilled water and dry at 40-80°C to constant weight for Cell Dry Weight (CDW) determination [48] [44]. c. For PHA extraction, treat the dry biomass with a 1:1 (v/v) mixture of NaClO (4%) and chloroform. Incubate at 37-40°C for 1 hour [48] [44]. d. Centrifuge the mixture; the PHA will be in the bottom chloroform phase. Precipitate the polymer by adding excess hexane, then recover and dry the PHA film [44].
• Analytical Methods: a. Gravimetric Analysis: Quantify the total PHA yield [48]. b. Nuclear Magnetic Resonance (NMR): Use ¹H NMR and Diffusion Ordered Spectroscopy (DOSY) to confirm the identity of the PHA blend and distinguish between P(3HB) and mcl-PHA [46] [47]. c. Gel Permeation Chromatography (GPC): Determine the molecular weight of the synthesized polymers [46]. d. Fourier-Transform Infrared Spectroscopy (FTIR): Confirm the presence of characteristic functional groups (e.g., C=O stretching at ~1720 cm⁻¹) [48] [44].

Key Research Reagent Solutions

The table below catalogs essential materials and their functions for PHA production in P. putida.

Table 1: Essential Research Reagents for PHA Production with P. putida

Reagent / Material	Function / Application	Example & Notes
Genome-Scale Model	In silico prediction of metabolic fluxes for target identification.	iJN1463 model for P. putida KT2440 [40].
COBRApy Software	Python package for performing constraint-based modeling and FBA [40].
Inducible/Constitutive Promoters	Control expression of PHA biosynthetic genes to tailor blend composition.	Four new constitutive promoters identified for P. putida [46].
Mineral Salt Medium (MSM)	Defined medium for fermentation; composition is optimized for high PHA yield.	Contains salts like Na₂HPO₄, KH₂PO₄, MgSO₄·7H₂O, and trace elements [44] [45].
Glycerol	Low-cost carbon substrate for mcl-PHA production.	Raw glycerol from biodiesel industry; P. putida has low maintenance energy on glycerol [45].
Lignin-Derived Phenolics	Renewable carbon sources from plant biomass.	p-Coumarate, Ferulate, Vanillate, 4-Hydroxybenzoate [15].
Chloroform	Solvent for extraction and purification of PHA from cell biomass [48] [44].
Nile Blue A Stain	Fluorescent dye for specific detection of PHA accumulation in cells during screening [44].

The table below consolidates key performance metrics from recent studies on PHA production using engineered P. putida and other isolates.

Table 2: Summary of Quantitative PHA Production Data

Strain / System	PHA Type / Blend	Key Performance Metrics	Cultivation Conditions & Notes
EngineeredP. putida [46] [47]	P(3HB)/mcl-PHA Blend	3HB content: 17.9 - 99.6 mol%Max. PHA titer: 1.48 ± 0.15 g/LPHA content: 52.2 ± 4.3 wt% of CDW	Controlled via promoter selection. Higher molecular weight for P(3HB) than mcl-PHA.
P. putida KT2440 [45]	mcl-PHA from Glycerol	PHA content: 29.7 wt% of CDW (low dilution rate, N-limitation)Maintenance (mATP): 0.175 mmol ATP/gCDW/h	Nitrogen-limited chemostat. Low maintenance on glycerol is advantageous.
Bacillus endophyticus [48]	PHB from Sucrose	PHA content: ~49.9% of CDW (Bioreactor)Max. PHA titer: ~0.82 g/L (Isolate Ht3d) [44]	Statistically optimized medium. Wild-type strain using simple carbon source.
Environmental Isolates(e.g., B. subtilis) [44]	PHA from Glucose	PHA content: 34.99 ± 5.61% (Optimized)Production rate: 0.034 g/L/h	Optimal conditions: pH 7, 35°C, 48 h.

Within the framework of Flux Balance Analysis (FBA) for metabolic engineering of Pseudomonas putida, this document details a structured protocol for designing and implementing efficient biosurfactant production pathways. Rhamnolipids are glycolipid biosurfactants with significant industrial potential in bioremediation, pharmaceuticals, and cosmetics [49]. However, their native production in the opportunistic pathogen Pseudomonas aeruginosa presents safety and regulatory challenges [50]. This application note outlines a metabolic engineering pipeline using the non-pathogenic chassis P. putida KT2440, leveraging FBA and experimental validation to achieve high-yield, growth-independent rhamnolipid production from simple carbon sources like glucose [49] [50]. The integration of in silico modeling with strain engineering provides a powerful strategy to overcome the complex regulatory networks of native producers and optimize carbon flux toward target metabolites.

Background and Rationale

The Case for EngineeringPseudomonas putida

P. putida KT2440 is a soil-dwelling, non-pathogenic bacterium with a versatile metabolism, making it an ideal industrial chassis [49] [16]. Its genome is well-annotated, and a wide array of genetic tools is available for its manipulation [16]. Unlike common industrial workhorses like E. coli and B. subtilis, P. putida demonstrates exceptional tolerance to high concentrations of rhamnolipids (>90 g/L), showing almost no change in growth rate or lag-phase, which is a critical prerequisite for a production host [50].

Rhamnolipid Biosynthesis Pathway

Rhamnolipids are composed of one or two rhamnose molecules (the hydrophilic head) linked to one or two β-hydroxy fatty acid chains (the hydrophobic tail) [50]. The synthesis requires two key precursors:

• dTDP-L-rhamnose: Derived from glucose-6-phosphate via a five-step pathway encoded by the rmlBDAC operon.
• β-hydroxyacyl-ACP: An intermediate of the fatty acid de novo synthesis pathway.

The dedicated rhamnolipid synthesis involves three key enzymes:

• RhlA: An acyltransferase that dimerizes two β-hydroxyacyl-ACP molecules to form 3-(3-hydroxyalkanoyloxy)alkanoate (HAA) [49] [50].
• RhlB: A rhamnosyltransferase that condenses dTDP-L-rhamnose with HAA to form mono-rhamnolipids [49] [50].
• RhlC: A second rhamnosyltransferase that adds another rhamnose to form di-rhamnolipids [50].

In the native producer P. aeruginosa, the expression of rhlA and rhlB is organized in an operon and tightly regulated by quorum sensing, making production challenging to control [49] [50]. Heterologous expression in P. putida disconnects production from this complex regulation.

The diagram below illustrates the core metabolic engineering strategy for introducing rhamnolipid production into P. putida.

Computational Design via Flux Balance Analysis

Protocol:In SilicoModel Reconstruction and Simulation

This protocol guides the reconstruction of a genome-scale metabolic model for P. putida to predict genetic interventions that maximize rhamnolipid yield.

Materials & Reagents:

• Software: Constraint-Based Reconstruction and Analysis (COBRA) Toolbox or similar FBA platform.
• Base Model: A curated genome-scale metabolic model for P. putida (e.g., iJP962) [49].
• Reaction Database: Such as BIGG or KEGG, for incorporating heterologous reactions.

Procedure:

• Model Reconstruction: a. To the base P. putida model, add the heterologous reactions catalyzed by RhlA and RhlB from P. aeruginosa [49]. b. Define the stoichiometry for the synthesis of mono-rhamnolipids from the precursors dTDP-L-rhamnose and HAA. c. Add an exchange reaction for rhamnolipids to allow the model to "export" the product.

• Simulation Setup: a. Set constraints to reflect the desired cultivation condition (e.g., M9 minimal medium with glucose as the sole carbon source). Constrain the glucose uptake rate to a physiologically relevant value (e.g., 10 mmol/gDW/h). b. Set the oxygen uptake rate to allow for aerobic conditions.

• Flux Balance Analysis: a. Perform FBA simulations with biomass maximization as the objective function to simulate wild-type growth. b. Perform FBA with rhamnolipid production as the objective function to identify the theoretical maximum yield. c. Use parsimonious FBA or related methods to find a flux distribution that achieves high product yield without unnecessary energy expenditure.

• Identification of Intervention Strategies: a. Perform reaction knock-out simulations to identify gene deletions that may increase product yield by eliminating competing pathways (e.g., polyhydroxyalkanoate (PHA) synthesis, which consumes lipid precursors) [50]. b. Use flux variability analysis to identify reactions with high variability, as these may be key control points in the network. c. Apply machine learning techniques (e.g., regression analysis on simulated flux distributions) to identify latent pathways and reactions that are most predictive of high rhamnolipid production [49].

Expected Outcomes: The model will predict a substantial increase in rhamnolipid synthesis for the engineered strain compared to the control. It will provide a list of candidate gene knock-outs and highlight critical metabolic nodes, such as the flux split between biomass formation and product synthesis, enabling growth-decoupled production [49] [50].

Experimental Validation and Strain Engineering

Protocol: Construction of a Rhamnolipid-ProducingP. putidaStrain

This protocol describes the genetic modifications required to convert P. putida KT2440 into a high-yield rhamnolipid producer.

Research Reagent Solutions

Reagent / Genetic Element	Function / Description
Plasmid pVLT31	Broad-host-range expression vector for Pseudomonas [50].
rhlAB Operon	Genes from P. aeruginosa encoding HAA synthase (RhlA) and rhamnosyltransferase I (RhlB) [49] [50].
rmlBDAC Operon	Genes for the dTDP-L-rhamnose synthesis pathway; enhances precursor supply [51].
Synthetic Promoter Library	A set of promoters of varying strength (e.g., Plac, Ptac) to fine-tune the expression of rhlAB and avoid metabolic burden [26].
CRISPR/Recombineering System	Toolset for targeted gene knock-outs (e.g., ΔphaC to knockout PHA synthesis) [50] [31].

Procedure:

• Strain Construction: a. Clone rhlAB Operon: Amplify the rhlAB genes from P. aeruginosa genomic DNA and clone them into an expression plasmid (e.g., pVLT31) under the control of a strong, constitutive promoter. b. Co-express Rhamnose Pathway: To enhance precursor supply, clone the rmlBDAC operon into a second plasmid or integrate it into the chromosome [51]. c. Introduce Constructs: Transform the constructed plasmid(s) into P. putida KT2440 via electroporation or conjugation.

• Genetic Optimization: a. Delete Competing Pathways: Use a CRISPR-based genome editing system to knock out the phaC gene, which is essential for PHA synthesis. This prevents carbon diversion to storage lipids [50]. b. Protein Engineering (Optional): To further enhance yield, engineer the RhlA enzyme for improved catalytic activity. For example, the mutant RhlA^F43W/G130N has been shown to significantly increase production [51].

• Fine-Tuning Expression: a. Promoter Engineering: Test a library of synthetic promoters to drive rhlAB expression. The goal is to create a high metabolic demand for precursors, which naturally pulls flux from the central carbon metabolism without causing toxicity [26]. b. The optimal strain should achieve a balance where the flux through the rhamnose pathway increases by up to 300% and the flux through fatty acid synthesis increases by 50% [26].

The following workflow summarizes the integrated computational and experimental process for developing a high-performance production strain.

Fermentation and Process Optimization

Protocol: Fed-Batch Fermentation for High-Density Production

This protocol describes a fed-batch fermentation process to achieve high rhamnolipid titers in a bioreactor.

Materials & Reagents:

• Bioreactor: A bench-top bioreactor (e.g., 5 L total volume) with controls for dissolved oxygen (DO), pH, temperature, and agitation.
• Production Medium: Basal Salt Medium (BSM) supplemented with a defined carbon source (e.g., glucose, glycerol) [52].
• Antifoam: A food-grade antifoam agent or the use of ethanol, which can also serve as a co-substrate and defoamer [53].

Procedure:

• Inoculum Preparation: a. Grow the engineered P. putida strain overnight in LB medium with appropriate antibiotics. b. Use this culture to inoculate a seed flask containing production medium. Grow until mid-exponential phase.

• Bioreactor Setup and Batch Phase: a. Transfer the production medium to the bioreactor and sterilize in situ. b. Inoculate the bioreactor to an initial optical density (OD₆₀₀) of ~0.1. c. Set initial conditions: temperature = 30°C, pH = 6.5 (controlled with NH₄OH or NaOH), agitation = 400-500 rpm, aeration = 1.0-1.5 vvm [52].

• Fed-Batch Operation: a. Initiate the feed of a concentrated carbon source (e.g., 500 g/L glucose or waste glycerol) once the initial batch carbon is depleted, typically indicated by a sharp rise in DO. b. Control the feed rate to maintain a low, constant residual substrate level, preventing overflow metabolism and catabolite repression. c. Monitor foaming closely. Implement a mechanical foam breaker or use a controlled feeding of ethanol (e.g., 1-2 g/L) which acts as both a carbon source and a defoamer [53].

• Process Monitoring: a. Take periodic samples to measure biomass (OD₆₀₀ or DCW), residual carbon, and rhamnolipid concentration. b. The fermentation is typically stopped after 70-100 hours when productivity declines.

Analytical Methods for Quantification

Protocol: Rhamnolipid Extraction and Analysis

Materials & Reagents:

• Extraction Solvent: Ethyl acetate or dichloromethane.
• Analytical Standard: Pure mono-rhamnolipid (e.g., L-rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydecanoate).
• Equipment: Centrifuge, rotary evaporator, HPLC system with a C18 reversed-phase column and a mass spectrometer (LC-MS) or a refractive index detector.

Procedure:

• Extraction: a. Acidify the culture broth to pH ~2.0 using concentrated HCl to precipitate rhamnolipids. b. Extract the acidified broth with an equal volume of ethyl acetate. Separate the organic phase by centrifugation. c. Repeat the extraction twice and pool the organic phases. d. Evaporate the solvent using a rotary evaporator. Weigh the crude rhamnolipid extract to determine the gross titer.

• Quantification (Orcinol Assay): a. Dissolve a portion of the crude extract in distilled water. b. Mix with an orcinol reagent (0.19% orcinol in 53% H₂SO₄). c. Incubate at 80°C for 30 minutes, cool, and measure the absorbance at 421 nm. d. Calculate the rhamnolipid concentration using a standard curve prepared with L-rhamnose.

• Congener Profile Analysis (LC-MS): a. Dissolve the extract in methanol and filter. b. Inject into the LC-MS system. Use a water-acetonitrile gradient (both containing 0.1% formic acid) for separation. c. Identify and quantify different rhamnolipid congeners (e.g., C₁₀-C₁₀ mono-rhamnolipid) based on their mass-to-charge ratio and comparison with available standards.

Performance Metrics and Benchmarking

The success of the FBA-guided engineering approach can be evaluated by comparing the performance of the engineered strains against benchmarks and theoretical maxima. The table below summarizes key performance indicators from published studies.

Table 1: Performance Benchmarks for Rhamnolipid Production in Engineered P. putida

Engineered Strain / Strategy	Carbon Source	Maximum Titer (g/L)	Productivity (g/L/h)	Yield (g/g substrate)	Key Features	Reference
KT2440 pVLT31_rhlAB (Initial Engineered)	Glucose	~2.3	0.015	0.15	Growth-independent production; PHA knockout	[50]
KT2440 with "Driven by Demand"	Sugar	N/A	N/A	0.40 (Cmol/Cmol)	Optimized promoter for rhlAB; ~55% theoretical yield	[26]
KT2440 with RhlAF43W/G130N & Δflag (Strain E3)	Glucose & Glycerol	28.6	0.30	N/A	Protein & metabolic engineering; highest titer in KT2440	[51]
Theoretical Maximum Yield	Glucose	N/A	N/A	~0.47 (Cmol/Cmol)	In silico predicted optimum	[26]
P. aeruginosa (Native Producer)	Plant Oils	>150	1.64	0.92	Pathogenic; complex regulation; high titer	[54]

Troubleshooting

• Low Titer / Yield: Verify the expression of rhlAB and rmlBDAC via RT-PCR. Ensure that competing pathways (e.g., PHA) have been successfully knocked out. Use FBA to simulate and identify other potential flux bottlenecks.
• Excessive Foaming: Increase the use of mechanical foam breaking or optimize the feed rate of ethanol as a chemical defoamer [53].
• Strain Instability: Maintain antibiotic selection pressure throughout the preculture stages. If using unstable plasmids, consider chromosomal integration of the key genes.
• Slow Growth of Engineered Strain: The metabolic burden of heterologous expression can slow growth. Use promoter engineering to fine-tune gene expression and balance growth with production [26].

Addressing FBA Limitations and Model-Experiment Gaps

Identifying and Resolving Metabolic Bottlenecks in Aromatic Compound Catabolism

Within the framework of Flux Balance Analysis (FBA) for metabolic engineering of Pseudomonas putida, a critical challenge is the identification and resolution of metabolic bottlenecks that limit the efficient catabolism of aromatic compounds. Lignin-derived aromatic feedstocks represent a vast renewable resource for producing value-added chemicals, yet their bioconversion is often hindered by innate metabolic checkpoints that constrain carbon flux and cofactor imbalance [15] [31]. This application note details the systematic experimental and computational protocols, based on recent multi-omics investigations, for diagnosing these limitations in P. putida KT2440 and implementing effective metabolic engineering strategies to overcome them. The methodologies outlined herein are essential for advancing the use of this robust microbial chassis in lignin valorization and biorefinery applications.

Background: Aromatic Catabolism and inherent Bottlenecks inP. putida

Pseudomonas putida KT2440 natively catabolizes various aromatic compounds via the β-ketoadipate pathway, funneling substrates like p-coumarate (COU), ferulate (FER), vanillate (VAN), and 4-hydroxybenzoate (4HB) into central metabolism through protocatechuate (PCA) [15]. However, quantitative multi-omics studies have consistently revealed that the native metabolic network, while versatile, possesses inherent bottlenecks at key nodes. These bottlenecks manifest as intracellular metabolite accumulation, extracellular overflow, and suboptimal cofactor regeneration, ultimately limiting the rates and yields of bioconversion processes [15] [31].

Recent 13C-fluxomics analysis has demonstrated that the native metabolism of P. putida undergoes significant remodeling to maintain energy charge during growth on aromatics. This involves upregulation of anaplerotic reactions and the glyoxylate shunt to balance carbon flow and generate crucial reducing equivalents [15]. Specifically, the metabolism adjusts to produce 50–60% of NADPH and 60–80% of NADH via these remodeled pathways, resulting in an ATP surplus up to 6-fold greater than during growth on succinate. Understanding and engineering these network properties is fundamental to overcoming bottlenecks.

The diagram below illustrates the primary catabolic pathways for hydroxycinnamates and hydroxybenzoates in P. putida KT2440, highlighting the key bottleneck nodes identified through experimental analysis.

Figure 1: Catabolic Pathways and Key Bottlenecks in P. putida. The diagram visualizes the primary routes for aromatic compound catabolism, pinpointing four major bottleneck nodes (Vdh, VanAB, PobA, PcaHG) identified through intracellular metabolomics and 13C kinetic profiling [15].

Quantitative Profiling of Metabolic Bottlenecks

Integrated analysis of metabolomics, proteomics, and 13C-fluxomics data has quantitatively identified several critical bottlenecks in the aromatic catabolism of P. putida. The table below summarizes these key nodes, their metabolic context, and the quantitative evidence supporting their identification.

Table 1: Experimentally Identified Metabolic Bottlenecks in Aromatic Catabolism of P. putida

Bottleneck Node	Pathway Context	Associated Gene(s)	Quantitative Evidence
Vdh	Coniferyl Branch (FER → Vanillin)	vdh	20-fold higher intracellular vanillin (4.3 ± 0.5 µmol/gCDW) vs. precursor feruloyl-CoA [15].
VanAB	Coniferyl/Hydroxybenzoate Branch (Vanillin → PCA)	vanA, vanB	Low PCA (0.8 ± 0.1 µmol/gCDW) with VAN feeding; inefficient conversion [15].
PobA	p-Coumaroyl Branch (COU → 4HB)	pobA	Extracellular accumulation of 4HB during growth on COU [15] [31].
PcaHG	Central Funnel (PCA → β-Ketoadipate)	pcaH, pcaG	Low intracellular PCA levels across multiple aromatic substrates [15].
Fumarase Hydratase	TCA Cycle	fumC1/PP_0944, fumC2/PP_1755, PP_0897	Essential for growth on p-CA in multi-gene knockout strains; requires careful expression tuning [31].

Impact on Cofactor Metabolism

A primary consequence of these bottlenecks is the disruption of cellular energy charge. Quantitative 13C-fluxomics has revealed that P. putida remodels its central metabolism on aromatic substrates to generate a significant surplus of ATP and reducing power. The flux redistribution is characterized by:

• Up to 30-fold increase in pyruvate carboxylase and glyoxylate shunt proteins [15].
• Anaplerotic carbon recycling through pyruvate carboxylase promotes TCA cycle fluxes, generating 50–60% of the NADPH yield and 60–80% of the NADH yield [15].
• The glyoxylate shunt sustains cataplerotic flux through malic enzyme, supplying the remaining NADPH required for biosynthesis and stress tolerance [15].

This metabolic rewiring ensures a favorable energy balance despite bottlenecks in the upstream peripheral pathways. Engineering strategies must therefore consider the systemic impact of modifying single nodes on this cofactor balancing act.

Experimental Protocols for Bottleneck Identification

This section provides a detailed workflow for employing multi-omics techniques to identify and quantify metabolic bottlenecks in engineered P. putida strains.

Protocol 1: Intracellular Metabolomics for Identifying Chokepoints

Principle: Direct measurement of intracellular metabolite concentrations can reveal bottlenecks where a metabolite pool expands significantly due to a kinetic limitation in its consuming reaction [15].

Materials:

• Quenching Solution: 60% (v/v) buffered ethanol at -40°C.
• Extraction Solvent: 60% (v/v) ethanol buffered with 10 mM ammonium acetate (pH 7.2).
• Analysis Instrumentation: LC-MS/MS system (e.g., Waters Acquity UPLC coupled to Thermo TSQ Quantum Ultra).

Procedure:

• Culture and Sampling: Grow P. putida KT2440 in M9 minimal medium with the target aromatic compound (e.g., FER, COU, VAN, 4HB) as the sole carbon source. Harvest cells at mid-exponential phase (OD600 ~0.5) by fast centrifugation (13,000 × g, 30 s, -4°C).
• Metabolite Quenching and Extraction: Immediately resuspend the cell pellet in 1 mL of cold quenching solution. Perform three sequential extractions with 0.5 mL of pre-warmed (78°C) extraction solvent, each for 1 minute. Pool the supernatants after centrifugation.
• Sample Preparation: Dry the pooled extract under vacuum (120 μbar). Resuspend the dried metabolites in 20 μL of MilliQ water for LC-MS/MS analysis.
• Data Analysis: Quantify the absolute concentrations of pathway intermediates (e.g., feruloyl-CoA, vanillin, vanillate, PCA). A bottleneck is indicated by a statistically significant accumulation of an intermediate relative to its precursor and product (e.g., the 20-fold higher vanillin concentration in the FER pathway) [15].

Protocol 2: 13C-Kinetic Flux Profiling for Resolving In Vivo Reaction Rates

Principle: Tracking the incorporation of a 13C-labeled substrate into downstream metabolites over time provides direct insight into in vivo reaction rates and can pinpoint steps with limited flux capacity [15].

Materials:

• 13C-Labeled Substrate: For example, [ring-13C6]-Ferulate or other universally/enzymatically labeled aromatic compounds.
• Custom Bioreactor: Allows for rapid medium switching and precise sampling.

Procedure:

• Pulse Experiment: Grow cells in minimal medium with unlabeled substrate until mid-exponential phase. Rapidly switch the feed to an identical medium containing the 13C-labeled substrate.
• Time-Course Sampling: Take multiple culture samples (biomass for 0.5–0.6 mg CDW) over a short time course (e.g., 0, 0.5, 1, 2, 5 minutes) using fast filtration or centrifugation.
• Metabolite Extraction and Analysis: Follow the extraction procedure from Protocol 1. Use LC-MS/MS to determine the 13C-labeling pattern and isotopic enrichment of intracellular metabolites.
• Flux Calculation: Model the time-dependent labeling data to estimate metabolic fluxes. A slower incorporation of the 13C-label into a specific metabolite pool compared to its precursor indicates a kinetic bottleneck at the consuming reaction. For instance, the 50% lower 13C incorporation in vanillin versus feruloyl-CoA within 1 minute of the isotope switch confirms the Vdh bottleneck [15].

The workflow for implementing these complementary protocols is illustrated below.

Figure 2: Experimental Workflow for Bottleneck Identification. The diagram outlines the sequential and integrated application of metabolomics and kinetic flux profiling protocols to pinpoint metabolic chokepoints.

Metabolic Engineering Strategies to Overcome Bottlenecks

Once a bottleneck is identified, targeted metabolic engineering strategies can be deployed to resolve the flux limitation. The table below lists key reagents and genetic tools for implementing these strategies in P. putida.

Table 2: Research Reagent Solutions for Metabolic Engineering in P. putida

Reagent / Tool	Function / Application	Example Use Case
pSEVA Vectors	Modular, broad-host-range plasmids for gene expression.	Overexpression of ubiC (chorismate lyase) and aroGD146N (feedback-resistant DAHP synthase) for PHBA production [22].
CRISPR/recombineering	Systems for precise genome editing (deletions, insertions).	Deletion of competing genes (pobA, pheA, trpE) or putative bottleneck genes (vanAB) [22] [31].
Synthetic Promoter Library	A library of characterized promoters for tuning gene expression strength.	Optimizing expression of rhlAB for rhamnolipid synthesis; titrating expression of essential genes like PP_0897 [26] [31].
Genome-Scale Model (GEM)	Computational model for predicting metabolic fluxes and gene essentiality.	iJN1462 (KT2440) and iSH1474 (S12) models used for predicting growth-coupling designs and flux distributions [55] [3].

Strategy 1: Targeted Overexpression and Deletion

This classic approach involves reinforcing limiting steps and removing competing reactions.

• Protocol for Overexpression:
  • Gene Selection: Identify the structural gene of the limiting enzyme (e.g., ubiC for chorismate lyase, aroB for 3-dehydroquinate synthase) [22] [56].
  • Vector Construction: Clone the gene into an appropriate pSEVA plasmid under a constitutive or inducible promoter from a synthetic library (e.g., strong promoter JE111111) [56].
  • Strain Transformation: Introduce the constructed plasmid into the production host via electroporation.
• Protocol for Gene Deletion:
  • Target Identification: Identify genes encoding enzymes that divert carbon away from the desired product (e.g., pobA for PHBA degradation, pheA/trpE for competing chorismate consumption) [22].
  • Deletion Construct: Use pEMG plasmids or CRISPR/recombineering systems to create in-frame deletions [22] [31].
  • Strain Validation: Verify the deletion by PCR and phenotypic assays (e.g., loss of ability to grow on the deleted enzyme's substrate).

Strategy 2: Combinatorial Optimization of Pathway Expression

For complex pathways like the shikimate pathway, balancing the expression of multiple genes is crucial.

• Protocol using Statistical Design of Experiments (DoE):
  • Factor Selection: Define the genes in the pathway to be optimized (e.g., aroB, aroQ, aroE, aroK for shikimate pathway) [56].
  • Design Matrix: Select a statistical design (e.g., Plackett-Burman) to create a minimal, orthogonal set of strain variants, each with a specific combination of genes expressed at "high" or "low" levels. This drastically reduces the number of strains to be built and tested from a full combinatorial set.
  • Strain Construction & Screening: Build the strains using modular genetic parts (promoters, RBS) and measure the product titer (e.g., p-aminobenzoic acid).
  • Modeling and Prediction: Fit a linear regression model to the screening data to identify genes with significant positive or negative effects on production. Use the model to predict optimal expression levels for a new round of engineering [56].

Strategy 3: Implementation and Validation of Growth-Coupling Designs

FBA and GEMs can be used to compute gene deletion sets that couple product formation to growth, ensuring stable production.

• Protocol for Growth-Coupling Strain Engineering:
  • In Silico Design: Use algorithms like cMCS (constrained Minimal Cut Sets) on a GEM (e.g., iJN1462) to identify a set of gene deletions that make product formation essential for growth on the target substrate (e.g., p-coumarate) [31].
  • Staged Implementation: Delete the predicted genes sequentially from the host genome. Monitor growth and product formation after each deletion. Some deletions (e.g., fumC1, fumC2) may be benign, while others (e.g., PP_0897) may require careful tuning [31].
  • Titration of Essential Reactions: If a required deletion proves lethal or overly detrimental, use promoter titration (see Table 2) to reduce the expression of the corresponding enzyme to a minimal, non-lethal level instead of complete deletion [31].
  • Validation: Characterize the final strain in controlled bioreactors to validate the predicted growth-coupled phenotype and measure the final product yield.

Overcoming Gene Essentiality and Redundancy Challenges in Multi-Gene Deletions

In the context of Flux Balance Analysis (FBA)-driven metabolic engineering of Pseudomonas putida, a critical challenge arises when implementing in silico-predicted multi-gene deletion strategies. Genome-scale metabolic models (GSMMs) provide gene essentiality predictions that guide strain design [57] [6]. However, experimental implementation often reveals limitations due to gene essentiality under specific conditions and enzymatic redundancies not fully captured by models [31]. This application note details integrated computational and experimental protocols to overcome these barriers, enabling successful implementation of growth-coupled production strains in P. putida.

Computational Prediction of Gene Essentiality

Fundamentals of FBA-Based Essentiality Screening

Flux Balance Analysis employs constraint-based modeling to predict essential metabolic reactions and genes. The methodology involves:

• In silico single deletion analysis: Systematically removing each metabolic reaction from the network and simulating growth using FBA [57]
• Essentiality threshold: Reactions are classified as essential if their deletion reduces growth below 10% of wild-type flux through the biomass reaction [57]
• Gene-protein-reaction (GPR) mapping: Boolean logic statements link genes to protein complexes and reactions, enabling translation of reaction essentiality to gene essentiality [4]

Limitations in Predicting Redundancy and Contextual Essentiality

GSMMs frequently fail to predict:

• Isozyme redundancy: Multiple genes encoding enzymes catalyzing the same reaction [31]
• Conditional essentiality: Genes non-essential in rich media but essential in minimal or production media [31]
• Incomplete annotation: Metabolic functions of under-characterized proteins not represented in models [31]

Table 1: Accuracy of Gene Essentiality Predictions in P. putida Metabolic Models

Model Name	Genes Included	Prediction Accuracy	Key Limitations
iJP815 [4] [6]	815 (15% of genome)	75% auxotrophy correct	Incomplete aromatic metabolism
iJN1462 [2]	1,462 (27% of genome)	Improved over previous	Limited non-sugar carbon sources

Experimental Tools for Multi-Gene Deletion

Advanced Genome Editing Systems

Two primary systems enable efficient multi-gene deletion in P. putida:

This system enables deletion of large chromosomal regions through:

• Linear DNA fragment integration: 100-bp homology arms flanking antibiotic resistance markers
• Marker excision: Cre-lox system removal of selection markers post-integration
• Key advantage: Enables deletion of regions up to 101.7 kb in single recombineering rounds

A rapid, all-in-one plasmid system features:

• Single-plasmid approach: Combines Cas9, sgRNA, and homology-directed repair template
• Rapid curing: pBBR1MCS2 backbone easily cured at 30°C without inducers
• Editing efficiency: Optimized with 500-bp homology arms
• Iterative editing: Requires <1.5 days per edit cycle

Protocol: Multi-Gene Deletion Workflow

Diagram 1: Integrated computational and experimental workflow for implementing multi-gene deletions in P. putida.

Case Study: Overcoming Fumarase Hydratase Redundancy

Growth-Coupling Design for p-Coumarate to Glutamine

A four-gene deletion design targeted:

• PP_1378 (α-ketoglutarate/3-oxoadipate permease)
• Three fumarate hydratases: PP0897, PP0944 (fumC1), PP_1755 (fumC2) [31]

Experimental Implementation Challenges

• Triple deletion strain (∆PP1378, ∆PP1755, ∆PP_0944): Viable but suboptimal production [31]
• Quadruple deletion (adding ∆PP_0897): Lethal on p-coumarate minimal medium despite in silico predictions [31]
• Fumarase dependency: Essential TCA cycle flux maintained through PP_0897 activity [31]

Resolution Strategy: Promoter Titration

• Partial knockdown: Replaced native PP0897 promoter with low-activity variants (pJ23109, PP0415) [31]
• Controlled expression: ~8-fold reduction in PP_0897 expression enabled growth and production [31]
• Flux optimization: Fine-tuned fumarate hydratase activity to balance TCA cycle and production fluxes [31]

Table 2: Quantitative Analysis of Fumarase Hydratase Deletion Strains

Genotype	Growth on p-Coumarate	Glutamine Production	Key Findings
∆PP1378, ∆PP1755, ∆PP_0944	Normal	Suboptimal	Partial growth coupling achieved
∆PP1378, ∆PP1755, ∆PP0944, ∆PP0897	No growth	None	Essential function revealed
PPP0415-PP0897 (partial knockdown)	Reduced	High	Successful growth coupling

Integrated Computational-Experimental Framework

Protocol: Essentiality Refinement Pipeline

Diagram 2: Iterative refinement pipeline for identifying and overcoming gene essentiality and redundancy.

Machine Learning-Enhanced Curation

The AMMEDEUS approach employs:

• Model ensembles: Generate multiple models consistent with experimental data [58]
• Feature importance: Machine learning identifies structural variants influencing predictions [58]
• Curation prioritization: Highlights database annotations needing refinement [58]

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Reagents for Multi-Gene Deletion Studies

Reagent/System	Function	Key Features	Application Context
RecET recombineering system [59]	Large fragment deletion	GC-content independent; markerless; 100-bp homology arms	Deleting redundant gene clusters
pBBR-Cas9 system [60]	CRISPR/Cas9 editing	Single-plasmid; easily cured; 500-bp homology arms	Rapid iterative gene deletions
lox71-tetA(C)-lox66 cassette [59]	Selection and counter-selection	Tetracycline resistance; Cre-excisable	Marker recycling for multiple deletions
pJB658-recET vector [59]	Recombineering protein expression	Tight Pm/XylS regulation; plasmid instability enables curing	Controlled recombinase expression
iJN1462 metabolic model [2]	Gene essentiality prediction	1,462 genes; 2,929 reactions; validated with experimental data	In silico deletion design

Successful implementation of multi-gene deletion strategies in P. putida requires integrated computational-experimental approaches. Key principles include:

• Redundancy mapping: Systematic combinatorial deletion testing to identify isozyme networks
• Essentiality context: Validation under production conditions, not just rich media
• Expression tuning: Promoter engineering as an alternative to complete gene deletion
• Iterative refinement: Using experimental failures to improve model accuracy

These protocols provide a framework for overcoming the challenges of gene essentiality and redundancy in metabolic engineering projects using P. putida, ultimately enabling more predictable implementation of growth-coupled production strains for biotechnology applications.

Incorporating Enzyme Kinetics and Regulatory Constraints into FBA

Flux Balance Analysis (FBA) is a constraint-based computational method widely used to predict metabolic fluxes in genome-scale metabolic models (GEMs). Conventional FBA relies primarily on stoichiometric constraints and mass balance, assuming the metabolic network is in a steady state. However, standard FBA does not account for critical biological limitations such as enzyme kinetics and regulatory constraints, which often results in predictions that deviate from experimental observations. Incorporating these additional layers of constraint significantly enhances model predictive accuracy by more realistically capturing cellular metabolism. This protocol details methods for integrating enzyme kinetics and regulatory information into FBA, with specific application to metabolic engineering of Pseudomonas putida.

Theoretical Framework

From Stoichiometric to Constraint-Based Models

The foundation of FBA is the stoichiometric matrix S, which represents the connectivity of all metabolic reactions in the network. The fundamental equation is:

Sv = 0

where v is the vector of metabolic fluxes. The solution space is constrained by lower and upper bounds on fluxes: α ≤ v ≤ β. The classic FBA problem identifies a flux distribution that maximizes a cellular objective (e.g., biomass yield) within these bounds [61].

To enhance the predictive power of FBA, the model can be extended by incorporating additional constraints:

• Enzyme Kinetics Constraints: Limit reaction fluxes based on the catalytic capacity of enzymes (kcat) and their available concentrations.
• Thermodynamic Constraints: Ensure reactions proceed in thermodynamically feasible directions.
• Regulatory Constraints: Incorporate transcriptional regulation and allosteric interactions that modulate enzyme activity.

These additions create a Multi-Constraint Metabolic Network Model (MCGEM), which provides a more accurate representation of cellular metabolism [62].

Mathematical Representation of Enzyme Constraints

The enzyme capacity constraint for a reaction i can be formulated as:

Equation Component	Description
( v_i )	Flux through reaction ( i )
( [E_i] )	Concentration of enzyme catalyzing reaction ( i )
( k_{cat}^i )	Turnover number of the enzyme for reaction ( i )
( MW_i )	Molecular weight of the enzyme

The total enzyme pool is limited, providing a global constraint:

[ \sum{i=1}^{n} [Ei] \leq [E_{total}] ]

where ( [E_{total}] ) is the total enzyme capacity available in the cell, which can be derived from proteomic data [62].

Protocol: Implementing Enzyme-Constrained FBA

This section provides a step-by-step protocol for constructing and simulating an enzyme-constrained metabolic model, using the GECKO (GEM with Enzymatic Constraints using Kinetic and Omics data) framework as a guide.

Model Construction and Curation

Step 1: Prepare the Genome-Scale Metabolic Model (GEM)

• Begin with a well-curated GEM for your target organism. For P. putida, the iJN1411 model is a high-quality starting point [63].
• Ensure the model is functionally complete and can produce biomass precursors and cofactors under defined conditions.

Step 2: Collect Enzyme Kinetic Parameters

• kcat values: Compile enzyme turnover numbers from databases (e.g., BRENDA, SABIO-RK) or primary literature. For P. putida-specific enzymes, manual curation may be necessary.
• Molecular Weights (MW): Obtain the molecular weight (in kDa) for each enzyme from protein sequence databases.
• Protein Abundance: If available, incorporate absolute protein abundance data from proteomics studies to inform enzyme concentration limits.

Step 3: Formulate the Enzyme Capacity Constraint

• For each reaction i in the model, add the constraint ( vi \leq k{cat}^i \times [E_i] ).
• Introduce a pseudo-reaction (( R_{pool} )) that consumes a "pool" of enzyme resources. The flux through this reaction is limited by the total measured or estimated protein mass fraction of the cell [62].

Step 4: Integrate Thermodynamic Constraints (Optional but Recommended)

• Use the Group Contribution Method to estimate the standard Gibbs free energy of formation (( \Delta_f G'^\circ )) for metabolites.
• Calculate the apparent Gibbs free energy of reaction (( \Delta_r G' )) using measured metabolite concentrations.
• Apply a thermodynamic feasibility constraint to prevent reactions from proceeding in a thermodynamically infeasible direction (positive ( \Delta_r G' ) for a forward reaction) [63] [62].

Simulation and Analysis

Step 5: Define Simulation Conditions

• Set the substrate uptake rate(s) according to your experimental setup.
• Define the composition of the growth medium to constrain exchange reactions accordingly.

Step 6: Solve the Enzyme-Constrained FBA Problem

• The optimization problem becomes: Maximize ( c^T v ) (e.g., biomass production) Subject to:
  • ( Sv = 0 ) (Mass balance)
  • ( \alphai \leq vi \leq \betai ) (Flux bounds)
  • ( vi \leq k{cat}^i \times [Ei] ) (Enzyme capacity)
  • ( \sum MWi \times [Ei] \leq P_{total} ) (Total enzyme pool)

Step 7: Analyze Results and Predict Metabolic Engineering Targets

• Compare the flux distributions from the enzyme-constrained model and the base model.
• Identify bottleneck reactions whose fluxes are strongly limited by enzyme capacity. These are potential overexpression targets.
• Use advanced algorithms like ecFSEOF (enzyme-constrained Flux Scanning based on Enforced Objective Flux) to systematically identify gene targets for overexpression, knockdown, or knockout to improve product yield [64] [65].

Figure 1: Workflow for constructing and simulating an enzyme-constrained FBA model.

Application Notes forPseudomonas putida

Case Study: Enhancing Acetyl-CoA-Dependent Bioproduction

Acetyl-CoA is a key precursor for many valuable chemicals. A kinetic model of P. putida's central carbon metabolism was constructed by integrating fluxomic and metabolomic datasets with manually curated enzyme mechanisms.

• Model Prediction: The kinetic model identified citrate synthase (encoded by gltA) and the essential acetyl-CoA carboxylase (encoded by accA) as key nodes controlling acetyl-CoA availability [41].
• Experimental Validation: CRISPRi (CRISPR interference) was used to dynamically knock down the expression of gltA and accA.
• Result: This intervention led to an 8-fold increase in intracellular acetyl-CoA levels and a subsequent 5-fold increase in poly(3-hydroxybutyrate) (PHB) titers in glucose-fed bioreactor cultures [41].

Case Study: ecFactory for Systematic Strain Design

The ecFactory tool leverages enzyme-constrained models (ecModels) to predict gene targets for overproducing 103 different chemicals in yeast, a methodology directly applicable to P. putida.

• Method: ecFactory combines enforced objective flux scanning with enzyme constraint-based filtering to prioritize the most critical and efficient genetic modifications [64].
• Outcome: The tool significantly reduced the number of candidate targets. For a given product, it filtered an initial list of ~85 gene targets down to an average of 7 for overexpression, 9 for knockdown, and 5 for knockout, dramatically increasing the precision of metabolic engineering designs [64].

Table 1: Key Reagent Solutions for Implementing Enzyme-Constrained FBA in P. putida

Research Reagent / Tool	Function / Application	Specific Example / Note
Genome-Scale Model (GEM)	Base metabolic network for constraint-based modeling.	P. putida KT2440 model iJN1411 (2,581 reactions, 1,411 genes) [63].
GECKO Toolbox	Automated pipeline for constructing enzyme-constrained models from GEMs.	Integrates kcat values, enzyme mass fractions; compatible with standard SBML models [64] [62].
ORACLE Framework	Constructs populations of large-scale kinetic models for uncertainty analysis.	Used to build kinetic models of P. putida with 775 reactions [63].
CRISPRi/dCas9 System	Enables tunable knockdown of essential and non-essential genes for model validation.	Used for dynamic control of gltA and essential accA genes in P. putida [41].
ecFactory Algorithm	Predicts and ranks high-priority metabolic engineering targets from ecModels.	Applies ecFSEOF and enzyme efficiency filters to minimize target list [64].

Table 2: Quantitative Parameters for Enzyme Constraints in P. putida Models

Parameter	Symbol	Example Value / Range	Data Source
Enzyme Turnover Number	( k_{cat} )	Order of ( 10^0 ) - ( 10^3 ) ( s^{-1} )	BRENDA Database, Literature
Molecular Weight of Enzyme	( MW )	kDa per enzyme	UniProt Database
Total Enzyme Mass Fraction	( P_{total} )	~0.55 g protein / gCDW	Proteomics data for P. putida
Maintenance Energy (on glycerol)	( m_{ATP} )	0.175 mmol ATP / (gCDW · h)	Physiological data from chemostat cultures [66].
Standard Gibbs Energy of Reaction	( \Delta_r G'^\circ )	Reaction-specific (kJ/mol)	Group Contribution Method [63].

The Scientist's Toolkit

Table 3: Essential Computational and Experimental Resources

Category	Tool / Reagent	Key Function
Computational Tools	GECKO Toolbox	Automates building of enzyme-constrained models [62].
	ORACLE Framework	Generates populations of large-scale kinetic models for robust predictions [63].
	ecFactory	Predicts and filters high-priority gene targets for strain design [64].
	AutoPACMEN	Automated integration of protein allocation constraints into metabolic networks [62].
Experimental Techniques	CRISPRi/dCas9	Provides dynamic, tunable gene knockdown for validating model-predicted targets [41].
	Chemostat Cultivation	Generates high-quality physiological data (e.g., maintenance energy) for model parametrization [66].
	LC-MS/MS (Proteomics)	Quantifies absolute enzyme abundances for constraining the enzyme pool [62].

Figure 2: Conceptual diagram showing how multiple constraint types are integrated into a base metabolic model to create a more predictive Multi-Constraint GEM (MCGEM).

Within the framework of Flux Balance Analysis (FBA) for metabolic engineering of Pseudomonas putida, computational strain design has emerged as a cornerstone for developing high-performance microbial cell factories. Two major families of algorithms have co-evolved to address this challenge: those based on flux balance analysis, initiated by the pioneering OptKnock framework, and those employing the concept of constrained Minimal Cut Sets (cMCS) [67] [68]. These methods enable the rational design of bacterial strains whose metabolic networks are rewired to overproduce target biochemicals efficiently. For P. putida—a metabolically versatile, stress-resistant bacterium with immense biotechnological potential—the application of these algorithms has proven particularly valuable [4] [69]. This protocol details the implementation of OptKnock and cMCS algorithms for robust strain design in P. putida, providing application notes, experimental validation methodologies, and resource guides for researchers.

Theoretical Foundation and Key Concepts

Growth-Coupled Production as a Design Principle

The fundamental principle underpinning both OptKnock and cMCS is growth-coupled production [70]. This approach engineers strains where biochemical production becomes obligatory for growth, making production an integral part of the organism's metabolic function. When such growth-coupled strains are subjected to adaptive laboratory evolution, they naturally evolve toward higher productivity as growth optimization drives flux through production pathways [67]. Two coupling strengths can be distinguished:

• Weak coupling: High product yield is achieved at maximal or near-maximal growth rates.
• Strong coupling: Production occurs even without growth, meaning substrate uptake enforces product formation under all conditions [70].

Studies demonstrate that strong growth-coupled production is feasible for over 96% of metabolites in major production organisms including E. coli, S. cerevisiae, C. glutamicum, A. niger, and Synechocystis sp., highlighting the broad applicability of this design principle [70].

Algorithm Families in Strain Design

Table 1: Comparison of Major Strain Design Algorithm Families

Feature	OptKnock Family	cMCS Family
Core Principle	Bilevel optimization (model vs. engineer)	Intervention sets blocking undesired phenotypes
Primary Approach	Flux Balance Analysis (FBA)	Elementary Mode/Vector Analysis
Mathematical Formulation	Mixed Integer Linear Programming (MILP)	Linear Programming (LP) & MILP
Intervention Types	Primarily gene knockouts	Knockouts, regulation, pathway insertion
Computational Complexity	High for genome-scale models	Very high, but recent improvements enable genome-scale application
Key Advantage	Identifies growth-coupled designs	Guarantees strong coupling when solutions exist

OptKnock Framework and Protocol

Core Algorithm and Mechanism

OptKnock, the first systematic optimization-based strain design method, employs a bilevel optimization framework to identify reaction deletion strategies that couple product synthesis to growth [67] [71]. The formulation consists of:

• Outer optimization problem: Maximizes product yield
• Inner optimization problem: Maximizes cellular growth rate, mimicking cellular objective [67]

Using duality theory, this bilevel problem is reformulated as a single Mixed Integer Linear Programming (MILP) problem. A key limitation of the original OptKnock is solution degeneracy in the inner problem, which can yield overly optimistic predictions. This has been addressed by extensions like RobustKnock, which uses a max-min strategy to ensure effective growth-coupling [67].

Implementation Protocol forP. putida

Table 2: Computational Implementation of OptKnock for P. putida

Step	Procedure	Tools/Resources
1. Model Preparation	Obtain curated GSMM (iJN746, iJP815, iML1515)	Biocyc, BIGG, MetaNetX
2. Constraints Definition	Set substrate uptake (e.g., glucose, p-coumarate) and environmental conditions	COBRA Toolbox, CVXPY
3. Problem Formulation	Implement bilevel optimization with growth and product objectives	MATLAB, Python (COBRApy)
4. Solution	Solve MILP using appropriate solvers	Gurobi, CPLEX, SCIP
5. Validation	Compare predicted yields with theoretical maximum and test robustness	FVA, MOMA, ROOM

Application Notes forP. putida

• Model Selection: For P. putida applications, use organism-specific genome-scale metabolic models such as iJN746 (746 genes, 950 reactions) or iJP815 (877 reactions, 886 metabolites) [4] [69]. These incorporate biotechnologically relevant pathways including polyhydroxyalkanoate (PHA) synthesis and aromatic compound catabolism.

• Non-Model Carbon Sources: When working with lignin-derived aromatics like p-coumarate (p-CA), account for potential substrate toxicity and incomplete metabolic data in model constraints [31].

• Genetic Tool Compatibility: Design deletion strategies compatible with available genetic tools for P. putida, considering that the percentage of irrepressible reactions (those that cannot be knocked out) can reach up to 34.5% in some models [70].

Constrained Minimal Cut Sets (cMCS) Framework and Protocol

Core Algorithm and Mechanism

The cMCS approach identifies minimal intervention sets that disrupt all undesired flux distributions while maintaining desired metabolic functionalities [72] [70]. In mathematical terms, for a metabolic network with stoichiometric matrix N and flux vector r, the steady-state condition is Nr = 0. The cMCS algorithm:

• Partitions the flux space into desired (D) and undesired (U) regions based on design objectives
• Identifies minimal reaction sets whose elimination blocks all fluxes in U while preserving at least one flux in D [72]

Unlike OptKnock, cMCS can enforce strong coupling where production is mandatory even without growth optimization [70]. Recent algorithmic advances now enable cMCS calculation directly from the stoichiometric matrix, making genome-scale applications feasible [72].

Implementation Protocol forP. putida

Table 3: cMCS Implementation Workflow for P. putida

Step	Key Procedures	Technical Notes
Problem Setup	Define desired (D) and undesired (U) flux spaces based on yield thresholds	Include maintenance of growth capability in desired space
cMCS Calculation	Apply MILP formulation to identify minimal intervention sets	Use direct computation methods from stoichiometric matrix
Solution Filtering	Remove solutions with irrepressible reactions	34.5% of reactions may be irrepressible in some models
Validation	Test coupling strength and robustness	Ensure strong coupling (production under all conditions)
Implementation Prioritization	Rank solutions by number of interventions	Smaller cutsets generally preferred for experimental implementation

Optimization and Scalability

For large-scale problems in P. putida, consider hybrid optimization approaches:

• PSOMCS: Combines particle swarm optimization with direct cMCS calculation for efficient identification of optimal knockout strategies [72]

• Metaheuristic Integration: Evolutionary algorithms or simulated annealing can enhance search efficiency for complex multi-objective problems [67] [72]

Case Studies inPseudomonas putida

PHA Production During Growth Phase

A model-driven approach successfully decoupled polyhydroxyalkanoate (PHA) production from nutrient limitation in P. putida [73]. Traditional PHA production occurs only in stationary phase under nutrient-limited conditions, requiring costly two-phase bioprocesses. Using growth-coupling algorithms, researchers engineered strains that produced PHA during growth phase, achieving up to 46% PHA/cell dry weight while maintaining a balanced carbon-to-nitrogen ratio [73]. This was applied to upcycling scenarios using enzymatically hydrolyzed polyethylene terephthalate (PET) as feedstock.

p-Coumarate to Glutamine Conversion

A comprehensive study implemented a four-gene deletion design in P. putida KT2440 for converting the lignin-derived aromatic compound p-coumarate (p-CA) to glutamine [31]. The design targeted:

• α-ketoglutarate/3-oxoadipate permease (PP_1378)
• Three fumarate hydratases (PP0897, PP0944, PP_1755)

While partial implementation (three deletions) showed growth coupling, complete implementation revealed unexpected essentiality of PP0897, highlighting challenges in completely inactivating metabolic reactions encoded by under-characterized proteins [31]. Promoter titration of PP0897 expression was required to achieve functional growth and production, demonstrating the need for post-computational optimization.

Synthetic Serine Cycles for Methanol Assimilation

Three synthetic serine cycle variants were implemented in P. putida for methanol assimilation using growth-coupled selection [74]. By linking methanol assimilation to serine biosynthesis (an essential amino acid), researchers created strains where methanol utilization supported growth. Recursive rewiring revealed novel metabolic topologies, including an enhanced serine-threonine cycle for improved C1 assimilation [74].

The Scientist's Toolkit

Table 4: Essential Research Reagents and Computational Tools

Resource	Type	Application in P. putida Strain Design
Genome-Scale Models	iJN746, iJP815, iML1515	Metabolic reconstruction for in silico simulation
Optimization Solvers	Gurobi, CPLEX, SCIP	Solving MILP/LP problems in OptKnock/cMCS
Genetic Engineering Tools	CRISPR/recombineering, Promoter libraries	Implementing computed gene deletions/regulations
Analytical Platforms	HPLC, GC-MS, NMR	Quantifying product yields and metabolic fluxes
Culture Systems	Bioreactors, M9 minimal medium	Validating growth-coupled production phenotypes

Troubleshooting and Optimization Guidelines

• Non-Functional Designs: If computed designs fail in vivo, examine isozyme activity and promiscuous enzymes not captured in the model [31]. For the p-CA to glutamine conversion, fumarate hydratase (FUM) activity was found to be rate-limiting despite algorithm predictions.

• Low Yield Solutions: When product yields fall below predictions, apply adaptive laboratory evolution to select for mutants with improved coupling [67] [70].

• Computational Challenges: For large intervention sets, employ heuristic methods like OptGene (genetic algorithms) or PSOMCS (particle swarm optimization) to identify feasible solutions with reasonable computational cost [67] [72].

• Essential Gene Conflicts: When essential reactions are targeted, implement promoter titration rather than complete knockout to achieve required flux reduction while maintaining viability [31].

OptKnock and cMCS represent powerful algorithmic frameworks for designing robust, growth-coupled production strains in Pseudomonas putida. While OptKnock employs bilevel optimization to align cellular and production objectives, cMCS guarantees strong coupling through targeted intervention in network functionality. Successful implementation requires integration of sophisticated computational modeling with experimental validation and optimization. As the field advances, these algorithms will play an increasingly critical role in harnessing P. putida's versatile metabolism for sustainable bioproduction from renewable and recalcitrant feedstocks.

The Design-Build-Test-Learn (DBTL) cycle is a foundational framework in modern metabolic engineering and synthetic biology, enabling the systematic development and optimization of microbial cell factories. This iterative process integrates computational design with experimental validation to accelerate strain engineering for the production of valuable chemicals. When applied to Pseudomonas putida—a gram-negative soil bacterium valued for its metabolic versatility and stress tolerance—DBTL cycles facilitate the translation of in silico predictions into robust industrial bioprocesses [75] [76].

Flux Balance Analysis (FBA) serves as a critical component in the Design phase of these cycles. FBA uses genome-scale metabolic models (GEMs) to predict metabolic flux distributions at steady state, enabling researchers to identify potential genetic modifications that optimize target metabolite production. The predictive capability of FBA relies on constraints-based modeling, where the stoichiometry of metabolic networks and physiological limitations define a solution space of possible metabolic states [77]. For P. putida, which possesses a complex metabolic network capable of utilizing diverse carbon sources, FBA provides invaluable insights for prioritizing engineering targets before embarking on resource-intensive experimental work [75].

The integration of machine learning (ML) with traditional DBTL frameworks has recently emerged as a powerful approach to overcome limitations in predictive modeling. ML algorithms can capture complex, non-linear relationships between genetic modifications, media composition, and metabolic outcomes that may be difficult to model using purely mechanistic approaches. This hybrid strategy is particularly valuable for navigating the intricate metabolic regulation of non-model organisms like P. putida and for optimizing multifactorial processes such as media formulation [78] [79] [76].

Application Notes: Implementing DBTL for P. putida Engineering

Case Study: Media Optimization for Flaviolin Production

A recent application of ML-enhanced DBTL cycles for P. putida KT2440 demonstrated remarkable success in optimizing flaviolin production. Flaviolin serves as a proxy for malonyl-CoA, a key precursor for polyketides and fatty acids with applications in fuel, material, and pharmaceutical production [78]. The implementation involved a semi-automated, active learning process that substantially improved production metrics through iterative experimentation.

Table 1: Performance Improvements in Flaviolin Production via ML-Guided DBTL

Performance Metric	Improvement	Key Finding
Titer	60-70% increase	Achieved through multiple optimization campaigns
Process Yield	350% increase	Demonstrated substantial process efficiency gains
Critical Factor	NaCl concentration	Identified as most influential media component

The DBTL process revealed the unexpected importance of sodium chloride concentration, with optimal production occurring at salinity levels comparable to seawater, near the tolerance limit of P. putida [78]. This counterintuitive finding underscores the value of ML-guided exploration in identifying non-obvious optimization targets that might be overlooked in knowledge-driven approaches.

Case Study: Establishing C1 Metabolism in P. putida

DBTL cycles have also been successfully deployed to engineer novel metabolic capabilities in P. putida, such as the assimilation of one-carbon (C1) substrates like formate and methanol. This achievement demonstrates how iterative strain engineering can expand the biotechnological application range of this organism toward more sustainable feedstocks [35].

The engineering strategy employed a modular pathway design implemented through rational engineering, growth-coupled selection, and adaptive laboratory evolution (ALE). The implementation of the reductive glycine pathway (rGlyP) enabled P. putida to utilize formate and methanol as sole carbon and energy sources, with the resulting strain achieving a doubling time of approximately 24 hours on methanol [35]. This case exemplifies how DBTL cycles can integrate multiple engineering approaches to address complex metabolic engineering challenges.

Table 2: DBTL Framework for Engineering Synthetic Methylotrophy in P. putida

DBTL Phase	Implementation	Outcome
Design	Modular reductive glycine pathway design	Blueprint for C1 assimilation
Build	Genomic integration of pathway modules	Stable strain construction
Test	Physiological characterization under C1 conditions	Identification of growth limitations
Learn	Reverse engineering of adaptive mutations	Insights for further optimization

Experimental Protocols

Protocol 1: Semi-Automated Media Optimization Pipeline

This protocol outlines the semi-automated pipeline for media optimization, as implemented for flaviolin production in P. putida KT2440 [78]. The process enables high-throughput testing of media compositions with minimal hands-on time.

Materials and Reagents:

• P. putida KT2440 strain engineered for flaviolin production
• 48-well deep-well plates
• Automated liquid handling system
• BioLector microbioreactor system or similar
• Microplate reader capable of measuring absorbance at 340 nm
• Stock solutions of media components (12-13 variable components)

Procedure:

• Media Design Implementation: Use an automated liquid handler to combine stock solutions according to the media designs generated by the machine learning algorithm (Automated Recommendation Tool, ART).
• Dispensing and Inoculation: Dispense the designed media into three or four replicate wells of a 48-well plate. Inoculate each well with the engineered P. putida strain.
• Cultivation: Cultivate the cultures for 48 hours in an automated cultivation platform (e.g., BioLector) with controlled conditions (O₂ transfer, shaking speed, humidity).
• Product Quantification: Measure flaviolin production by analyzing culture supernatant absorbance at 340 nm using a microplate reader.
• Data Management: Upload production data and corresponding media designs to a data repository (e.g., Experiment Data Depot, EDD).
• ML-Guided Design: Use ART to analyze the data and recommend improved media designs for the next DBTL cycle.

Technical Notes:

• The entire process requires approximately three days to test 15 media designs in triplicate/quadruplicate.
• Hands-on time is less than four hours when the pipeline is established.
• For validation, follow up high-throughput absorbance measurements with authoritative assays (e.g., HPLC) for selected optimal conditions.

Protocol 2: Integrating FBA with Machine Learning for Strain Design

This protocol describes a computational approach for combining FBA with machine learning to predict optimal strain designs, as validated through simulated DBTL cycles [79].

Materials and Software:

• Genome-scale metabolic model of P. putida
• Constraint-based modeling software (e.g., COBRA Toolbox)
• Machine learning environment (e.g., Python with scikit-learn)
• Kinetic modeling package (e.g., SKiMpy for pathway representation)

Procedure:

• Pathway Definition: Identify the target metabolic pathway for optimization and define the reaction network, including relevant enzyme concentrations.
• Kinetic Modeling: Implement the pathway within a kinetic model of central metabolism to simulate metabolic fluxes under different enzyme expression levels.
• Training Data Generation: Simulate a large combinatorial space of pathway enzyme concentrations to generate input-output data for ML training.
• Model Training: Train ML algorithms (e.g., gradient boosting or random forest) to predict product flux from enzyme expression levels.
• Design Recommendation: Use the trained ML model to predict optimal enzyme expression combinations for maximizing target metabolite production.
• Experimental Implementation: Build and test the top predicted strain designs experimentally.
• Model Refinement: Incorporate experimental results to refine the ML model for subsequent DBTL cycles.

Technical Notes:

• Gradient boosting and random forest models have demonstrated strong performance in the low-data regime typical of initial DBTL cycles [79].
• This approach is particularly valuable for navigating non-intuitive flux responses to enzyme perturbations.
• Simulated DBTL cycles using this framework have shown that starting with a larger initial cycle is favorable when the total number of strains to be built is limited.

Visualization of DBTL Workflows

DBTL Cycle Integration with FBA and Machine Learning

Diagram 1: DBTL Cycle with FBA and ML Integration. This workflow illustrates the iterative integration of FBA and machine learning throughout the DBTL cycle for metabolic engineering of P. putida.

FBA-Informed Strain Design Process

Diagram 2: FBA-Informed Strain Design Process. Detailed workflow for using Flux Balance Analysis with a P. putida genome-scale model to identify strategic genetic modifications for metabolic engineering.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Reagents and Platforms for DBTL Implementation

Tool Category	Specific Solution	Function in DBTL Cycle
Computational Tools	Automated Recommendation Tool (ART) [78]	ML algorithm for experimental design recommendation
	Genome-Scale Metabolic Models [77] [75]	Predict metabolic fluxes and identify engineering targets
	SKiMpy [79]	Kinetic modeling of metabolic pathways
Experimental Platforms	BioLector Microbioreactor [78]	High-throughput cultivation with online monitoring
	Automated Liquid Handling Systems [78]	Precise media preparation and sample processing
	Experiment Data Depot (EDD) [78]	Centralized data management for experimental results
Strain Engineering	CRISPR-Cas9 for P. putida [75]	Precise genome editing
	Modular Cloning Systems [35]	Standardized assembly of genetic constructs
	Ribosome Binding Site Libraries [80]	Fine-tuning gene expression levels
Analytical Methods	HPLC [78]	Authoritative quantification of target metabolites
	High-Throughput Absorbance Assays [78]	Rapid product screening
	13C-Metabolic Flux Analysis [81] [35]	Experimental validation of intracellular fluxes

The integration of iterative DBTL cycles with FBA predictions and machine learning recommendations represents a powerful paradigm for metabolic engineering of P. putida. This approach enables researchers to efficiently navigate the complex design space of metabolic engineering, balancing exploration of non-intuitive solutions with exploitation of biological knowledge. The documented cases of flaviolin production optimization and C1 metabolism establishment demonstrate the tangible benefits of this framework in achieving substantial improvements in production metrics and expanding the biosynthetic capabilities of this industrially relevant microorganism.

As the field advances, the continued refinement of genome-scale models for P. putida, coupled with increasingly sophisticated machine learning algorithms and high-throughput experimental capabilities, promises to further accelerate the DBTL cycle. This progression will enhance our ability to bridge in silico predictions with experimental validation, ultimately enabling more efficient development of P. putida as a microbial cell factory for sustainable bioproduction.

Validating FBA Predictions with Multi-Omics and Comparative Analysis

Integrating 13C-Fluxomics, Proteomics, and Metabolomics for Model Validation

Constraint-based metabolic models, such as Flux Balance Analysis (FBA), provide powerful computational frameworks for predicting cellular physiology and guiding metabolic engineering strategies. However, these models generate hypotheses based on stoichiometric constraints and optimization principles that require experimental validation. For the engineering of microbial chassis organisms like Pseudomonas putida, the integration of multiple omics layers—specifically 13C-fluxomics, proteomics, and metabolomics—provides a comprehensive approach for validating and refining these models. This protocol details a systematic methodology for combining these analytical techniques to generate multi-dimensional data for functional model validation and improvement, with specific application to P. putida,

Experimental Design and Cultivation Conditions

Strain Selection and Preparation

For metabolic engineering of Pseudomonas putida, select appropriate strains based on project objectives. KT2440 is commonly used as a platform chassis for biotransformations [82]. Utilize wild-type and engineered strains with modified metabolic pathways for comparative analysis. For instance, implement strains with engineered TCA cycle or malonyl-CoA pathway modifications to investigate precursor supply for product synthesis [83] [84].

Cultivation Conditions

• Culture System: Perform cultivations in controlled bioreactors or parallel cultivation systems (e.g., mini-bioreactors or well-plates) to maintain metabolic steady-state [85].
• Medium Composition: Use defined mineral media with appropriate carbon sources. For P. putida, glucose is a common substrate, though its metabolism occurs via the unique EDEMP cycle [82] [86].
• Tracer Compounds: Implement 13C-labeled substrates for fluxomic analysis. For P. putida with cyclic glucose metabolism, use a combination of [1-13C], [6-13C], and 50% [13C6] glucose tracers to resolve parallel and cyclic metabolic routes [82] [86].
• Sampling Points: Collect samples during mid-exponential growth phase under metabolic steady-state conditions. Ensure proper quenching of metabolic activity for metabolomic samples.

Table 1: Cultivation Parameters for P. putida Multi-omics Studies

Parameter	Recommended Condition	Notes
Temperature	30°C	Optimal for P. putida growth
pH	6.8-7.2	Maintain with appropriate buffer
Aeration	>30% dissolved oxygen	Critical for aerobic metabolism
Carbon Source	10-20 g/L glucose	Use mixture of 13C tracers
Cultivation Scale	100 mL - 1 L	Minimum biomass for multi-omics

Multi-omics Data Acquisition

13C-Fluxomics Analysis

13C metabolic flux analysis (13C-MFA) quantifies intracellular metabolic fluxes by tracing the fate of 13C-labeled atoms through metabolic networks [87] [88].

Protocol:

• Tracer Experiment: Grow cells on specifically designed 13C-labeled substrates. For P. putida, use three parallel labeling experiments with [1-13C], [6-13C], and 50% [13C6] glucose to resolve the complex EDEMP cycle [82] [86].
• Isotopic Steady-State Verification: Confirm isotopic steady-state by measuring labeling patterns at multiple time points (e.g., 2, 3, and 4 hours after inoculation) [88].
• Biomass Hydrolysis: Harvest cells by rapid filtration and hydrolyze biomass in 6M HCl at 105°C for 24 hours to release proteinogenic amino acids [82].
• Derivatization: Derive amino acids for GC-MS analysis using N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) [82].
• GC-MS Analysis:
  • Column: DB-5MS or equivalent (30 m × 0.25 mm × 0.25 µm)
  • Temperature program: 150°C for 2 min, ramp to 250°C at 3°C/min, hold for 5 min
  • Ionization: Electron impact at 70 eV
  • Scan range: m/z 150-650 [82] [88]
• Data Processing: Extract mass isotopomer distributions (MIDs) for proteinogenic amino acids. Correct raw data for natural isotope abundances using standard algorithms [87].

Table 2: Key Mass Fragments for Metabolic Flux Analysis in P. putida

Amino Acid	Mass Fragment	Atoms Represented	Metabolic Pathway Information
Alanine	m/z 260	C1-C3 of Ala	Glycolysis/ED pathway pyruvate
Valine	m/z 288	C1-C5 of Val	Pentose phosphate pathway
Serine	m/z 390	C1-C3 of Ser	Glycolytic intermediates
Glutamate	m/z 432	C1-C5 of Glu	TCA cycle activity
Aspartate	m/z 418	C1-C4 of Asp	Oxaloacetate metabolism
Phenylalanine	m/z 336	C1-C9 of Phe	Phosphoenolpyruvate & erythrose-4-phosphate

Metabolomics Analysis

Metabolomics provides snapshots of metabolite pool sizes, complementing flux data by revealing regulatory bottlenecks and thermodynamic constraints [89] [88].

Protocol:

• Sampling and Quenching: Rapidly collect culture samples (1-2 mL) and quench in cold methanol (-40°C) to immediately halt metabolic activity.
• Metabolite Extraction:
  • Use cold methanol/water/chloroform (3:1:1) extraction method
  • Vortex vigorously for 30 seconds, incubate on ice for 10 minutes, and centrifuge at 14,000 × g for 5 minutes
  • Collect aqueous phase for polar metabolites [88]
• LC-MS Analysis:
  • Instrument: UHPLC coupled to high-resolution mass spectrometer
  • Column: HILIC or reversed-phase for polar metabolites
  • Mobile phase: Acetonitrile/water with ammonium acetate or formate buffer
  • Ionization: ESI positive and negative modes
  • Scan range: m/z 70-1000 [89] [88]
• Data Processing: Use untargeted metabolomics workflows for peak detection, alignment, and identification against authentic standards.

Proteomics Analysis

Proteomics quantifies enzyme abundance, providing a direct link between gene expression and metabolic capacity [90].

Protocol:

• Protein Extraction: Lyse cells in urea/thiourea buffer (6M urea, 2M thiourea, 50 mM Tris-HCl, pH 8.0) with protease inhibitors.
• Protein Digestion: Reduce with DTT, alkylate with iodoacetamide, and digest with trypsin (1:50 enzyme:protein) overnight at 37°C.
• LC-MS/MS Analysis:
  • Instrument: NanoLC coupled to tandem mass spectrometer
  • Column: C18 reversed-phase (75 µm × 25 cm)
  • Gradient: 2-35% acetonitrile in 0.1% formic acid over 120 minutes
  • Data acquisition: Data-dependent acquisition (DDA) or data-independent acquisition (DIA)
• Data Processing: Identify and quantify proteins using database search engines (MaxQuant, Proteome Discoverer) against P. putida proteome database.

Data Integration and Model Validation

Multi-omics Data Integration Framework

Integrate fluxomic, metabolomic, and proteomic data within a computational framework to validate and refine FBA models:

• Flux-Proteomics Correlation: Compare measured enzyme abundances from proteomics with predicted flux values from FBA. High discrepancies may indicate post-translational regulation or incorrect model constraints [90].
• Metabolite-Flux Relationships: Analyze relationships between metabolite pool sizes and flux values. Thermodynamic constraints can be inferred from metabolite ratios near equilibrium reactions [88].
• Model Refinement: Use inconsistent findings between omics layers to identify missing regulatory constraints or incorrect network gaps in the FBA model.

Statistical Validation Methods

• Goodness-of-Fit Testing: For 13C-MFA, use chi-square statistical test to evaluate agreement between measured and simulated MIDs [87] [88].
• Flux Confidence Intervals: Determine statistical precision of flux estimates using Monte Carlo sampling or parameter continuation [87].
• Multi-omics Concordance Analysis: Develop correlation metrics to assess agreement between proteomic abundances and flux values, and between metabolite pool sizes and flux changes.

Table 3: Expected Correlations Between Multi-omics Data Layers for Model Validation

Data Comparison	Expected Correlation	Interpretation of Deviation
Enzyme abundance (proteomics) vs. Flux (fluxomics)	Positive correlation	Post-translational regulation, enzyme saturation
Metabolite pool size vs. Reaction flux	Variable (substrates: negative; products: positive)	Thermodynamic constraints, allosteric regulation
FBA prediction vs. 13C-measured flux	Strong agreement	Missing constraints in model, incorrect gene-protein-reaction rules
ATP-yielding flux vs. ATP demand	Stoichiometric balance	Incorrect maintenance values, energy spilling reactions

Case Study: Validating P. putida Metabolic Model for Malonyl-CoA Engineering

To illustrate the application of this integrated approach, we present a case study from recent literature on engineering malonyl-CoA availability in P. putida [84]:

Experimental Setup:

• Strains: Wild-type P. putida KT2440 versus engineered strains with ACC (acetyl-CoA carboxylase) overexpression and targeted gene knockdowns via CRISPRi.
• Multi-omics Data Acquisition:
  • 13C-fluxomics with [1-13C] glucose to quantify carbon flux through acetyl-CoA node
  • Targeted metabolomics for malonyl-CoA, acetyl-CoA, and TCA cycle intermediates
  • Proteomics analysis of enzymes in central carbon metabolism
• Model Validation Insights:
  • Fluxomics revealed redirected carbon through glycolysis and TCA cycle in engineered strains
  • Proteomics confirmed successful knockdown of predicted target genes
  • Metabolomics validated increased malonyl-CoA pools in optimized strains
  • Integrated data identified unexpected flux bottlenecks not predicted by initial FBA model

The integrated multi-omics validation led to model refinement including additional thermodynamic and regulatory constraints, resulting in improved predictive accuracy for further strain engineering.

The Scientist's Toolkit

Table 4: Essential Research Reagents and Platforms for Multi-omics Studies

Category	Specific Tool/Reagent	Function	Example Application
Tracers	[1-13C] glucose	Isotopic labeling	Resolves parallel metabolic pathways [82]
	[6-13C] glucose	Isotopic labeling	Distinguishes ED pathway from PPP [82]
	50% [13C6] glucose	Isotopic labeling	Provides comprehensive labeling constraints [82]
Analytical Platforms	GC-MS	Mass isotopomer measurement	Proteinogenic amino acid labeling analysis [82] [88]
	LC-MS (Q-TOF, Orbitrap)	Metabolite identification & quantification	Polar and charged metabolite analysis [89] [88]
	NanoLC-MS/MS	Protein identification & quantification	Proteome-wide abundance measurements [90]
Software Tools	INCA	13C Metabolic Flux Analysis	Flux estimation with statistical evaluation [88]
	OpenFLUX	13C Metabolic Flux Analysis	Flux calculation for complex networks [82] [86]
	MaxQuant	Proteomics data analysis	Protein identification and quantification [90]
	XCMS	Metabolomics data processing	Peak detection and alignment [89]
Biosensors	Malonyl-CoA biosensor	High-throughput screening	Rapid identification of optimal strains [84]

Quantitative Decoding of Carbon and Energy Metabolism in Engineered Strains

Within the framework of a broader thesis on Flux Balance Analysis (FBA) for metabolic engineering of Pseudomonas putida, this application note provides detailed protocols for the quantitative decoding of its carbon and energy metabolism. P. putida KT2440 is a metabolically versatile soil bacterium widely explored as a chassis for biotechnology, including the valorization of lignin-derived aromatic compounds [15] [2]. A critical challenge in this endeavor is understanding and engineering the intricate coupling between carbon processing and cofactor generation. This document outlines integrated multi-omics and computational methodologies to achieve a quantitative understanding of metabolic fluxes and proteome allocation, enabling the prediction of cofactor imbalances and guiding strategic metabolic engineering.

Theoretical Background and Key Concepts

Flux Balance Analysis (FBA) and Genome-Scale Modeling

Flux Balance Analysis is a constraint-based mathematical approach for simulating metabolism at the genome-scale. It calculates the flow of metabolites through a metabolic network under the assumption of steady state, where metabolite concentrations are constant [27]. The system is described by the equation: [ S \cdot \vec{v} = 0 ] where ( S ) is the stoichiometric matrix and ( \vec{v} ) is the vector of metabolic fluxes. This underdetermined system is solved by linear programming to find a flux distribution that maximizes a biological objective function, often biomass production [27].

The reconstruction of a high-quality Genome-Scale Metabolic Model (GEM or M-model) is foundational. The model iJN1462 for P. putida KT2440 represents a significant advancement, containing 1,462 genes, 2,929 reactions, and 2,155 metabolites [2]. It provides a comprehensive knowledge base for computing phenotypic properties and predicting gene essentiality.

From Metabolic Models to Proteome-Aware ME-Models

Traditional M-models do not account for the biosynthetic costs of enzymes. The more advanced Model of Metabolism and Gene Expression (ME-model), iPpu1676-ME, mechanistically describes gene expression pathways and their resource demands [7]. This model consists of 7,526 metabolites, 14,414 reactions, and 1,676 genes, offering an unprecedented level of detail for P. putida [7]. ME-models predict proteome limitation and overflow metabolism without needing additional constraints, providing more accurate simulations of cellular physiology and resource allocation [7].

Metabolic Flux Distribution on Phenolic Acids

Recent multi-omics investigation of P. putida KT2440 grown on ferulate (FER), p-coumarate (COU), vanillate (VAN), and 4-hydroxybenzoate (4HB) revealed profound metabolic remodeling compared to growth on succinate [15].

Table 1: Key Proteomic and Metabolic Changes during Growth on Phenolic Acids vs. Succinate

Metric	Observed Change	Physiological Implication
Transport & Catabolic Proteins	>140-fold increase	Enhanced uptake and initial catabolism of aromatic compounds [15]
Pyruvate Carboxylase	Up to 30-fold increase	Metabolic remodeling, anaplerotic carbon recycling into TCA cycle [15]
Glyoxylate Shunt Proteins	Up to 30-fold increase	Cataplerotic flux maintenance, supporting NADPH production [15]
ATP Surplus	Up to 6-fold greater	High energy yield from aromatic carbon metabolism [15]
NADPH Yield	50-60% via pyruvate carboxylase, remainder via glyoxylate shunt & malic enzyme	Coupling of carbon flux with essential reducing power generation [15]

Table 2: Identified Bottlenecks in Native Phenolic Acid Catabolism

Bottleneck Node	Pathway Location	Experimental Evidence
Vdh	Coniferyl branch	20-fold higher intracellular vanillin vs. precursor; slower 13C-incorporation [15]
VanAB	Coniferyl branch	Low PCA levels even with VAN as direct carbon source [15]
PobA	p-Coumaroyl branch	Extracellular metabolic overflow observed in prior studies [15]
PcaHG	Downstream of both branches	Inefficient conversion to β-ketoadipate [15]

Metabolic Impact of Heterologous Protein Production

Heterologous protein production in P. putida triggers significant metabolic rearrangements. Once the metabolic load exceeds the host's free capacity, it causes a decoupling of anabolism and catabolism, resulting in a large excess of energy production relative to the requirements of protein biosynthesis [91]. This metabolic burden exerts stronger control on carbon fluxes than on energy fluxes, demonstrating the flexibility of P. putida's central metabolic network to sustain energy production [91].

Experimental Protocols

This section provides detailed methodologies for key experiments in quantitative metabolism analysis.

Protocol 1: 13C-Metabolic Flux Analysis (13C-MFA)

Principle: 13C-MFA estimates in vivo metabolic fluxes by integrating extracellular specific rates with 13C-labeling patterns of intracellular metabolites measured under metabolic steady state [92].

Procedure:

• Culture and Labeling: Grow P. putida KT2440 in a defined minimal medium with a single carbon source (e.g., 4HB, VAN, glucose, succinate). Use a labeled substrate (e.g., [U-13C]-glucose) once steady-state growth is achieved in a bioreactor.
• Metabolite Extraction: Rapidly sample culture (~10 mL) and quench metabolism immediately (e.g., in cold 60% methanol). Perform intracellular metabolite extraction using a methanol/water/chloroform solvent system.
• Mass Spectrometry Analysis: Derivatize polar metabolite extracts (e.g., for GC-MS analysis). Measure mass isotopomer distributions (MIDs) of key central carbon metabolites (e.g., amino acids, organic acids, sugar phosphates).
• Flux Calculation:
  • Measure specific substrate uptake, biomass, and by-product secretion rates.
  • Input stoichiometric model (e.g., iJN1462), measured extracellular fluxes, and MIDs into a flux estimation software platform (e.g., COBRApy).
  • Employ an iterative fitting algorithm to find the flux map that best simulates the experimentally observed MIDs.

Protocol 2: Constraining ME-Models with Multi-Omics Data

Principle: ME-model predictions are validated and refined using transcriptomic (RNA-Seq) and translatomics (Ribo-Seq) data to analyze translational prioritization and proteome allocation [7].

Procedure:

• Multi-Omics Data Generation:
  • Grow P. putida in biological triplicates under defined conditions.
  • For RNA-Seq: Extract total RNA, prepare sequencing libraries, and sequence.
  • For Ribo-Seq: Treat cells with cycloheximide, harvest, and digest with RNase I. Isulate ribosome-protected mRNA fragments and prepare libraries for sequencing.
• Data Quality Control:
  • Align reads to the P. putida KT2440 reference genome.
  • Calculate counts-per-million (CPM) for each gene.
  • Assess replicate correlation (Pearson correlation >0.9 is expected).
• Translational Efficiency (TE) Calculation:
  • ( TE = \frac{\text{Ribo-Seq CPM}}{\text{RNA-Seq CPM}} )
  • Identify pathways with high translational prioritization using a one-tailed Mann-Whitney U test on gene ranks from both datasets.
• Model Interrogation: Contrast the computed translational efficiencies and pathway prioritization with the enzyme usage and resource allocation predictions generated by the iPpu1676-ME model.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Reagents and Tools for Metabolic Analysis in P. putida

Item Name	Function/Application	Relevant Protocol
Stable Isotope-Labeled Substrates (e.g., [U-13C]-Glucose)	Tracer for determining intracellular metabolic fluxes via 13C-MFA.	13C-MFA [15] [92]
iJN1462 Genome-Scale Model (GEM)	Computational knowledge base of P. putida metabolism for FBA simulations.	FBA/13C-MFA [2]
iPpu1676-ME Model (ME-Model)	Model of Metabolism and Gene Expression for predicting proteome allocation.	ME-model Analysis [7]
Fluxer Web Application	Tool for computing, analyzing, and visualizing genome-scale metabolic flux networks.	Flux Visualization [93]
GC-MS or LC-MS Instrumentation	Analytical platform for measuring metabolite concentrations and 13C-labeling patterns.	13C-MFA, Metabolomics [15] [92]
RNA-Seq & Ribo-Seq Kits	Reagents for profiling transcriptome and translatome to constrain ME-models.	Multi-omics for ME-models [7]
PQQ Cofactor	Essential cofactor for native methanol dehydrogenase activity in C1 metabolism engineering.	Methylotrophy Engineering [74]

Visualization of Metabolic Pathways and Fluxes

Tools like Fluxer (https://fluxer.umbc.edu) enable automated computation and visualization of genome-scale metabolic flux networks from SBML models [93]. It can generate spanning trees to show the most important pathways contributing to biomass or a metabolite of interest, and calculate the k-shortest metabolic paths between two compounds [93]. The diagram below illustrates the key metabolic nodes and fluxes in P. putida when utilizing phenolic compounds, as revealed by 13C-fluxomics [15].

Comparative Performance Analysis of Different GSMMs and Algorithms

Flux Balance Analysis (FBA) has become an indispensable methodology in metabolic engineering, enabling the prediction of metabolic fluxes in genome-scale metabolic models (GSMMs) under steady-state conditions [94]. For the industrial workhorse Pseudomonas putida KT2440—a metabolically robust bacterium prized for its versatility in biocatalysis and bioremediation—GSMMs provide a computational framework to predict and optimize metabolic performance for sustainable bioproduction [95] [7]. The comparative analysis of different GSMMs and the algorithms that leverage them is therefore critical for guiding effective strain design. This application note details the primary GSMMs and algorithms used for P. putida, providing structured comparisons and standardized protocols to facilitate their application in metabolic engineering research.

The reconstruction of a high-quality GSMM is a foundational step, which involves compiling a biochemical, genetic, and genomic (BiGG) knowledge-base from genome annotations, biochemical databases, and organism-specific literature [5]. For P. putida KT2440, several iterations of models have been developed, with the two most prominent being the metabolic model (M-model) iJN1462 and the more recent model of metabolism and gene expression (ME-model) iPpu1676-ME.

Table 1: Comparison of Key GSMMs for P. putida KT2440

Feature	iJN1462 (M-model)	iPpu1676-ME (ME-model)
Model Type	Metabolic (M-model)	Metabolism & Gene Expression (ME-model)
Core Reference	(Nogueira et al., 2020) [95]	(Liao et al., 2025) [7]
Metabolite Count	~2,150	~7,526
Reaction Count	~2,928	~14,414
Gene Count	~1,462	~1,676
Key Capabilities	Prediction of growth rates, nutrient uptake, by-product secretion; gene essentiality analysis.	Prediction of proteome allocation, biosynthetic costs; mechanistic prediction of overflow metabolism.
Notable Application	Identification of intervention strategies via Minimal Cut Sets (MCS) for growth-coupled production [95].	Revealing translational prioritization and proteome limitations without additional constraints [7].

The ME-model significantly expands upon the M-model by explicitly representing the gene expression machinery, including transcription, translation, and post-translational modifications [7]. This allows iPpu1676-ME to account for the biosynthetic costs of enzymes, leading to more accurate predictions of metabolic behavior, such as proteome limitation and overflow metabolism, without needing externally imposed constraints [7].

Critical Algorithms for Metabolic Engineering and Their Performance

Various computational algorithms have been developed to interrogate GSMMs and identify genetic interventions for metabolic engineering. The following are key algorithms applied to P. putida.

Table 2: Key Algorithms for Strain Design Using GSMMs

Algorithm	Type	Primary Objective	Key Inputs	Outputs	Performance Notes
Flux Balance Analysis (FBA) [94]	Constraint-Based Optimization	Predict flux distribution to maximize an objective (e.g., growth).	Stoichiometric matrix (S), exchange fluxes, objective function.	Optimal growth rate, flux distribution for all reactions.	Fast; good for growth prediction; does not account for enzyme cost.
Minimal Cut Set (MCS) [96] [95]	Constraint-Based Intervention	Find minimal reaction sets to delete for growth-coupled production.	GSMM, target product, minimum product yield.	Sets of reactions to eliminate.	Computationally intensive; enables strong growth-coupling; can be difficult to implement fully [96].
ME-Model Simulation [7]	Proteome-Constrained Optimization	Predict growth and metabolism under proteome limitation.	ME-model, nutrient uptake rates.	Growth rate, flux distribution, enzyme expression levels.	Higher predictive accuracy; recapitulates overflow metabolism; more complex and data-intensive.

The MCS algorithm, in particular, has been successfully used to design P. putida strains for the production of indigoidine, achieving high titers, rates, and yields (TRY) by coupling production to growth [95]. However, a challenge noted in implementations is that predicted gene deletions can sometimes be difficult to realize experimentally due to hidden essentiality or unaccounted-for biological functions, as was the case with the fumarate hydratase PP_0897 [96].

Experimental Protocols for Key Analyses

Protocol: Performing Flux Balance Analysis with a GSMM

This protocol outlines the steps to perform a basic FBA simulation to predict the maximal growth rate of P. putida KT2440 on a defined carbon source.

• Model Acquisition and Preparation: Obtain a GSMM for P. putida in SBML format (e.g., iJN1462). Import the model into a suitable software environment, such as the COBRA Toolbox for MATLAB or Python [5] [94].
• Define Environmental Constraints: Set the lower and upper bounds of the exchange reaction for the primary carbon source (e.g., glucose) to represent its uptake rate (e.g., -8.15 mmol/gDW/h). Constrain the uptake of other nutrients (N, P, S sources) and the secretion of by-products as required by the experimental condition [94].
• Set the Objective Function: Define the biomass reaction as the objective function to be maximized.
• Solve the Linear Programming Problem: Use an LP solver (e.g., GLPK, Gurobi) to find the flux distribution that maximizes the objective function, subject to the stoichiometric constraint (Sv = 0) and the reaction bounds [94].
• Output and Validation: The primary output is the maximum theoretical growth rate. The flux distribution for all reactions can be analyzed. Validate the prediction by comparing it with experimentally observed growth rates from literature [7].

Protocol: Implementing a Growth-Coupling Design using MCS

This protocol describes the process for identifying and implementing a growth-coupling strategy for a target metabolite.

• In Silico Design:
  • Model Curation: Ensure the GSMM includes a demand reaction for the target product (e.g., indigoidine). Validate the model's predictive capability for precursor synthesis (e.g., glutamine) [95].
  • MCS Computation: Use the MCS algorithm to calculate minimal sets of reactions whose elimination forces the production of the target metabolite at a specified minimum yield (e.g., 80% of theoretical maximum) [95].
  • Gene-Reconciliation: Map the identified reactions to their corresponding genes using the model's Gene-Protein-Reaction (GPR) rules. Manually curate the list to exclude genes associated with essential functions or multifunctional proteins [95].
• Strain Construction:
  • Genetic Tool Selection: Choose appropriate genetic tools for gene knockout (e.g., CRISPR/recombineering) or knockdown (e.g., CRISPRi) [96] [95].
  • Implementation: Sequentially or multiplex the genetic modifications into a production host P. putida strain that has been engineered with the necessary heterologous pathways (e.g., bpsA and sfp for indigoidine production) [95].
• Validation and Testing:
  • Phenotypic Characterization: Cultivate the engineered strain in minimal media with the target carbon source. Measure growth (OD), substrate consumption, and product titer over time [96] [95].
  • Adaptive Laboratory Evolution (ALE): If growth is impaired, subject the strain to ALE to select for suppressor mutations that restore fitness, potentially revealing unforeseen network interactions [96].

Visualization of Workflows

The following diagrams illustrate the logical relationships and workflows for the core processes described in this note.

Diagram 1: Decision workflow for selecting a GSMM and algorithm.

Diagram 2: GSMM reconstruction and enhancement pipeline.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Reagent Solutions for P. putida Metabolic Engineering

Reagent/Material	Function/Application	Example & Notes
Genome-Scale Model	In silico prediction of metabolic behavior.	iJN1462 (for FBA, MCS); iPpu1676-ME (for proteome-aware simulations).
CRISPR Tools	Gene knockout/knockdown for implementing interventions.	CRISPR/recombineering for deletion [96]; dCpf1-based CRISPRi for multiplex repression [95].
Production Pathway	Enables synthesis of non-native target product.	Genomic integration of bpsA (NRPS) and sfp (phosphopantetheinyl transferase) for indigoidine [95].
Specialized Media	Cultivation under defined conditions for phenotype testing.	M9 minimal medium with target carbon source (e.g., glucose, p-coumarate) [96] [95].
Analytical Tools	Quantification of growth, substrate, and product.	Colorimetric assays for metabolites (e.g., indigoidine for glutamine proxy) [96] [95].

Within the framework of Flux Balance Analysis (FBA) for metabolic engineering of Pseudomonas putida, growth-coupled production stands as a foundational strategy for strain design. This approach ingeniously rewires microbial metabolism such that the synthesis of a target bioproduct becomes an obligatory prerequisite for cellular growth, preventing the loss of production capability due to genetic drift and aligning the strain's evolutionary objective with the engineer's production goal [70]. The application of this principle to lignin-derived, non-sugar carbon sources is particularly relevant for developing sustainable bioprocesses. P. putida KT2440, a robust soil bacterium with a native proficiency for catabolizing aromatic compounds, serves as an exemplary chassis for this purpose [97] [98]. This case study details the experimental and computational protocols for evaluating growth-coupled production in P. putida engineered to convert the lignin-derived acid, p-coumarate (p-CA), into the nitrogenous chemical glutamine, and subsequently into the blue pigment indigoidine, which serves as a visual and quantifiable reporter [99] [96].

Quantitative Analysis of Metabolic Performance

Key Quantitative Findings from Phenolic Carbon Metabolism in Wild-TypeP. putida

A multi-omics investigation of P. putida KT2440 grown on various lignin-derived phenolic acids revealed a remarkable reorganization of central metabolism to optimize energy generation. The data below serve as a benchmark for understanding the native metabolic state before engineering.

Table 1: Comparative Growth and Energy Metrics of P. putida on Phenolic Substrates vs. Succinate

Substrate	Growth Rate (h⁻¹)	Substrate Depletion Rate (mmol gCDW⁻¹ h⁻¹)	Biomass Yield (gCDW mol C⁻¹)	Energy Charge
Succinate (Reference)	~0.90-1.00	16.0 ± 2.0	~25.0	0.70 (Baseline)
4-Hydroxybenzoate	0.88	15.9 ± 3.1	~25.0	0.88
Vanillate	0.53	8.2 ± 1.5	~24.5	0.87
p-Coumarate	0.68	9.9 ± 2.1	~24.8	0.90
Ferulate	0.61	6.7 ± 1.8	~24.9	0.91

Table 2: Cofactor Yields and Critical Fluxes in Phenolic Carbon Metabolism

Metabolic Parameter	Value on Phenolic Acids	Value on Succinate
NADPH Yield	50-60% (via TCA cycle)	Primarily via transhydrogenase
NADH Yield	60-80%	Lower than on phenolics
ATP Yield	Up to 2-fold higher	Baseline
Pyruvate Carboxylase Flux	Up to 30-fold increase	Low/Baseline
Glyoxylate Shunt Flux	Up to 30-fold increase	Low/Baseline
Anaplerotic Carbon Recycling	Significant via Pyruvate Carboxylase	Less prominent

Performance of Engineered Growth-Coupled Strains

Engineering growth-coupled production requires the implementation of specific gene deletions predicted by genome-scale model (GSM) algorithms. The following data summarize the outcomes of such engineering efforts.

Table 3: Performance of Engineered P. putida Strains for p-Coumarate to Indigoidine Production

Strain Description	Growth on M9 p-CA	Indigoidine Titer	Key Findings & Rationale
Wild-Type + bpsA/sfp	Robust	Low (Non-coupled)	Baseline production; no growth coupling.
Partial Cutset (∆PP1378, ∆PP0944, ∆PP_1755, ∆fleQ)	Robust	7.3 g/L [99]	Demonstrates phenotypic growth coupling; high yield (77% theoretical).
Complete Cutset (Partial + ∆PP_0897)	No Growth	0 g/L [96]	PP_0897 is dispensable alone but essential in combination, indicating functional redundancy and model gaps.
Complete Cutset + Low PP_0897 Expression	Restored, but reduced	Re-established	Titrating PP_0897 expression is crucial for balancing TCA flux with growth-coupling design viability.

Experimental Protocols

Protocol 1: Computational Design of Growth-Coupled Strains Using Constrained Minimal Cut Sets (cMCS)

Objective: To identify a set of gene deletions that enforce strong coupling between growth on p-coumarate and the production of glutamine.

Materials:

• Genome-Scale Metabolic Model (GSM) of P. putida KT2440 (e.g., iJN1463).
• Constrained Minimal Cut Sets (cMCS) algorithm software [70] [96].
• Computing hardware capable of solving Mixed Integer Linear Programming (MILP) problems.

Procedure:

• Model Curation: Confirm the GSM includes accurate reactions for p-coumarate uptake and catabolism via the β-ketoadipate pathway, as well as glutamine synthesis.
• Define Physiological Constraints:
  • Set substrate uptake (e.g., p-coumarate) to a physiologically relevant maximum.
  • Allow unlimited uptake of essential ions, O₂, and NH₄⁺ (nitrogen source for glutamine).
  • Set the biomass reaction as the primary objective to be maximized.
• Define Coupling Constraints:
  • Set a minimum product yield threshold (Y_prod/sub) for glutamine, typically a significant fraction (e.g., 50-80%) of its theoretical maximum.
• Run cMCS Algorithm:
  • Execute the cMCS algorithm to find the smallest set of reaction knockouts that renders any growth solution contingent upon meeting the minimum glutamine yield.
• Design Validation In Silico:
  • Simulate growth and production flux in the designed mutant strain to verify the coupling phenotype.
  • Map the identified reactions to their corresponding genes in the P. putida KT2440 genome. A predicted design for glutamine production may include deletions of:
    • PP1378: An α-ketoglutarate/3-oxoadipate permease, preventing diversion of TCA cycle intermediates.
    • fumC1 (PP0944), fumC2 (PP1755), and PP0897: Genes encoding fumarase hydratase (FUM) isozymes, creating a controlled bottleneck in the TCA cycle [96].

Protocol 2: Strain Construction and Laboratory Evolution

Objective: To genetically implement the computed design and restore robustness through adaptive laboratory evolution (ALE).

Materials:

• P. putida KT2440 wild-type strain.
• CRISPR/recombineering tools for P. putida.
• M9 minimal medium agar and liquid cultures with p-coumarate (e.g., 20 mM) as sole carbon source.
• E. coli strains for molecular biology.
• Indigoidine production genes (bpsA and sfp) integrated into the chromosome or on a plasmid [99].

Procedure:

• Sequential Gene Deletion:
  • Using CRISPR/recombineering, delete the target genes (e.g., PP1378, PP0944, PP_1755) in the P. putida host already equipped with the indigoidine production system.
  • Confirm deletions via colony PCR and sequencing.
• Handling Essential/Problematic Knockouts:
  • If a final knockout (e.g., PP_0897) is lethal for growth on p-coumarate, employ promoter titration. Replace the native promoter of the essential gene with a weaker, tunable promoter (e.g., from the Anderson collection) to reduce its expression to a minimal, yet sufficient level [96].
• Adaptive Laboratory Evolution (ALE):
  • Inoculate the slow-growing engineered strain into fresh M9 p-coumarate medium.
  • Serially passage the culture every 48-72 hours or upon visible growth, transferring to fresh medium.
  • Monitor optical density (OD660) and indigoidine accumulation (visible blue color, A612 measurement) over multiple passages (weeks to months).
  • Isolate evolved clones with improved growth and production from the endpoint culture [99].

Protocol 3: ¹³C-Metabolomics and Fluxomics for Validation

Objective: To experimentally quantify intracellular carbon fluxes and validate the predicted metabolic rewiring.

Materials:

• Engineered and control P. putida strains.
• M9 minimal medium with [U-¹³C] p-coumarate as the sole carbon source.
• Quenching solution (e.g., cold 60:40 methanol:water).
• LC-MS/MS system for metabolomics.
• Fluxomics software (e.g., INCA, 13C-FLUX).

Procedure:

• Cultivation and Isotope Labeling:
  • Grow strains to mid-exponential phase in M9 with unlabeled p-coumarate.
  • Rapidly switch the medium to M9 containing [U-¹³C] p-coumarate.
  • Take time-point samples (e.g., at 0, 15, 30, 60, 120 seconds) for kinetic metabolomics.
• Metabolite Extraction:
  • Rapidly quench metabolism by injecting culture aliquots into -40°C quenching solution.
  • Perform metabolite extraction using a standardized protocol for intracellular metabolomics.
• LC-MS/MS Analysis:
  • Analyze the extracted metabolites via LC-MS/MS to determine the mass isotopomer distributions (MIDs) of key central carbon metabolites (e.g., PEP, pyruvate, TCA cycle intermediates).
• 13C-Fluxomic Modeling:
  • Integrate the measured MIDs, extracellular fluxes (growth, substrate uptake), and proteomics data (if available) into a compartmented metabolic model.
  • Use flux estimation software to compute the most probable intracellular flux map that fits the experimental data.
  • Key Validation: Confirm the predicted high fluxes through anaplerotic (pyruvate carboxylase) and cataplerotic (glyoxylate shunt + malic enzyme) nodes, which are critical for cofactor balancing during aromatic catabolism [97] [15].

Pathway and Workflow Visualization

Metabolic Pathway Engineering for Growth-Coupled Production

This diagram illustrates the key metabolic engineering interventions in the central metabolism of P. putida to achieve growth-coupled production from p-coumarate.

Integrated Workflow for Growth-Coupling Evaluation

This diagram outlines the complete iterative cycle (Design-Build-Test-Learn) for developing and validating a growth-coupled production strain.

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Reagents and Tools for Metabolic Engineering of P. putida

Category	Reagent / Tool	Function / Application	Example / Note
Computational Tools	Genome-Scale Metabolic Model (GSM)	In silico prediction of metabolic fluxes and gene essentiality.	P. putida KT2440 model (e.g., iJN1463).
	cMCS Algorithm	Identifies minimal reaction knockouts to enforce growth-coupled production.	Used to design knockout strategies for glutamine production [96].
Genetic Tools	CRISPR/Recombineering System	Enables precise genome editing (deletions, insertions) in P. putida.	Essential for implementing computed gene knockouts.
	Tunable Promoter Libraries	Allows for fine-control of gene expression levels.	Anderson promoter collection; used to titrate essential gene expression (e.g., PP_0897) [96].
Analytical Tools	13C-Labeled Substrates	Tracer for kinetic metabolomics and fluxomic analysis of central carbon metabolism.	[U-13C] p-Coumarate [97] [15].
	LC-MS/MS System	Quantifies metabolite levels and isotopic enrichment (mass isotopomer distributions).	Validation of metabolic rewiring.
Bioproduction Reporters	Indigoidine Biosynthetic Genes (bpsA/sfp)	Visual and quantifiable reporter for glutamine production.	Condenses 2 glutamine molecules into blue pigment [99] [96].

Benchmarking FBA Predictions Against Experimental Growth and Product Yields

Flux Balance Analysis (FBA) serves as a cornerstone of constraint-based modeling, enabling prediction of metabolic phenotypes from genome-scale metabolic models (GEMs). Within metabolic engineering of Pseudomonas putida KT2440—a robust, soil-dwelling bacterium with considerable biotechnological potential—the accuracy of FBA predictions is paramount for designing efficient microbial cell factories [30] [4]. This protocol provides a detailed framework for benchmarking FBA predictions against experimental data, specifically tailored for P. putida, to validate and refine metabolic models, thereby enhancing their predictive power for growth and product yield.

Theoretical Background and Key Concepts

Fundamentals of Flux Balance Analysis

FBA is a constraint-based approach that computes steady-state metabolic flux distributions within a GEM. It relies on the stoichiometric matrix S of all metabolic reactions, where the optimization of an objective function (e.g., biomass growth) is subject to mass-balance constraints and reaction bounds: Maximize Z = cᵀv, subject to Sv = 0 and vₘᵢₙ ≤ v ≤ vₘₐₓ [4]. While FBA is powerful for predicting phenotypes, its quantitative accuracy can be limited without careful constraint setting and validation [100].

The P. putida Metabolic Network

The metabolic network of P. putida KT2440 is characterized by a versatile central metabolism, including a complete Entner-Doudoroff (ED) pathway, pentose phosphate pathway (PPP), and rich aromatic compound degradation routes [10] [4]. Key reconstructed GEMs for P. putida include iJN746 (746 genes, 950 reactions) and iJP815 (877 reactions) [10] [4]. Understanding these network features is essential for interpreting FBA predictions and physiological data.

Computational and Experimental Methodologies

Workflow for Benchmarking FBA Predictions

The following diagram outlines the core iterative process for benchmarking and refining FBA models.

Protocol 1: In Silico Prediction of Growth Phenotypes

Step 1: Model and Growth Medium Configuration

• Select a GEM: Utilize a curated P. putida GEM, such as iJN746 [10] or iJP815 [4].
• Define the in silico medium: Set the exchange reaction bounds to reflect the experimental minimal medium composition. For example, to simulate M9 glucose medium, set the lower bound of the glucose exchange reaction to -10 mmol/gDW/h and open exchange reactions for essential ions and oxygen.
• Set the objective function: Typically, this is the biomass reaction (e.g., BIOMASS_KT2440).

Step 2: Simulation and Prediction

• Perform FBA using a solver (e.g., via the COBRA Toolbox in MATLAB or Python) to maximize the biomass objective function.
• Record the predicted growth rate (in h⁻¹) and key substrate uptake/product secretion fluxes.

Protocol 2: Experimental Determination of Growth and Product Yields

Step 1: Cultivation Conditions

• Strain: Use P. putida KT2440 or an engineered derivative.
• Medium: Use a defined minimal medium (e.g., M9) with the target carbon source (e.g., 20 mM glucose, p-coumarate, or xylose [101] [96]).
• Cultivation system: Perform batch cultivations in biological triplicate in baffled shake flasks or a bioreactor with controlled temperature (e.g., 30°C) and agitation.

Step 2: Data Collection

• Growth kinetics: Monitor optical density (OD₆₀₀) at regular intervals. Calculate the maximum specific growth rate (µₘₐₓ) by fitting the exponential phase data.
• Substrate and product quantification: At mid-exponential phase, take samples for HPLC or GC-MS analysis to quantify substrate consumption and product formation (e.g., PHA, glutamine) [96] [102]. Calculate yields (Yₚ/ₛ in mg/g) from concentration changes.

Protocol 3: Advanced Hybrid Modeling with Machine Learning

Traditional FBA can be enhanced by integrating machine learning (ML) to predict condition-specific uptake bounds, addressing a major source of prediction error [100].

Step 1: Data Preparation for ML

• Generate a training dataset comprising environmental conditions (e.g., carbon source type and concentration) and corresponding experimentally measured uptake fluxes or growth rates.

Step 2: Model Integration and Training

• Employ a hybrid Neural-Mechanistic model architecture, where a neural network layer predicts uptake flux bounds (V_in) from medium composition (C_med). This layer is coupled to a mechanistic FBA solver that computes the metabolic phenotype (V_out) [100].
• Train the hybrid model by minimizing the loss between predicted and experimental fluxes/growth rates.

The architecture of this hybrid approach is depicted below.

Data Integration and Analysis

Quantitative Comparison Table

Benchmark FBA predictions by comparing them to experimental data. The table below provides a template and example data from recent studies.

Table 1: Benchmarking FBA Predictions against Experimental Data for P. putida

Strain / Condition	Carbon Source	Experimental µₘₐₓ (h⁻¹)	Predicted µₘₐₓ (h⁻¹)	Experimental Product Yield	Predicted Product Yield	Key Discrepancies & Insights
P. putida EM42 (PD310) [101]	D-Xylose	0.11	~0.30 (Initial FBA)	N/A	N/A	Initial FBA over-predicted growth; 13C-MFA revealed carbon cycling via Gnd, explaining flux bottleneck.
Engineered PHA Producer [102]	Ferulic Acid (20 mM)	N/A	N/A	PHA: ~270 mg/L	Model-guided	FBA identified ferulic acid toxicity and cofactor imbalances as yield-limiting factors.
Engineered for p-Coumarate [96]	p-Coumarate	Reduced in ∆fum strains	Zero in full cMCS	Glutamine (via indigoidine): Coupled to growth	Strong growth-coupling predicted	Model predicted essentiality of fumarase (FUM); experimental titration of PP_0897 expression was required for viability.
Hybrid Neural-Mechanistic Model [100]	Various (E. coli & P. putida)	N/A	Significantly closer to experimental values than classic FBA	N/A	Improved prediction	ML-predicted uptake bounds dramatically improved quantitative growth rate predictions.

Statistical and Quantitative Discrepancy Analysis

• Calculate error metrics: Determine the Mean Absolute Error (MAE) and Root Mean Square Error (RMSE) between predicted and experimental growth rates/yields.
• Identify systematic gaps: Consistent over-prediction of growth may indicate unrealistic thermodynamic assumptions or missing regulatory constraints. Under-prediction of product yield may suggest incomplete pathway knowledge or incorrect enzyme capacity constraints.

Case Study: Benchmarking Xylose Metabolism in Engineered P. putida

Background and Rationale

Wild-type P. putida cannot natively utilize D-xylose. Engineering involves introducing the xylose isomerase pathway (xylA and xylB genes) and the XylE transporter [101]. Benchmarking FBA predictions for this non-native substrate is crucial for guiding further strain improvement.

Experimental and Computational Integration

• Initial FBA: The iJN746 model, when provided with a xylose uptake reaction, may over-predict the growth rate of a newly engineered strain (e.g., PD310, µₚᵣₑdᵢcₜₑd ≈ 0.30 h⁻¹) compared to the experimental reality (µₑₓₚ = 0.11 h⁻¹) [101].
• 13C-Metabolic Flux Analysis (MFA): To resolve the discrepancy, 13C-flux analysis was performed. This revealed a partial carbon cycling flux where ~89% of xylose carbon was funneled through fructose-6-phosphate back to 6-phosphogluconate, creating a futile cycle and reducing the flux through the higher-yield ED pathway [101].
• Model Refinement: The GEM can be updated to reflect the observed internal flux distribution, leading to more accurate predictions. Subsequent engineering (e.g., deregulating glycolysis by deleting hexR) helped align the model with observed physiology.

The Scientist's Toolkit: Essential Reagents and Tools

Table 2: Key Research Reagent Solutions for FBA Benchmarking in P. putida

Item Name	Function/Application	Specific Example / Comment
Genome-Scale Model iJN746	Foundation for in silico FBA simulations.	Accounts for 746 genes and 950 reactions. Essential for predicting growth and essentiality [10].
CRISPR/Cas9n-λ-Red Tool	High-efficiency genome editing for strain construction.	Used to engineer xylose pathways or delete genes (e.g., fumC1, PP_1378) predicted by FBA [96] [102].
Constrained Minimal Cutset (cMCS)	Computational algorithm for growth-coupled design.	Identifies gene deletion sets that force product formation (e.g., coupling p-coumarate to glutamine) [96].
13C-Labeled Substrates	Experimental determination of intracellular fluxes via 13C-MFA.	Critical for validating and refining FBA-predicted flux distributions (e.g., using 1,2-13C D-xylose) [101].
Hybrid Neural-Mechanistic Model	Architecture combining ML and FBA.	Improves prediction accuracy by learning condition-specific uptake bounds from experimental data [100].

Troubleshooting and Common Pitfalls

• Systematic Over-prediction of Growth: This often stems from inadequate constraints on substrate uptake or failure to model transcriptional regulation. Solution: Incorporate measured uptake rates from experiments or use ML to predict them [100]. Implement regulatory constraints if known (e.g., hexR deletion derepresses glycolysis [101]).
• Failure to Predict Gene Essentiality: May be due to incomplete network gaps or isozyme redundancy. Solution: Validate model against gene essentiality datasets and use 13C-MFA to fill network gaps [4].
• Implementation Failure of in silico Designs: Some gene deletions predicted by growth-coupling algorithms may be unviable due to unknown essential functions. Solution: Use promoter titration to fine-tune gene expression instead of complete knockout, as demonstrated for the fumarase gene PP_0897 [96].

Conclusion

Flux Balance Analysis has proven to be an indispensable tool for unlocking the biotechnological potential of Pseudomonas putida, enabling the rational design of strains for producing valuable biomedical compounds. The integration of GSMMs with multi-omics data provides a powerful framework for validating model predictions and understanding complex genotype-phenotype relationships. Future directions should focus on developing next-generation models that incorporate transcriptional regulation, kinetic parameters, and dynamic flux analysis to better predict microbial behavior in industrial bioreactors. These advances will further solidify P. putida's role as a chassis for sustainable biomanufacturing of pharmaceuticals, biopolymers, and specialty chemicals, bridging the gap between computational design and clinical-scale production.

References

• 1. Current status and applications of genome-scale metabolic ... [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-019-1730-3]
• 2. High‐quality genome‐scale metabolic modelling of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7078882/]
• 3. Genome-Scale Reconstruction and Analysis of the ... [https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1000210]
• 4. Genome-Scale Reconstruction and Analysis of the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2563689/]
• 5. A protocol for generating a high-quality genome-scale ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3125167/]
• 6. Genome-scale metabolic network of Pseudomonas putida ... [https://www.ebi.ac.uk/biomodels/MODEL1507180044]
• 7. Model of metabolism and gene expression predicts ... [https://www.nature.com/articles/s41540-025-00521-1]
• 8. Synthetic C1 metabolism in Pseudomonas putida enables ... [https://pubmed.ncbi.nlm.nih.gov/40824035/]
• 9. Pathway-Consensus Approach to Metabolic Network ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5234801/]
• 10. A genome-scale metabolic reconstruction of Pseudomonas ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2569920/]
• 11. Large-scale kinetic metabolic models of Pseudomonas putida ... [https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-020-1665-7]
• 12. A genome-scale metabolic reconstruction of Pseudomonas ... [https://systemsbiology.ucsd.edu/publications/2008/genome-scale-metabolic-reconstruction-pseudomonas-putida-kt2440-ijn746-cell]
• 13. Pathway-Consensus Approach to Metabolic Network ... [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169437]
• 14. Genome-scale metabolic network model and phenome of ... [https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-023-09940-y]
• 15. Quantitative decoding of coupled carbon and energy ... [https://www.nature.com/articles/s42003-025-08723-3]
• 16. Comparison of Three Xylose Pathways in Pseudomonas ... [https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2019.00480/full]
• 17. Comparison of 432 Pseudomonas strains through ... [https://www.nature.com/articles/srep38699]
• 18. A navigation guide of synthetic biology tools for ... [https://www.sciencedirect.com/science/article/pii/S0734975021000380]
• 19. Pseudomonas putida as a functional chassis for industrial ... [https://www.sciencedirect.com/science/article/pii/S1096717618301502]
• 20. Industrial biotechnology of Pseudomonas putida: advances ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7447670/]
• 21. Reconfiguration of metabolic fluxes in Pseudomonas ... [https://www.nature.com/articles/s41396-020-00884-9]
• 22. Metabolic Engineering of Pseudomonas putida KT2440 for the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5124731/]
• 23. Flux Balance Analysis | Virginia - iGEM 2025 [https://2025.igem.wiki/virginia/fba]
• 24. Constraint-based modeling - openCOBRA [https://opencobra.github.io/MASS-Toolbox/Toolbox-HTML/html/tutorial/Constraint-based%20modeling.html]
• 25. Optimization-based framework with flux balance analysis (FBA ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12578352/]
• 26. Creating metabolic demand as an engineering strategy in ... [https://www.sciencedirect.com/science/article/pii/S2214030116300268]
• 27. Flux balance analysis [https://en.wikipedia.org/wiki/Flux_balance_analysis]
• 28. What is flux balance analysis? - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3108565/]
• 29. In-silico-driven metabolic engineering of Pseudomonas ... [https://pubmed.ncbi.nlm.nih.gov/23164576/]
• 30. Pseudomonas putida as a synthetic biology chassis and a ... [https://www.sciencedirect.com/science/article/pii/S0958166923001350]
• 31. Addressing genome scale design tradeoffs in ... [https://www.nature.com/articles/s41540-024-00480-z]
• 32. Determination of growth-coupling strategies and their underlying principles | BMC Bioinformatics | Full Text [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-019-2946-7]
• 33. Determination of growth-coupling strategies and their ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6714386/]
• 34. A growth-coupling strategy for improving the stability of ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-024-02548-1]
• 35. Synthetic C1 metabolism in Pseudomonas putida enables ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12421819/]
• 36. Systematizing the different notions of growth-coupled product synthesis and a single framework for computing corresponding strain designs - PubMed [https://pubmed.ncbi.nlm.nih.gov/34432943/]
• 37. A synthetic C2 auxotroph of Pseudomonas putida for ... [https://pubmed.ncbi.nlm.nih.gov/36155822/]
• 38. Growth-coupled selection of synthetic modules to accelerate cell factory development | Nature Communications [https://www.nature.com/articles/s41467-021-25665-6]
• 39. Adapting OptCouple to Identify Strategies with Increased ... [https://www.mdpi.com/2218-1989/15/5/309]
• 40. Engineering - | Purple - iGEM 2025 [https://2025.igem.wiki/concordia-shanghai/engineering]
• 41. Model-guided dynamic control of essential metabolic ... [https://www.sciencedirect.com/science/article/pii/S1096717621001245]
• 42. Properties, production, and modification of ... [https://www.sciencedirect.com/science/article/pii/S2667378924000051]
• 43. Production of polyhydroxyalkanoate (PHA) biopolymer from ... [https://pubs.rsc.org/en/content/articlehtml/2025/ra/d4ra08505a]
• 44. Analysis and optimization of polyhydroxyalkanoates ... [https://bmcmicrobiol.biomedcentral.com/articles/10.1186/s12866-025-04314-8]
• 45. Integrated analysis of gene expression and metabolic fluxes in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4855977/]
• 46. Microbial synthesis of polyhydroxyalkanoate blends with ... [https://www.sciencedirect.com/science/article/pii/S1871678425000603]
• 47. Microbial synthesis of polyhydroxyalkanoate blends with ... [https://pubmed.ncbi.nlm.nih.gov/40466967/]
• 48. Statistical optimisation of polyhydroxyalkanoate production in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8590663/]
• 49. In silico engineering of Pseudomonas metabolism reveals ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6301282/]
• 50. Growth independent rhamnolipid production from glucose ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/1475-2859-10-80]
• 51. Hyperproduction of Rhamnolipid in P. putida by Protein ... [https://pubmed.ncbi.nlm.nih.gov/41081329/]
• 52. Optimizing rhamnolipid bio-surfactant production in a ... [https://link.springer.com/article/10.1007/s00449-025-03224-3]
• 53. Killing Two Birds With One Stone – Strain Engineering ... [https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2020.00899/full]
• 54. Recent fermentation developments for improved rhamnolipid ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12165997/]
• 55. Genome-scale metabolic network model and phenome of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10790481/]
• 56. Combinatorial engineering pinpoints shikimate pathway ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12487284/]
• 57. Metabolic models and gene essentiality data reveal essential ... [https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006556]
• 58. Guiding the Refinement of Biochemical Knowledgebases ... [https://www.sciencedirect.com/science/article/pii/S2405471219303928]
• 59. Protocols for RecET‐based markerless gene knockout and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6922525/]
• 60. A single-plasmid-based, easily curable CRISPR/Cas9 system ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-024-02634-4]
• 61. 流平衡分析（FBA） 转载 [https://blog.csdn.net/ruby912/article/details/91398842]
• 62. 多约束代谢网络模型的研究进展 [https://actamicro.ijournals.cn/html/cjbcn/2022/2/gc22020531.htm]
• 63. Large-scale kinetic metabolic models of Pseudomonas putida ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7048048/]
• 64. 上海交大等开发细胞工厂系统化设计新工具，可预测基因改造靶点 ... [https://www.angelobiotech.com/newsshow/279.html]
• 65. 酶约束模型融合进化算法设计产物合成最优化菌株方法 [https://patents.google.com/patent/CN119418752A/zh]
• 66. Integrated analysis of gene expression and metabolic fluxes in ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0470-2]
• 67. Co-evolution of strain design methods based on flux balance ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8193246/]
• 68. Co-evolution of strain design methods based on flux ... [https://www.sciencedirect.com/science/article/pii/S2214030115000048]
• 69. A genome-scale metabolic reconstruction of Pseudomonas ... [https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-2-79]
• 70. Growth-coupled overproduction is feasible for almost all ... [https://www.nature.com/articles/ncomms15956]
• 71. OptDesign: Identifying Optimum Design Strategies in Strain ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9016760/]
• 72. Optimal knockout strategies in genome-scale metabolic ... [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-017-1483-5]
• 73. A model-driven approach to upcycling recalcitrant ... [https://www.sciencedirect.com/science/article/pii/S2211124724003073]
• 74. Systematic engineering of synthetic serine cycles in ... [https://www.sciencedirect.com/science/article/pii/S0167779925002161]
• 75. Pseudomonas putida as a platform for medium‐chain length α ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10963910/]
• 76. a solution to involution of design–build–test–learn cycle [https://www.sciencedirect.com/science/article/abs/pii/S0958166922000453]
• 77. Development and experimental verification of a genome-scale ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2728707/]
• 78. Machine learning-led semi-automated medium ... [https://www.nature.com/articles/s42003-025-08039-2]
• 79. Simulated Design–Build–Test–Learn Cycles for Consistent ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10510747/]
• 80. The knowledge driven DBTL cycle provides mechanistic ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-025-02729-6]
• 81. In silico reconstruction and experimental validation of ... [https://bioresourcesbioprocessing.springeropen.com/articles/10.1186/s40643-018-0212-x]
• 82. GC-MS-based 13C metabolic flux analysis resolves the ... [https://www.sciencedirect.com/science/article/pii/S1096717618304725]
• 83. Contribution | Tsinghua - iGEM 2025 [https://2025.igem.wiki/tsinghua/contribution]
• 84. Computer-assisted multilevel optimization of malonyl-CoA ... [https://www.sciencedirect.com/science/article/pii/S1096717625000448]
• 85. Recent advances in high-throughput 13 C-fluxomics [https://www.sciencedirect.com/science/article/abs/pii/S0958166916302373]
• 86. GC-MS-based 13C metabolic flux analysis resolves the ... [https://pubmed.ncbi.nlm.nih.gov/30831266/]
• 87. Publishing 13C metabolic flux analysis studies: A review and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5866723/]
• 88. Integrated isotope-assisted metabolomics and 13 C metabolic ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-015-0329-y]
• 89. Integration of metabolomics and other omics [https://pmc.ncbi.nlm.nih.gov/articles/PMC11659354/]
• 90. Special Issue : Integration of Proteomics and Metabolomics [https://www.mdpi.com/journal/metabolites/special_issues/MCIA46XR0S]
• 91. Metabolic impact of heterologous protein production in ... [https://pubmed.ncbi.nlm.nih.gov/37918614/]
• 92. Learning from quantitative data to understand central ... [https://www.sciencedirect.com/science/article/abs/pii/S0734975017301179]
• 93. Fluxer: a web application to compute, analyze and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7319574/]
• 94. Genome-scale modeling for metabolic engineering - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC4455951/]
• 95. Genome-scale metabolic rewiring improves titers rates and ... [https://www.nature.com/articles/s41467-020-19171-4]
• 96. Addressing genome scale design tradeoffs in Pseudomonas ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11732973/]
• 97. Quantitative Analysis of Coupled Carbon and Energy ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11974891/]
• 98. Lignin-Degrading Enzymes and the Potential of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12029670/]
• 99. Maximizing microbial bioproduction from sustainable ... [https://www.sciencedirect.com/science/article/pii/S2211124723010987]
• 100. A neural-mechanistic hybrid approach improving the ... [https://www.nature.com/articles/s41467-023-40380-0]
• 101. Synthetically-primed adaptation of Pseudomonas putida to ... [https://www.nature.com/articles/s41467-024-46812-9]
• 102. Development of a CRISPR/Cas9n-based tool for metabolic ... [https://www.nature.com/articles/s42003-020-0824-5]